COVID-19 and co-infections

COVID-19 Resource Page

Last updated Nov 30, 2021.

Events and Opportunities 
ASP Guidance and Tools
Clinical Interventions
Government and Public Health Policy and Communications
Multimedia
Perspective
Published Literature
Research Hubs

Events and Opportunities

Dec 3, 2021, event - A University of Exeter MRC Centre for Medical Mycology Myco-Clinic will focus on "Covid-19 associated fungal infections," with presentations on pulmonary aspergillosis from Joost Wauters, MD, PhD, and sinus-orbital mucormycosis from Ritu Arora, MD.

Dec 6–7, 2021, event - The 2021 Milken Institute Partnering for Patients Forum will highlight the needs, insights, and ideas generated by and for the patient community as the world continues to grapple with COVID-19 and its impact, including discussions on health equity, rare disease therapy development and access, antimicrobial resistance, and other topics.

Dec 15, 2021, event - The UK Academcy of Medical Sciences and the Department of Health and Social Care will host a virtual workshop on "Antimicrobial resistance research: learnings applied from COVID-19." Attendance is by invitation only, and a report will be available following the meeting.

Feb 15, 2022, deadline - The Journal of Fungi is accepting submissions for a special issue on "Fungal Infections and COVID-19."

Mar 20, 2022, deadline - The Journal of Clinical Medicine has issued a call for submissions to a special issue on "Recent Updates in the Management of Pneumonia and COVID-19," which aims to provide up-to-date evidence on optimal care, diagnosis, and antimicrobial stewardship for patients with respiratory infections in the context of pandemic-related changes to diagnostic and treatment strategies.

Apr 15, 2022, CE deadline - Medscape is offering an online course on "The Treatment of Secondary Bacterial Infections in Patients with COVID-19," authored by Ali Hassoun, MD. The course is valid for Continuing Education credit through Apr 15, 2022.

May 31, 2022, deadline Antibiotics issued a call for papers to be included in a special issue on "The Use of Antibiotics in COVID-19 Infections."

Jun 30, 2022, deadline BMC Infectious Diseases issued a call for papers to be included in a collection on "Impact of COVID-19 Health Policies on Other Infectious Diseases."

Jun 30, 2022, deadline Antibiotics issued a call for papers to be included in a special issue on "Clinical Infectious Diseases and Medical Education in Antimicrobial Use," with possible topics to include the impact of COVID-19 on antimicrobial use and training.

ASP Guidance and Tools

Guidance and tools for antimicrobial therapy and stewardship, including the prevention and treatment of bacterial and fungal coinfections, in COVID-19 patients

Sep 30, 2021 - The free three-part webinar series "Recognition and Management of Bacterial Pneumonia in Patients with COVID-19," hosted by the Society of Infectious Diseases Pharmacists and ProCE, is available for continuing education credit through Sep 24, 2022.

Jul 23, 2021 - The American College of Chest Physicians published an infographic on antimicrobial stewardship and COVID-19, outlining signs of co-infection, possible diagnostics, principles of antimicrobial treatment for pneumonia and septic shock, and criteria for de-escalation.

Jun 22, 2021 - The COVID-19 Real-Time Learning Network, a project of the US Centers for Disease Control and Prevention and the Infectious Diseases Society of America, updated its comprehensive literature review and resource list on co-infection and antimicrobial stewardship.

Feb 17, 2021 - The British Columbia Centre for Disease Control provides guidance on tuberculosis and COVID-19, including recommendations for infection prevention, medication management, vaccination, anxiety, and stigma.

Jan 11, 2021 - A Public Health Ontario "What We Know So Far" document summarizes research related to the prevalence and predictors of antibiotic prescribing and antimicrobial stewardship strategies in patients with COVID-19.

Nov 19, 2020 - PrescQIPP launched a data dashboard to support antimicrobial stewardship activities across the UK National Health Service during the COVID-19 pandemic.

Oct 22, 2020 - In observance of World Antibiotic Awareness Week and European Antibiotic Awarenesss Day, Public Health England published a "Resources toolkit for healthcare professionals in England in the context of the COVID-19 pandemic."

Oct 15, 2020 - Choosing Wisely Canada released a new edition of the Cold Standard Toolkit, which provides three clinical tools to support the virtual and in-person management of respiratory tract infections during the COVID-19 pandemic and cold and flu season.

Oct 7, 2020 - The Scottish Antimicrobial Prescribing Group published advice on antimicrobial use related to community respiratory infections and COVID-19, as well as advice on hospital antimicrobial stewardship during the pandemic.

Oct 5, 2020 - The Antimicrobial Stewardship Program at St. Louis Children's Hospital provides guidelines on antimicrobial treatment and guidance for the treatment of COVID-19/Multisystem Inflammatory Syndrome in Children (MIS-C).

Aug 28, 2020 - An updated document from the Duke Antimicrobial Stewardship Outreach Network describes considerations for continuation of antibiotic therapy in COVID-19 patients.

Aug 5, 2020 - In commentary for the Clinical Laborary & Standards Institute, Romney M. Humphries, PhD, Graeme Forrest, MD, and Janet A. Hindler, MT, MCLS, summarize the intersection of COVID-19 and antimicrobial resistance (AMR) and discuss the role of the clinical microbiology lab in stewardship now and in preparation for rising AMR later.

Jun 11, 2020 - On the AIMED forum, Joe Hessell, PharmD, Gaëtan Khim, MD, and Mona Kheng summarize best practices and guidelines for antimicrobial prescribing and stewardship in COVID-19 patients addressed during a recent World Health Organization Regional Office for South-East Asia webinar.

May 27, 2020 - The World Health Organization released interim guidance on the clinical management of COVID-19, which recommends against antibiotics for suspected or confirmed mild COVID-19 and against antibiotics in moderate COVID-19 unless there is suspicion of a bacterial infection.

May 12, 2020 - The Sinai Health System–University Health Network Antimicrobial Stewardship Program developed educational materials for patients on COVID-19 medication myths and the status of knowledge and research on drugs to prevent and manage COVID-19

May 1, 2020 - The UK National Institute for Health and Care Excellence released guidelines to ensure the best antibiotic management of suspected or confirmed bacterial pneumonia in hospitalized adults during the COVID-19 pandemic.

Apr 30, 2020 - In a post for the Global Antibiotic Research & Development Partnership REVIVE blog, Andrew Seaton, MBChB, MD, discusses the impact of COVID-19 on antimicrobial stewardship, outlining how providers can assess the need for empirical antibiotic therapy in COVID-19 patients and best practices for prescibing if a secondary bacterial infection is suspected, also noting that the best antimicrobial stewardship intervention will be an available SARS-CoV-2 vaccine.

Apr 24, 2020 - Ireland's Health Protection Surveillance Centre released guidance statements for antimicrobial stewardship and the diagnosis of bacterial infections in COVID-19 patient care.

Apr 10, 2020 - The Sepsis Alliance's COVID-19 information page features resources related to the prevention and management of sepsis during the COVID-19 pandemic.

Apr 1, 2020 - In a post for the British Society for Antimicrobial Chemotherapy, Andrew Seaton, MBChB, MD, outlines principles of antimicrobial prescribing and stewardship for COVID-19 patients.

Mar 30, 2020 - The COVID-19 Antimicrobial Therapy Standards Committee—a group of clinicians, pharmacologists, ethicists, and patient partners in the greater Toronto area—posted a living Google Document that summarizes clinical practice guidelines for antimicrobial, antiviral, and immunomodulatory therapy in COVID-19 patients. The most up-to-date version is hosted by the Sinai Health System–University Health Network Antimicrobial Stewardship Program.

Mar 30, 2020 - The Brown School of Public Health Center for Long-Term Care Quality & Innovation developed an infection tracking log, video tutorials, and a user guide to enable improved data collection and visualization in long-term settings. The tracking log was built to help with antibiotic stewardship programs, but it is inclusive of all data documented for infections, including respiratory diseases like COVID-19.

Mar 30, 2020 - In response to the COVID-19 pandemic, the Sinai Health System–University Health Network Antimicrobial Stewardship Program updated its diagnostic and treatment guidelines for ventilator-associated pneumonia.

Mar 20, 2020 - The Surviving Sepsis Campaign released Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).

Clinical Interventions

Studies and interventions related to identification and evidence-informed care of bacterial coinfections and drug resistance in COVID-19 patients

Feb 12, 2021 - The UK National Institute for Health Research and UK Research and Innovation announced funding for research projects to tackle COVID-19 in low- and middle-income countries, including funding for a project led by Scotland's University of St. Andrews, Tanzania's Catholic University of Health and Allied Sciences, and Uganda's Makerere University to study COVID-19 and antimicrobial resistance.

Jan 25, 2021 - The UK National Institute for Health Research reports on PRINCIPLE trial findings that azithromycin or doxycycline did not reduce recovery time or prevent hospital admission for people older than 50 with early-stage COVID-19 

Jan 7, 2021 - The Australia–Indonesia Institute announced the recipients of its COVID-19 Special Grants, including an award to Ausvet to deliver online epidemiological training to enhance Indonesia's capacity to conduct One Health surveillance of antimicrobial resistance and use.

Dec 10, 2020 - The UK National Institute for Health Research announced an award of £731,858 (about $968,705 USD) for a study led by the University of Leeds that will investigate if a procalcitonin blood test is effective in reducing antibiotics and/or improving patient outcomes in COVID-19 patients.

Nov 2, 2020 - A press release from the University of Manchester describes the adaptation of the ADAPT-Sepsis study to include seriously ill COVID-19 patients in the work to increase effectiveness and appropriateness of antibiotic prescribing for patients with suspected sepsis.

Nov 2, 2020 - Adaptive Phage Therapeutics announced a Texas deployment of its investigational PhageBank therapy in response to an outbreak of carbapenem-resistant Acinetobacter baumannii infections in COVID-19 patients.

Nov 2, 2020 - On The Conversation, Lara Marks, DPhil, and Andrew Morris, MBChB, PhD, discuss the use of a rapid diagnostic test for patients with COVID-19 and suspected ventilator-associated pneumonia in a UK intensive care unit, finding that the array card was able to identify secondary bacterial infections and affect antibiotic prescribing.

Oct 29, 2020 - In Contagion, Molly M. Miller, PharmD, et al describe the experience of implementing a polymerase chain reaction pneumonia panel at Nebraska Medicine during the COVID-19 pandemic, discussing the identification of community-acquired bacterial infections and resistance genes and the effect on antibiotic prescribing and de-escalation.

Oct 13, 2020 - Researchers from the Pan-African Network for Rapid Research, Response and Preparedness for Infectious Diseases Epidemics (PANDORA) received a $65,000 grant from the British Society for Microbial Chemistry to study the impact of COVID-19 infection prevention and control measures on transmission of hospital acquired infections and antimicrobial resistance in Sudan and Zambia.

Oct 12, 2020 - A group of public, private, and nonprofit organizations led by the African Union Commission through the Africa Centres for Disease Control and Prevention launched the Africa Pathogen Genomics Initiative, a 4-year partnership that will receive $100 million USD to expand access to next-generation genomic sequencing tools and training designed to strengthen COVID-19 and antimicrobial resistance surveillance and laboratory networks across the continent.

Sep 28, 2020 - In its September newsletter, Connecting Organisations for Regional Disease Surveillance (CORDS) highlights projects and policy activities related to surveillance for COVID-19 and antimicrobial resistance across Africa, Asia, and Europe.

Sep 28, 2020 - OpGen announced the completion of a study conducted in collaboration with Karolinska Institutet on the use of a rapid diagnostic test to identify bacterial co-infections in COVID-19 pneumonia patients. Data from the study were presented at the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Disease on Sep 24.

Sep 25, 2020 - The Toronto Antimicrobial Resistance Research Network (TARRN) is carrying out a living systematic review and meta-analysis on bacterial co-infection and secondary infection in patients with COVID-19.

Sep 2, 2020 - In the Houston Chronicle, Julie Garcia describes how members of the Tailored Antibacterials and Innovative Laboratories for Phage Research at Baylor College of Medicine have adapted their methods for bacteriophage hunting to conducting COVID-19 surveillance via wastewater and mapping areas with possible high infection rates in Houston.

Aug 27, 2020 - In news from the University of California San Diego, Heather Buschman, PhD, profiles the work of Jennifer Le, PharmD, MAS, in adapting the development of therapeutic drug monitoring programs for vancomycin to the care of critically ill COVID-19 patients in Vietnam.

Aug 24, 2020 - News from the Carolina Antimicrobial Stewardship Program highlights dramatic reductions in Clostridioides difficile (C diff) infections at UNC hospitals during the COVID-19 pandemic, noting that an infection prevention and antimicrobial stewardship workgroup will renew a series of multidisciplinary efforts to continue to prevent C diff infections.

Aug 10, 2020 - The Fleming Fund reports on progress in building antimicrobial resistance surveillance capacity and One Health partnerships in Bhutan, highlighting how cross-sector collaborations have boosted the ability to share information and equipment during the COVID-19 pandemic.

Jun 25, 2020 - News from the Carolina Antimicrobial Stewardship Program (CASP) highlights how CASP has integrated the management of remdesivir approvals, distribution, and tracking across all UNC Health hospitals into the program's daily antimicrobial stewardship processes.

Jun 11, 2020 - The Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) has adapted its protocol to allow surveillance of antimicrobial use in COVID-19 patients.

May 7, 2020 - A press release from the University of Dundee details how a team of researchers, led by James Chalmers, MBChB, PhD, has received £287,000 in funding to develop ways to rapidly diagnose bacterial co-infection and antimicrobial resistance in COVID-19 patients.

May 5, 2020 - A project based at the Oxford Biomedical Research Centre is studying the impact of SARS-CoV-2 on hospital admissions, antimicrobial prescribing, and serious bacterial infections across Oxfordshire.

Apr 21, 2020 - OpGen announced that its subsidiary, Curetis, will work with Karolinska Institutet to use Curetis' Unyvero HPN (Hospitalized Pneumonia Panel) to identify bacterial coinfections in COVID-19 patients hospitalized in intensive care units.

Apr 14, 2020 - In Horizon, Ian Le Guillou, PhD, MChem, describes how COMBACTE-NET, which has built a network of more than 300 European hospitals to run clinical trials for new antibiotics against drug-resistant pathogens, is using its existing research infrastructure to test promising treatments for COVID-19.

Government Policy and Communications

News and commentary on the governmental and policy response to antimicrobial use, access, and development in response to the COVID-19 pandemic

Nov 17, 2021 - In a briefing for the Pan American Health Organization, Director Carissa F. Etienne, MBBS, MSc, announced that countries in the Americas—notably Argentina, Ecuador, Guatemala, Paraguay, and Uruguay— are reporting surges in drug-resistant infections that may be associated with misuse of antimicrobials in the treatment of COVID-19, asking also that countries use their expanded COVID-19 surveillance systems to track antimicrobial resistance and develop evidence-based guidelines for antimicrobial use.

Nov 3, 2021 - The World Health Organization Regional Office for Europe published an infographic on AMR and COVID-19, which highlights the importance of correct diagnosis and appropriate antibiotic use and is available in Albanian, English, Romanian, Russian, Serbian, and Turkish.

Oct 31, 2021 - The G20 Rome Leaders' Declaration reaffirms commitments that may help countries recover from the COVID-19 pandemic, including a commitment to global efforts that take a One Health approach to antimicrobial resistance and stewardship, along with renewed efforts to achieve the Sustainable Development Goals and a shortened development cycle for vaccines, therapeutics, and diagnostics.

Oct 22, 2021 - The Pan American Health Organization issued an epidemiological alert on the emergence and increase of new combinations of carbapenemases in Enterobacterales in Latin America and the Caribbean during the COVID-19 pandemic.

Oct 20, 2021 - The Food and Agriculture Organization of the United Nations developed a COVID-19 Response and Recovery action sheet on food systems transformation in the context of antimicrobial resistance across Africa.

Sep 21, 2021 - Health Protection Scotland published the "Healthcare Associated Infection Annual Report 2020," which looks at healthcare-associated infection prevention, containment of antimicrobial resistance, and the impact of COVID-19 during 2020. Findings include a fairly low rate of nosocomial COVID-19 cases (2.6%, or 3,389) and an increase over the last 4 years in the incidence of healthcare-associated E coli bacteremias. Incidence for healthcare-associated Clostridioides difficile infection and Staphylococcus aureus bacteremia increased during the 2019–2020 period, with the authors noting that the effects of COVID-19 on healthcare delivery have made comparisons with previous years difficult.

Apr 15, 2021 - Ireland's Health Information and Quality Authority published inspection reports from three hospitals and one rehabilitation unit on compliance with infection prevention and control activities during the COVID-19 pandemic, finding that two of the three hospitals with antimicrobial stewardship programs in place were affected by changes in staffing resources, and that the rehabilitation unit lacked ongoing monitoring for antimicrobial stewardship activities.

Mar 3, 2021 - The Finnish Institute for Health and Welfare issued a press release on the effect of the COVID-19 pandemic on the implementation of the Nordic Council of Ministers Nordic-Russian Cooperation Programme on Antimicrobial Resistance, with the only activity that remained in progress being a study of attitudes and behaviors toward antibiotic use among clinicians and patients in northwest Russia.

Mar 2, 2021 - The Kaiser Family Foundation published a fact sheet on the US government's involvement in global tuberculosis efforts, especially as it relates to multidrug-resistant infections, highlighting that the impact of the COVID-19 pandemic will shape the next 5 years of US global tuberculosis strategies.

Feb 6, 2021 - The Pan American Health Organization issued an epidemiological alert on "Candida auris outbreaks in health care services in the context of the COVID-19 pandemic," providing guidance for national authorities on surveillance, diagnosis, infection prevention and control, screening, and case management.

Dec 28, 2020 - The Society for Healthcare Epidemiology of America, the Association for Professionals in Infection Control and Epidemiology, and the Society of Infectious Diseases Pharmacists issued a request to the US Department of Health and Human Services to suspend the use of quality measure data for healthcare-associated infections to assess reimbursement for inpatient services, citing COVID-19–related disruptions in staffing, supply shortages and reuse, and patient populations that may lead to increases in nosocomial infections and the transmission of multidrug-resistant organisms.

Dec 18, 2020 - The World Health Organization released a report on progress and coordination toward antimicrobial resistance global and national action plans over 2020, highlighting the focus on developing guidelines for appropriate antibiotic use in the context of COVID-19 and the need to continue prioritizing antimicrobial stewardship, WASH (water, sanitation, and hygiene), and infection prevention in low- and middle-income countries during the pandemic.

Dec 17, 2020 - The World Health Organization published a speech from the Director-General on the need to maintain focus on antimicrobial resistance (AMR) during the COVID-19 pandemic, as well as a summary of recent global efforts to address AMR.

Nov 16, 2020 - The US Centers for Disease Control and Prevention published an update on antibiotic use and the implementation of antibiotic stewardship programs in the US, with a focus on the effects of COVID-19. The report also includes new and updated resources for antibiotic stewardship implementation.

Oct 6, 2020 - Australia's Minister of Health, Greg Hunt, JD, MA, announced that as part of Australia's 2020-21 health budget under its COVID-19 pandemic plan, the government will be providing more than $22.5 million to continue antimicrobial use and resistance surveillance, along with furthering Australia's national antimicrobial strategy.

Sep 14, 2020 - The opening of the reorganized and renamed Korea Disease Control and Prevention Agency (KDCA) highlighted KDCA's focus on containing the resurgence of COVID-19 and playing a stronger role in infectious disease response, including efforts to improve antimicrobial resistance management capacity and the management of drug-resistant tuberculosis.

Aug 12, 2020 - The Infectious Diseases Society of America, the Cystic Fibrosis Foundation, the American Society for Microbiology, the Pew Charitable Trusts, and Trust for America's Health wrote a letter urging US Congressional leaders to consider antimicrobial resistance as a component of the COVID-19 response

May 1, 2020 - The World Health Organization announced a collaboration with the European Investment Bank to support countries in addressing the health impact of COVID-19, beginning with initiatives to address urgent needs and strengthen primary health care in ten African countries and including cooperation to address funding for solutions to antimicrobial resistance and investment barriers to new antimicrobials and diagnostics.

Mar 23, 2020 - In the Dhaka Tribune, Kamrul Hasan reports on government officials' request that members of the public in Bangladesh refrain from unprescribed use of antibiotics to treat suspected or confirmed COVID-19.

Multimedia

Podcasts, webinars, infographics, and other educational resources that address the connections between COVID-19 and antimicrobial resistance and stewardship

Nov 21, 2021 - On Contagion, John Parkinson speaks with Priya Nori, MD, Cornelius Clancy, MD, and Jacinda Abdul-Mutakkabir, PharmD, MPH, about how antibiotic prescribing practices have changed during the pandemic.

Nov 11, 2021 - On Contagion, Nina Cosdon interviews Nicola Petrosillo, MD, about the prevalence of and risk factors for Clostridioides difficile infection in Italian hospitals during the COVID-19 pandemic.

Nov 2, 2021 - The Centre of Regulatory Excellence at Duke-National University of Singapore posted a recording of the "Managing Antimicrobial Resistance in Asia: Identification & Implementation of Breakthrough Solutions" webinar, which highlights the impact of COVID-19 on antimicrobial resistance work across Asia and ways of moving forward, with faciliation from John Lim, MBBS, MS, SM, and presentations from Hsu Li Yang, MBBS, MPH, Fabio La Mola, MBA, Lin Yueh Nuo, PhD, and Barry Weinman, MPH, MBA.

Oct 29, 2021 - In an American Society for Microbiology video, Cesar A. Arias, MD, PhD, MSc, Sevtap Arikan-Akdagli, MD, Bhavarth Shukla, MD, MPH, and Dimitrios P. Kontoyiannis, MD, ScD, PhD, discuss "Candida auris at the Intersection of the COVID-19 Pandemic."

Oct 12, 2021 - On the Association for Professionals in Infection Control and Epidemiology "5-second Rule" podcast, host Silvia Quevedo, MS, speaks with Allison Weinmann, MD, about antimicrobial stewardship during the COVID-19 pandemic.

Sep 30, 2021 - In the recording of a Philippine One Health University Network webinar, Flor Marie Immanuelle R. Pilapil-Amante, DVM, MSc, presents on "Antimicrobial Resistance: How It Fits in the COVID-19 Picture."

Sep 28, 2021 - The Global Antibiotic Research & Development Partnership posted a recording and a summary of a dialogue on lessons learned from COVID-19 that may help the international community address antimicrobial resistance.

Sep 22, 2021 - A discussion between Jenelle Krishnamoorthy, PhD, MS, and Steve Morrison, PhD, at the Concordia Annual Summit highlights the importance of maintaining focus on antimicrobial resistance during the COVID-19 pandemic.

Sep 14, 2021 - In a Commonwealth Pharmacists Association webinar, Diane Ashiru-Oredope, MPharm, PhD, MPH, and Victoria Rutter, MPharm, lead a discussion on the role of the Commonwealth Health Partnerships on Antimicrobial Stewardship in supporting the COVID-19 response in Ghana, Tanzania, Uganda, and Zimbabwe.

Sep 1, 2021 - In an Xtalks Life Science podcast, Sarah Hand, MSc, Sydney Perelmutter, MJ, and Mira Nabulsi, MJ, discuss the importance of surveillance in preventing increases in antimicrobial resistance and the link between COVID-19 and bacterial co-infections.

Sep 1, 2021 - On Contagion, John Parkinson speaks with Priya Nori, MD, about Montefiore Health System's experience in providing care during infectious disease outbreaks, including Ebola and COVID-19, highlighting the importance of paying attention to other pathogens, notably Candida auris, during the pandemic.

Aug 18, 2021 - In an Ethics Talk for the AMA Journal of Ethics, host Audiey Kao, MD, PhD, speaks with Olivia Kates, MD, about the ethics of antibiotic use during the COVID-19 pandemic.

Aug 3, 2021 - A World Health Organization Regional Office for the Western Pacific video describes how the "Stewards for the Future" program adapted 2020 World Antibiotic Awareness Week activities to COVID-19 restrictions and concerns.

Aug 2, 2021 - In an American Society for Microbiology video inspired by a Reddit Ask Me Anything discussion, Azeem Ahmad, PhD, discusses associations between COVID-19, hand sanitizer use, and antibiotic resistance, as well as issues concerning animal antibiotic use, bacteriophages, and actions that individuals can take against antimicrobial resistance.

Jul 26, 2021 - In a recording of a webinar hosted by the Global Health Network, a panel introduces the AMR Knowledge Hub, discusses research and knowledge gaps that must be addressed for an effective global response to antimicrobial resistance, and describe how lessons learned from the pandemic response could be applied to reducing AMR risks in low- and middle-income countries.

Jul 15, 2021 - In a presentation for the Antimicrobial Resistance Centre at the London School of Hygiene & Tropical Medicine, Laura Piddock, PhD, discusses "Tackling the silent antimicrobial resistance pandemic: what can be learnt from the global response to COVID-19."

Jul 6, 2021 - In Center for Strategic & International Studies Pandemic Planet podcast, J. Stephen Morrison, PhD, speaks with Dame Sally Davies, MBChB, MSc, about how COVID-19 has shown a light on efforts against antimicrobial resistance as a key element of global health security.

Jul 2, 2021 - In an IDPodcasts presentation, Suhel Sabunwala, MBBS, speaks about the relationships between COVID-19 and secondary bacterial infections, antimicrobial use and stewardship, and the antimicrobial supply chain.

Jul 1, 2021 - In a brief video for ReAct, Anthony D. So, MD, MPA, describes how lessons learned from the COVID-19 pandemic can inform a better understanding of antimicrobial resistance.

Jun 30, 2021 - In a ThermoFisher Scientific and SelectScience webinar, Ron Daniels, MB ChB, describes links between sepsis and COVID-19 and discusses the compatibility between progress on sepsis and antimicrobial resistance.

Jun 28, 2021 - The British Society for Antimicrobial Chemotherapy offers an online course on "Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship," which, in part, educates users on the connections between COVID-19 and procalcitonin testing.

Jun 22, 2021 - In a presentation for the Antibiotic Stewardship and Prevention of Infection in Communities (ASPIC) Yuvaraja's College Chapter, Mysore, Anusha Rohit, MD, PhD, describes issues associated with inappropriate antibiotic use for COVID-19 patients.

Jun 10, 2021 - In a webinar hosted by Medpace, Brian Murphy, MD, Jennifer Schneider, PhD, and Daniel F. Sahm, PhD, discuss "Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance—Lessons Learned during the COVID Pandemic."

Jun 1, 2021 - On Contagion, John Parkinson speaks with Armani Hawes, MD, and Payal K. Patel, MD, MPH, about a study they led to examine changes in Clostridioides difficile testing and infection rates during the first wave of the COVID-19 pandemic at a Michigan hospital.

May 26, 2021 - The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) posted a summary and recording of its second global meeting, highlighting the implications of COVID-19 on global antimicrobial resistance surveillance, the need to strengthen links between surveillance and clinical data, and more.

May 13, 2021 - In Pharmacy Practice News, Debra A. Goff, PharmD, speaks about the challenge of negotiating the need for antimicrobial stewardship and the demands of care for COVID-19 patients during the pandemic.

May 10, 2021 - In a webinar hosted by the American Hospital Association and sponsored by BD, Eddie Stenehjem, MD, MSc, Rebekah Moehring, MD, MPH, and Kalvin Yu, MD, discuss "Antimicrobial Stewardship and HAI Prevention: Insights from COVID-19."

Apr 27, 2021 - In a Wolters Kluwer Health webinar moderated by Liz Tomsik, PharmD, and Bill Alvarez, PharmD, Sarah Wieczorkiewicz, PharmD, and Emily Heil, PharmD, highlight lessons learned from antimicrobial treatment of patients with COVID-19 to lay out a roadmap and case studies for improved and patient-centered antimicrobial stewardship.

Apr 13, 2021 - In a recording of a LabRoots webinar, Christian Giske, MD, PhD, discusses factors involved in diagnosing bacterial pneumonia in COVID-19 patients, and Drew Bell, PhD, describes complex case studies of lower respiratory tract bacterial infection and rapid molecular diagnostic testing.

Apr 8, 2021 - On the Society for Healthcare Epidemiology of America "Rapid Response" podcast, host Jennifer Hanrahan, DO, speaks with David van Duin, MD, PhD, about current knowledge related to COVID-19 and antimicrobial resistance.

Mar 30, 2021 - The British Society for Antimicrobial Chemotherapy posted a recording of the webinar "The impact of Covid-19 on chronic wound management and the effect on antimicrobial stewardship," co-hosted by the European Wound Management Association and featuring presentations from Karen Ousey, PhD, MA, Leanne Atkin, PhD, MHSc, Ojan Assadian, MD, and Jonathan Sandoe, MBChB, PhD.

Mar 30, 2021 - The Global Antibiotic Research and Development Partnership posted a recording and slides from the webinar "Learning from COVID-19 to tackle the silent pandemic of antibiotic resistance," featuring presentations from Manica Balasegaram, BM BS, MSc, Joanne Liu, MD, and Marc Mendelson, MBBS, PhD. 

Mar 10, 2021 - ReAct Africa and Students Against Superbugs–Africa posted a recording of presentations on "Research on the Silent Pandemic (Antimicrobial Resistance) amidst COVID-19," featuring presentations from Mirfin Mpundu, BPharm, MPH, MBA, Tapfumanei Mashe, and Freddy Eric Kitutu, PhD, MS.

Mar 8, 2021 - In a podcast for the University of South Wales, Emma Hayhurst, PhD, speaks about how some mitigation efforts, such as antibiotic use and increased use of antimicrobial cleaning products, associated with the COVID-19 pandemic may exacerbate antimicrobial resistance.

Mar 1, 2021 - In an episode of The Doctor's Kitchen podcast, Ravina Kullar, PharmD, MPH, describes how her experiences with drug resistance inspired her career in infectious diseases and discusses current science on COVID-19 and co-infections, also noting the need for improved investagations into the relationship between the pandemic and antimicrobial use and resistance.

Feb 25, 2021 - The American Hospital Association posted a recording of a webinar on "Antimicrobial Stewardship and HAI Infection Prevention: Insights from COVID-19," featuring presentations from Kalvin Yu, MD, Rebekah Moehring, MD, MPH, and Edward A. Stenehjem, MD, MSc.

Feb 23, 2021 - The European Society of Clinical Microbiology and Infectious Diseases posted a recording of a symposium on COVID-19 and antimicrobial stewardship, chaired by Jeroen Schouten, MD, PhD, and Jose Ramon Pano-Pardo, MD, and featuring presentations from Timothy M. Rawson, MBBS, PhD, Paul Verweij, MD, Larissa May, MD, MSPH, and Céline Pulcini, MD, PhD.

Feb 18, 2021 - In a Birkbeck Inspires lecture, Sanjib Bhakta, DPhil, PhD, MSc, discusses "Antimicrobial Drug Resistance in the COVID-19 Pandemic and Beyond..."

Feb 17, 2021 - On the Scientists' Channel, Romney Humphries, PhD, describes the effects of the COVID-19 pandemic on antimicrobial resistance and supply chain shortages in clinical laboratories.

Feb 15, 2021 - The International Alliance of Patients' Organizations posted a recording from the 2nd Asia Pacific Patients Congress on "Antimicrobial Resistance—what can we expect from the COVID-19 pandemic?," featuring presentations from Neda Milevska-Kostova, MPharm, PhD, MCPPM, MSc, Jay Purdy, MD, PhD, Tim Jinks, PhD, and Sundeep Sarin, PhD, MBA, MTech, MS.

Feb 6, 2021 - On the "Science is fun!" podcast, host Peter Turnbaugh, PhD, speaks with Gerry Wright, PhD, about what COVID-19 has revealed about research and investment needs in antimicrobial resistance and infectious diseases.

Jan 26, 2021 - In an Infectious Diseases Society of America "Let's Talk ID" podcast, Barbara Alexander, MD, speaks with Amanda Jezek about how infectious diseases physicians can help shape policy on antimicrobial resistance and physician compensation during the COVID-19 pandemic.

Jan 12, 2021 - In an Association for Professionals in Infection Control and Epidemiology (APIC) "5 Second Rule" podcast, host Silvia Quevedo, MS, speaks with Ann Marie Pettis, RN, BSN, on plans for infection control, including a rededication to antimicrobial stewardship, after the pandemic, along with APIC's new #PreventtheSpreadPledge campaign.

Jan 12, 2021 - In a California Prevention Training Center "Speaking Frankly: The State of Sexual Health" podcast, host Jennifer Rogers, MA, speaks with George Rutherford, MD, about parallels between HIV and COVID-19 research and response, COVID-19 vaccine availability in the US, and the role of prevention in the future of antimicrobial resistance.

Dec 31, 2020 The Irish Medication Safety Network posted slides from a presentation given by Sarah Fenton, MPharm, MSc, on "Delivering Antimicrobial Stewardship Education during the COVID-19 Pandemic," which highlights a "bite-sized" approach to delivering new antimicrobial guidelines at an Irish maternity hospital during the pandemic.

Dec 22, 2020 - The Pan American Health Organization developed a short video on the connections between COVID-19, antibiotic use, and antimicrobial resistance.

Dec 22, 2020 - The Scottish Antimicrobial Prescribing Group posted presentations from a meeting on addressing current challenges in antimicrobial stewardship, including presentations on the impact of the COVID-19 pandemic on antibiotic use in Scotland, antibiotic prescribing in patients with suspected COVID-19 in Scottish acute care hospitals, antimicrobial stewardship challenges from NHS Lothian and Tayside, and more.

Dec 14, 2020 - In a webinar hosted by the Society for Academic Emergency Medicine, Larissa May, MD, MSPH, presents on "Antimicrobial Stewardship in the Emergency Department in the Era of COVID-19."

Dec 3, 2020 - The International Vaccine Institute posted the recording of a webinar on "Evidence to Action: Advancing the Antimicrobial Resistance Agenda during a Pandemic," which was co-hosted by the International Centre for Antimicrobial Resistance Solutions and the Embassy of Denmark in Korea and featured presentations from Park Neung-hoo, PhD, MA, Magnus Heunicke, Dame Sally Davies, MBChB, MSc, and Hanan H. Balkhy, MD, along with moderation from Sabiha Essack, BPharm, MPharm, PhD.

Nov 30, 2020 - City University of London posted a recording of a webinar on "Involvement of nurses in antimicrobial stewardship: an essential component to the COVID-19 response," presented by Enrique Castro Sanchez, PhD, and hosted by the Infection Prevention Society.

Nov 22, 2020 - In a webinar for Australia's National Centre for Antimicrobial Stewardship and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Krispin Hajkowicz, MBBS, chairs a panel on COVID-19, regional antimicrobial stewardship, and antibiotic development.

Nov 20, 2020 - In a video for the Alliance for the Prudent Use of Antibiotics, Jeroen Schouten, MD, PhD, discusses antimicrobial stewardship in acute and critical care during COVID-19.

Nov 19, 2020 - On the Society for Healthcare Epidemiology of America podcast, Jennifer Blumenthal, MD, Jennifer Hanrahan, DO, MSc, Jessina McGregor, PhD, Cara Varley, MD, and Holly Villamanga, MD, review news, guidelines, and case studies related to bacterial co-infections in COVID-19 patients.

Nov 18, 2020 - VALUE-Dx provides communications and advocacy materials on antibiotic use during COVID-19, as well as the importance of diagnostics for COVID-19 and bacterial infections.

Nov 11, 2020 - In an episode of MSD's "The Steward," host Mark Johnson speaks with Sunny Kaul, MBBS, PhD, MSc, about the impact of COVID-19 on antimicrobial stewardship.

Nov 10, 2020 - In a webinar hosted by the Intensive Care Society, Sara Scott, MBBS, moderates a discussion among Andrew Waldon, MBBS, PhD, Abid Hussain, MBChB, and Stephanie Thomas, MBChB, MSc, about antimicrobial use in intensive care, particularly as it relates to COVID-19 patients and patients receiving extracorporeal membrane oxygenation (ECMO). 

Nov 6, 2020 - In a World Health Organization "Science in 5" video, host Vismita Gupta Smith, MA, speaks with Hanan Balkhy, MD, about the role of antibiotic prescribing and resistance during COVID-19

Nov 5, 2020 - In a bioMérieux video, Mark Miller, MD, MSc, describes the importance of remembering that antimicrobial resistance is an ongoing problem during the COVID-19 pandemic.

Oct 29, 2020 - In a webinar hosted by European Health Forum Gastein and organized by MSD, Jacki Davis moderates a discussion on "AMR and COVID-19: How can Europe incentivise R&D to protect our future?," featuring an interview with Cristian-Silviu Buşoi, PhD, about the role of the European Parliament in antibiotic research and development, a presentations from Christine Årdal, PhD, and a panel discussion among Jeremy Knox, MSc, Jenelle Krishnamoorthy, PhD, MS, and John Ryan about incentives for new antibiotics. 

Oct 28, 2020 - In the recording of a webinar hosted by Choosing Wisely Canada and the College of Family Physicians of Canada, Doreen Day, MHSc, moderates presentations from Jerome Leis, MD, MSc, and Allan Grill, MD, MPH, on "A Practical Approach to Managing RTIs in the Era of COVID-19 and Virtual Care: How can we continue to use antibiotics wisely in primary care?"

Oct 27, 2020 - The Pan American Health Organization posted communications materials for World Antibiotic Awareness Week 2020, including social media cards on antimicrobial resistance and COVID-19.

Oct 23, 2020 - On an EMG (European Medical Group) Health podcast, host Jonathan Sackier, MBChB, speaks with Sabiha Essack, BPharm, MPharm, PhD, about antibiotic overprescribing, antimicrobial resistance, the difference between management of COVID-19 patients in inpatient and outpatient settings, and resource allocation in health systems during the COVID-19 pandemic.

Oct 22, 2020 - In a "Science with Sam" YouTube video, Samantha Henry, PhD candidate at the Institute of Structural and Molecular Biology, and Karina Caetano, MRes, raise awareness of the ways in which the COVID-19 pandemic may affect antimicrobial resistance. 

Oct 20, 2020 In a recording of a Erasmus+ PREVENT IT: Risk Management and Prevention of Antibiotics Resistance webinar, Carlos Palos, MD, discusses "Challenges of Infection Prevention & Control and Antimicrobial Stewardship during the COVID-19 Pandemic."

Oct 19, 2020 - In a Global Strategy Lab video, Lindsay Wilson, MSc, provides insight into a recent commentary in Globalization and Health that examined lessons from the COVID-19 pandemic that can be applied in preparation for possible societal, economic, political changes wrought by rising antimicrobial resistance.

Oct 15, 2020 - An archived webcast and PDF presentations from the 2-day virtual Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) meeting on "Antimicrobial Resistance and COVID-19" are available to view and download.

Oct 13, 2020 - A recording of the first webinar in the "AMR in the Light of COVID-19" series is now available to view. Join Dame Sally Davies, MBChB, MSc, as she moderates a conversation on "The global movement of microorganisms: Tracking the spread of difficult-to-treat infections" among our Director Michael Osterholm, PhD, MPH, and Hanan Balkhy, MD, John Nkengasong, PhD, and H. Rogier van Doorn, MD, PhD. The webinar series is hosted by the Antimicrobial Resistance Fighter Coalition, in partnership with CIDRAP, the American Society for Microbiology, Wellcome, the Surveillance and Epidemiology of Drug-resistant Infections Consortium, and the US Centers for Disease Control and Prevention.

Oct 6, 2020 - On the US Food and Drug Administration's FDA Insight podcast, host Anand Shah, MD, speaks with Steve Solomon, DVM, about the One Health approach to antimicrobial resistance (AMR) and the impact of the COVID-19 pandemic on AMR.

Sep 29, 2020 - In a Boston University School of Public Health, Karen Weintraub, MA, speaks with Muhammad Zaman, PhD, about the high use of antibiotics and the timescale of antibiotic resistance in the context of the COVID-19 pandemic and government action.

Sep 24, 2020 - In a recording of a London School of Hygiene & Tropical Medicine–Charité Global Health Lecture Series webinar, Dame Sally Davies, MBChB, MSc, Petra Gastmeier, MD, Jyoti Joshi, MD, MSc, and Veronika von Messling, DVM, DrMedVet, discuss "AMR beyond COVID-19: How can a 'One Health' approach lead to building back better?"

Sep 24, 2020 - On the Society for Healthcare Epidemiology of America podcast, in collaboration with the Infectious Diseases Society of America, Payal Patel, MD, MPH, and Emily Spivak, MD, speak about the value of antimicrobial stewardship programs during the COVID-19 pandemic.

Sep 23, 2020 - Recordings from the two-day US Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria meeting to discuss the intersection of COVID-19 and antimicrobial resistance are available to view. [Part 1] [Part 2] [Part 3] [Part 4]

Sep 22, 2020 - A recording of the Joint Programming Initiative on AMR webinar on "How do we simultaneously manage the acute COVID-19 pandemic and escalating antibiotic resistance?" with Constance Schultz, MD, PhD, Charu Kaushic, PhD, Steven Hoffman, JD, PhD, MA, Margo Warren, MA, Ghada Zoubiane, PhD, Sabiha Essack, BPharm, MPharm, PhD, Otto Cars, MD, PhD, and Ramanan Laxminarayan, PhD, MPH, is available to view online.

Sep 22, 2020 - On Contagion, Grant M. Gallagher speaks with Debra Goff, PharmD, about antibiotic over-prescribing early during the COVID-19 pandemic and how clinicians can apply lessons learned to improve patient care and antimicrobial stewardship.

Sep 10, 2020 - In a CIDRAP-ASP Stewardship Spotlight podcast, host Marnie Peterson, PharmD, PhD, speaks with CIDRAP-ASP research associate Natalie Vestin, MPH, about Vestin's journey to public health, her work in communicating scientific information to a broad audience, and the impact of COVID-19 on antimicrobial stewardship.

Sep 8, 2020 - A recording of the webinar "Civil Society Organizations' Support for Antimicrobial Resistance Control during COVID-19 Pandemic," hosted by ReAct Africa and the Africa Centres for Disease Control and Prevention, features presentations from Esteller Mbadiwe, MPharm, MSc, Tapiwanashe Kujinga, LLB, LLM, Vanessa Carter, and Julian Nyamupachitu, MSc. 

Sep 8, 2020 - In a Coda Cure podcast, Elizabeth Hermsen, PharmD, MBA, speaks on "The Resistance—Antmicrobial Resistance through a COVID-19 Lens."

Sep 7, 2020 - In a Coda Cure podcast, Derek Angus, MD, MPH, speaks on "Pandemic Sepsis Research through a COVID-19 Lens—Are We Failing?"

Aug 20, 2020 - In a question-and-answer session hosted by EducationPlus, CIDRAP-ASP Advisory Committee member Jason Newland, MD, MEd, discusses concerns raised about COVID-19 and children.

Aug 11, 2020 - The British Society for Antimicrobial Chemotherapy (BSAC) features an interview with Alexandre Costa, PhD, about the particular threat posed to young children by drug-resistant infections, along with efforts undertaken by UNICEF to work with civil society organizations to prevent and manage antimicrobial resistance, antibiotic overuse during the pandemic, and service disruptions related to COVID-19.

Aug 5, 2020 - The Pan American Health Organization (PAHO) published an infographic on antimicrobial resistance and COVID-19, highlighting the importance of testing and appropriate antibiotic therapy.

Jul 29, 2020 - On PBS NewsHour, correspondent Paul Solman features perspectives on the barriers faced by antibiotic developers, also highlighting the possible contributions of the COVID-19 pandemic on antimicrobial resistance rates and the antibiotic pipeline.

Jul 27, 2020 - In a recording of a webinar hosted by the European Molecular Biology Laboratory, Alison Holmes, MD, MPH, MA, discusses "Antimicrobial use, antimicrobial resistance and COVID-19."

Jul 24, 2020 - A recording of a briefing to the US Congress on antimicrobial resistance and COVID-19, hosted by the Infectious Diseases Society of America, in partnership with BIO, Cystic Fibrosis Foundation, Duke-Margolis Center for Health Policy, Partnership to Fight Infectious Disease, and the Pew Charitable Trusts, is now available to view online.

Jun 30, 2020 - The British Society for Antimicrobial Chemotherapy (BSAC) features an interview with Hanan Balkhy, MD, World Health Organization Assistant Director-General for Antimicrobial Resistance (AMR), about how new global AMR data will be used and the possible impacts of the COVID-19 pandemic on future AMR rates.

Jun 17, 2020 - On NPR's Fresh Air, host Terry Gross speaks with CIDRAP-ASP Director Michael Osterholm, PhD, MPH, about risk and uncertainty surrounding US states' decisions to reopen, the politicization of and governmental response to public health issues, concerns surrounding antimicrobial resistance, along with more timely issues.

Jun 1, 2020 - In the Public Health On Call podcast from Johns Hopkins Bloomberg School of Public Health, host Josh Sharfstein, MD, speaks with Julie Gerberding, MD, MPH, on why emerging infectious diseases are an ongoing threat and ways in which the COVID-19 pandemic may contribute to increasing antimicrobial resistance.

May 16, 2020 - In an Infectious Diseases Society of America podcast on "COVID-19: Secondary Infections," host Nadia Singh, MBA, speaks with Helen Boucher, MD, and Neil Clancy, MD, about the prevention and management of secondary bacterial infections during COVID-19 illness and recovery.

May 15, 2020 - The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antimicrobial Stewardship (ESGAP) hosted a webinar on "Antimicrobial Stewardship in COVID-19 Times."

May 13, 2020 - In a BBC Radio Merseyside interview, host Tony Snell speaks with Adam Roberts, PhD, about secondary infections and antibiotic use in patients who have COVID-19, also addressing any consequences for antimicrobial resistance.

May 12, 2020 - On a Pharmacy in Practice podcast, host Johnathan Laird, MPharmS, speaks with Stephen Hughes, MPharm, MSc, MBA, about COVID-19 and the future of antibiotic use and development.

May 7, 2020 - A recording of the webinar "AMR in a post-pandemic world," featuring presentations from Mirfin Mpundu, BPharm, MPH, MBA, Susan Nayiga, MSc, and Chinyere Okoro, PhD, MSc, and hosted by the London School of Hygiene & Tropical Medicine Antimicrobial Resistance Centre is now available to view.

May 7, 2020 - ReAct Africa and Africa Center for Disease Control and Prevention hosted a discussion on "Reflections on post COVID-19 & global health including lessons for future responses to pandemics and antimicrobial resistance," featuring presentations from Tim Jinks, PhD, Otto Cars, MD, PhD, Patricia Geli, PhD, MPhil, MSc, Stefan Peterson, MD, PhD, and Robert Skov, MD.  

May 1, 2020 - As part of the ReAct Africa and Africa Center for Disease Control and Prevention COVID-19 webinar series, Caline Mattar, MD, discussed COVID-19 and antimicrobial resistance [Slides].

Apr 27, 2020 - In a Centre for Policy Research ThoughtSpace podcast, hosts Yamini Aiyar, MA, MSc, and and Jishnu Das, PhD, speak with Madhukar Pai, MD, PhD, Nandita Venkatesan, MA, and Sarthak Rastogi, MD, about the effect of COVID-19 and the resulting lockdowns in disrupting diagnoses of tuberculosis and access to medications in India

Apr 13, 2020 - In a Society of Infectious Diseases Pharmacists Breakpoints podcast, host Erin McCreary, PharmD, speaks with Julie Ann Justo, PharmD, MS, and Jason Pogue, PharmD, about efforts to interpret data on potential COVID-19 treatments, the changing roles and duties of antimicrobial stewardship professionals, and the importance of communication and information-sharing in provider knowledge and patient care.

Apr 10, 2020 - In a COVID-19 Update podcast series hosted by the Society for Healthcare Epidemiology of America, experts discuss questions related to personal protective equipment, diagnostic testing, healthcare surge planning, and the involvement of antimicrobial stewardship programs.

Perspective 

Perspective, commentary, and opinion on the connections between COVID-19 and antimicrobial resistance, bacterial and fungal coinfections, global antimicrobial drug access and shortages, and antimicrobial research and development

Nov 24, 2021 Down to Earth published a report Antibiotic Awarenes Week 2021: A pandemic within the pandemic highlighting increased antibiotic consumption during the pandemic.

Nov 24, 2021 - In Down to Earth, Nafis Faizi, MBBS, describes how irrational antibiotic use was more prominent in strained healthcare systems during the pandemic.

Nov 22, 2021 - The European Public Health Alliance published a policy brief on the interplay between COVID-19 and antimicrobial resistance, exploring the direct and indirect impacts of responses to the pandemic relevant to antimicrobial resistance, along with policy and political reactions to those impacts.

Nov 19, 2021 - In a medRxiv preprint, Aleksandra J. Borek, PhD, MA, et al interview general practitioners in England about the impact of the COVID-19 pandemic on antibiotic prescribing and stewardship in community care.

Nov 19, 2021 - A press release from the Global Hygiene Council highlights the importance of maintaining pandemic-related hygiene practices as a tool to prevent antimicrobial resistance.

Nov 18, 2021 - Quality of Care NL, a collaborative effort between healthcare entities in Newfoundland and Labrador, published data on antibiotic prescribing across the province during the pandemic.

Nov 18, 2021 - In a Q&A session for Aotearoa New Zealand's Science Media Centre, Kristin Dyet, PhD, Jack Heinemann, PhD, Dame Juliet Gerrard, DPhil, Nigel French, BVSc, PhD, MSc, Htin Lin Aung, PhD, and Joanna McKenzie, BVSc, PhD, discuss the scale of antimicrobial resistance on Aotearoa New Zealand and the effects of the COVID-19 pandemic on antimicrobial stewardship efforts.

Nov 17, 2021 - In Infectious Disease Special Edition, Ethan Covey describes the experience of a US hospital in addressing an outbreak of Corynebacterium striatum associated with a surge of patients during the COVID-19 pandemic and lapses in infection prevention and control practices. The research was presented by Janice J. Kim, MD, at the IDWeek 2021 virtual meeting.

Nov 17, 2021 - On Down to Earth, Aravind Reghukumar, MD, highlights progress to increase One Health antibiotic literacy across the Indian state of Kerala as part of the the Kerala Antimicrobial Resistance Strategic Action Plan, outlining the impact of the COVID-19 pandemic on the plan's objectives, as well as the impact of the plan on infections prevention and antimicrobial stewardship practices during the pandemic.

Nov 17, 2021 - The Financial Express summarizes viewpoints from a Tata Institute for Genetics and Society webinar on connections between antimicrobial resistance and COVID-19 across India, focusing on potential areas for increased focus and investment.

Nov 1, 2021 - On Devex, Olanike Adeyemo, DVM, PhD, MVPH, discusses the need for a greater focus on antibiotic use and resistance in the agricultural sector, along with cross-disciplinary practices that focus on sustainable interventions, highlighting several lessons learned on antibiotic and biocide misuse during the pandemic.

Oct 26, 2021 In a Research Square preprint, Dr. Gianluca Zuglian et al assess changing patterns of prevalence and resistance in bacterial and fungal co-infections in COVID-19 patients in an Italian hospital.

Oct 25, 2021 - In Stat, Muhammad H. Zaman, PhD, Ravi Sundaram, PhD, MS, and Walter Gabriel, MPH, discuss the impact of falsified or substandard medications on controlling COVID-19 transmission, also highlighting the effect of the problem on antibiotic resistance and the potential for using the prevalence of substandard medications in certain areas as a drug resistance surveillance tool.

Oct 18, 2021 - On the Reflections on Infection Prevention and Control blog, Jon Otter, PhD, sets forth five infection prevention and control priorities for the next 3 to 5 years, the first being antimicrobial stewardship, followed by digital systems to enhance clinical services and the prevention of gram-negative bloodstream infections, surgical-site infections, and SARS-CoV-2 hospital transmission.

Oct 12, 2021 - On the Johns Hopkins Bloomberg School of Public Health Global Health NOW site, Manica Balasegaram, BM BS, MSc, and Souha S. Kanj, MD, describe the challenges faced by low- and middle-income countries in the context of the COVID-19 pandemic, antibiotic over-prescribing, and both unregulated and limited access to antibiotics.

Oct 11, 2021 - In a Research Square preprint, Ruwandi M. Kariyawasam, PhD, et al conduct a review of 38 studies and a meta-analysis of drug-resistant co-infections in patients with COVID-19 in various hospital and geographic settings.

Sep 30, 2021 - In a commentary for the British Society for Antimicrobial Chemotherapy, Louise Sweeney, MBChB, describes how the focus on population health and the lack of "quick fixes" during COVID-19 can help drive awareness of antimicrobial resistance

Sep 30, 2021 - On Contagion, John Parkinson describes a study presented at IDWeek 2021 on the incidence of co-infections and antimicrobial use in hospitalized COVID-19 patients who received care in 3 US hospitals in early 2021.

Sep 29, 2021 - In Infectious Disease Special Edition, David Wild reports on a poster presented at IDWeek 2021 that highlighted an initial rise in antibiotic use during the COVID-19 pandemic followed quickly by a decrease to sustained pre-pandemic levels across 110 Veterans Affairs hospitals, 108 of which care for the most complex and high-risk patients.

Sep 28, 2021 - The Stop TB Partnership released new data showing how the COVID-19 pandemic and low levels of funding represent the main barriers to ending tuberculosis (TB) by 2030, noting that the number of people receiving treatment for TB dropped by 21% in 2020.

Sep 15, 2021 - In a MedRxiv preprint, Hani Abdel Hafez Naseef Shtaya, PhD, et al describe bacterial and fungal co-infections among 321 COVID-19 patients in a Palestinian intensive care unit, finding a relatively high rate of bacterial co-infection (51.1%) and a 48.9% rate of fungal co-infection caused by Aspergillus fumigatus.

Sep 13, 2021 - In a profile for the University of Wisconsin-Madison School of Pharmacy, Mary Magnuson speaks with Lucas Schulz, PharmD, about his work in antimicrobial stewardship as the clinical coordinator for infectious disease at UW Health, highlighting an emphasis on appropriate antimicrobial use in COVID-19 guidelines and a practical assessment of the use of oritavancin to prevent long hospital stays during the pandemic

Sep 9, 2021 - On Open Access Government, Luke S. P. Moore, MBChB, PhD, MSc, describes workforce and structural changes that may optimize infection control and prevention of drug resistance in a post-pandemic future in which COVID-19 may become endemic, highlighting possible improvements to infrastructure and greater investment in training and supporting infection specialists in the management of drug-resistant and healthcare-associated infections.

Sep 8, 2021 - The Global Fund published a report on the impact of the COVID-19 pandemic on HIV, tuberculosis (TB), and malaria in 2020, finding significant declines in the percentage of people treated for drug-resistant TB and HIV/TB co-infections and reductions in activities to prevent malaria infection and testing.

Sep 2, 2021 - In The i, Beauty Dhlamini describes the role that global vaccine inequality may play in antimicrobial resistance, considering reports of high rates of antibiotic empirical therapy for suspected co-infections and disruptions to supply chains and healthcare access across the Global South.

Aug 27, 2021 - The World Health Organization summarizes discussions that occurred at the Technical Advisory Group of the Asia Pacific Strategy for Emerging Diseases and Public Health Emergencies July 2021 meeting on COVID-19 experiences in the region, with Indonesia highlighting pandemic-related threats to antimicrobial stewardship and the importance of viewing the role of antimicrobial resistance in health security.

Aug 19, 2021 - In Pharmacy Practice News, Gina Shaw, MA, summarizes a MAD-ID presentation on the US response to 20 outbreaks of antibiotic-resistant pathogens in COVID-19 treatment and observation units since April 2020, highlighting insights from Kerry LaPlante, PharmD, and Julie Ann Justo, PharmD, about concerns related to rises in extended-spectrum beta-lactamase (ESBL)-producing organisms and the diversion of antimicrobial stewardship personnel to other duties during the pandemic.

Aug 18, 2021 - In an Xtalks blog post, Sarah Hand, MSc, highlights points made by Brian Murphy, MD, MPH, Daniel F. Sahm, PhD, and Jennifer Schneider, PhD, during a recent webinar about the prevalence of bacterial infections in COVID-19 patients and the importance of investing in antimicrobial development and antimicrobial resistance surveillance during the pandemic. 

Aug 17, 2021 - In a CNBCTV18 editorial, Subramanian Swaminathan, MD, discusses research around the possibility of rising antimicrobial resistance following the COVID-19 pandemic, focusing on regional antibiotic use across India, resistance mechanisms in hospital wastewater, and the need to address pharmaceutical industry effluents.

Aug 13, 2021 - In a Global Antibiotic Research & Development Partnership REVIVE Antimicrobial Viewpoint, Stephen Senn, PhD, MSc, describes the statistical aspects of five phase 3 trials of COVID-19 vaccines to infer potential lessons for antimicrobial research and development.

Aug 10, 2021 - In the New Straits Times, Fadzilah Mohd Nor, MD, MPath, describes the pandemic-related challenges experienced by Malaysia's Universiti Teknologi Mara in conducting research on potential antibiotic compounds isolated from lichen in Antarctica, also highlighting the importance of ongoing collaborative polar research in addressing possible increases in antimicrobial resistance.

Jul 21, 2021 - In a Research Square preprint, Jorge Almeida, BPharm, et al describe patterns of antibiotic resistance in COVID-19 patients with healthcare-associated bacterial infections in the intensive care unit of a Mexican hospital that was converted to care of COVID-19 patients.

Jul 14, 2021 - In a Research Square preprint, Stephen Hughes, MPharm, MSc, MBA, discuss the potential of procalcitonin testing to guide antibacterial prescribing patients hospitalized with COVID-19, finding that a negative procalcitonin test (<0.25mg/L) on admission was associated with shorter antimicrobial courses, early cessation of therapy, and lower frequency of intensive care unit admission.

Jul 9, 2021 - The European Association of Urology (EAU) provides an overview of a presentation given by Jóse Medina-Polo, MD, PhD, on the prevention and management of drug-resistant urinary tract infections during the pandemic, highlighting infection control and antimicrobial stewardship practices that were implemented in a Spanish hospital.

Jul 8, 2021 - In Infection Control Today, Frank Diamond interviews Heather Saunders, RN, MPH, about how infection preventionists can learn from COVID-19 to become further involved in antimicrobial stewardship through partnerships with public health departments, involvement in surveillance activities, cross-disciplinary collaboration within hospitals, and ongoing education about emerging pathogens and prevention of transmission.

Jul 7, 2021 - In an opinion piece for the Jordan Times, Muhammad Hamid Zaman, PhD, describes the importance of improved public awareness, government investment in public health, data-sharing platforms, and regulatory frameworks for food systems in learning from COVID-19 to address drug-resistant infections. 

Jul 1, 2021 - In a post for the British Society for Antimicrobial Chemotherapy Vanguard Report, Marc Mendelson, MBBS, PhD, describes ways in which the pandemic response has spurred movements to address inequitable access to medicines, vaccines, and public health preventive measures across low- and middle-income countries, highlighting ways in which these lessons learned could be applied to the response to antimicrobial resistance.

Jul 1, 2021 - In The Indian Express, Anuradha Mascarenhas interviews N.K. Ganguly, MD, about prescribed and over-the-counter antibiotic use in India during the COVID-19 pandemic, as well as India's work to manage antibiotic resistance in pharmaceutical plant pollution and agriculture.

Jun 30, 2021 - On DownToEarth, Sunita Narain, DSc, PhD, describes ways in which the emergence and response to COVID-19 illuminates a path forward for the environmental and agricultural response to antimicrobial resistance management.

Jun 28, 2021 - In news from the Thunder Bay Regional Health Sciences Foundation, Donna Jeanpierre describes how pharmacists involved in the Thunder Bay Regional Health Sciences Center antimicrobial stewardship team were able to use their skills and best practices to pivot to providing medication managament in the intensive care unit, set up vaccination clinics, and provide support for patients' questions and concerns during the pandemic.

Jun 28, 2021 - On The Conversation, Claas Kirchhelle, DPhil, MA, and Rebecca Glover, MSc, MA, describe the potential of learning from COVID-19 vaccine trials to build a public-private antibiotic clinical trials infrastructure that incorporates a network of public clinical trial institutes engaged in research on priority pathogens in lieu of funding individual companies.

Jun 28, 2021 - On The Conversation, Rodney E. Rohde, PhD, describes increasing antimicrobial resistance among fungal infections worldwide, highlighting research on the interplay of COVID-19 and Candida auris infections.

Jun 28, 2021 - In Infection Control Today, Frank Diamond interviews Barbara Smith, RN, BSN, MPA, about data presented at the Association for Professionals in Infection Control and Epidemiology annual conference that highlighted no increases in Clostridioides difficile infections at a US hospital during the first wave of the COVID-19 pandemic despite increases in antibiotic use during the same period, a finding that may be partly attributable to heightened infections prevention and control practices.

Jun 24, 2021 - In a commentary for Gavi, Priya Joi, MSc, describes the rise in bacterial and fungal infections during the COVID-19 pandemic in India, highlighting implications for the future of antimicrobial resistance and the continuation of national vaccination programs.

Jun 22, 2021 - On Contagion, Mehrnaz Sadrolashrafi, PharmD, reviews evidence on the risk of nosocomial infections, and particularly fungal infections, associated with extracorporeal membrane oxygenation (ECMO) for COVID-19 patients.

Jun 21, 2021 - In the Dhaka Tribune, Ashrafur Rahaman Mahadi highlights perspectives on the threat of antimicrobial resistance and antibiotic use in Bangladesh during the pandemic.

Jun 9, 2021 - In The Indian Express, K. Madan Gopal, MBBS, MD, describes the pervasive threat of antimicrobial resistance during and following the COVID-19 pandemic, highlighting environmental aspects of drug resistant genes in hospital wastewater, agricultural effluents, and pollution from pharmaceutical production.

Jun 7, 2021 - In The Straits Times, Debarshi Dasgupta describes research and perspectives into the relationship between antibiotic use and drug-resistant infections across India, noting the need for clear government guidelines on antibiotic prescribing and de-escalation for patients with COVID-19.

Jun 7, 2021 - On DownToEarth, Mohd Imran Khan reports on shortages of amphotericin B liposome (Ambisome) amid rising cases of patients hospitalizeed with mucormycosis ("black fungus") in Bihar, India.

Jun 5, 2021 - In TODAYonline, Eveline Gan reports on rising rates of drug-resistant bacterial and fungal infections in Singapore, describing intersections with antimicrobial use during the COVID-19 pandemic and highlighting the need for new antimicrobial development funding models and a multi-sector approach to antimicrobial stewardship.

Jun 4, 2021 - In The Telegraph, Dame Sally Davies, MBChB, MSc, and Thomas Cueni, MS, discuss methods for ensuring that the issue of antimicrobial resistance in the context of the COVID-19 pandemic can go from policy papers and predictions to actions that provide the necessary investments in research and good governance.

Jun 2, 2021 - In the New Statesman, Tina Joshi, PhD, describes why an awareness of the many dimensions of antimicrobial resistance and stewardship must underpin improvements to health systems and national economies.

May 28, 2021 - L.E.K. Consulting published a report on antimicrobial resistance and innovation in diagnostics and research across the Asia-Pacific region, highlighting the implications of COVID-19 on antimicrobial use and drug-resistant infections.

May 28, 2021 - Health Education England's Genomic Education Programme highlights issues associated with the high use of antibiotics in COVID-19 patients, also noting that the use of genomic sequencing to track SARS-CoV-2 has the potential to be applied more widely to inform antibiotic stewardship and empirical therapy.

May 28, 2021 - On Health Policy Watch, Disha Shetty, MA, reports on conversations happening at the 74th World Health Assembly on the need for the COVID-19 pandemic to inform action against antimicrobial resistance, citing calls for a better understanding of the ties between health and economic crises, along with improved surveillance based on pandemic tools, from representatives from Bangladesh and Burkina Faso.

May 27, 2021 - In a post for the British Society for Antimicrobial Chemotherapy's Vanguard Report, Daniel Berman, MIA, and Ruth Neale, MChem, discuss access to antimicrobial resistance diagnostics in low- and middle-income countries and urge challenging the idea of what makes an intervention or technology "valuable" in the context of what the COVID-19 pandemic has revealed about the limits of centralized approaches to public health.

May 25, 2021 - A ReAct briefing for the 74th World Health Assembly makes recommendations for integrating the issue of antimicrobial resistance into pandemic preparedness frameworks, highlighting issues in common, including the need for improved human-health and zoonotic surveillance, a research and development model driven by health needs, greater transparency and prevention of shortages in pharmaceutical supply chains, and equitable access to medicines.

May 20, 2021 - On Healio, Kelly M. Percival, PharmD, highlights ways in which resources to track and prevent hospital-acquired infections have been strained by the demands of the COVID-19 pandemic, also outlining some tactics for maintaining infection control practices and surveillance infrastructure during times of emergency.

May 20, 2021 - In Scientific American, Maryn McKenna, MSJ, highlights research on pathogenic fungi around the world, highlighting the interplay between COVID-19 and superinfections with Candida auris or Aspergillus species, along with the work of researchers attempting to bring awareness and investment to antifungal and fungal vaccine development.

May 19, 2021 - In The Washington Post, Jennifer Hassan reports on shortages of amphotericin B, used to treat mucormycosis in COVID-19 patients, across India.

May 17, 2021 - On Ahram Online, Ingy Deif reports on a program launched during the pandemic to provide antimicrobial stewardship education to clinicians in 22 private and government hospitals across Egypt.

May 14, 2021 - On Medscape, Heidi Splete, MA, summarizes a presentation given by Valerie M. Vaughn, MD, at SHM Converge, the annual conference of the Society of Hospital Medicine, on practical approaches to evaluating risk for community-onset bacterial co-infections in COVID-19 patients, reducing antibiotic use in patients with asymptomatic bacteriuria, shortening the duration of antibiotics for community-acquired pneumonia, clarifying the need for antibiotics at discharge.

May 14, 2021 - India's Council of Scientific & Industrial Research describes the urgent need to ensure care for patients with multidrug-resistant and extensively drug-resistant tuberculosis in India following the second wave of the COVID-19 pandemic.

May 13, 2021 - On the blog of the Center for Bioethics and Social Justice at Michigan State University, Karen M. Meagher, PhD, invites discussion on social justice, economic, and ethical issues held in common by the COVID-19 pandemic and commitments to eliminating tuberculosis.

May 12, 2021 - On The Hill, Jaclyn Levy, MS, and Franklin D. Kramer outline four critical steps that the US government can take that build on lessons learned from COVID-19 to address future infectious disease outbreaks: 1) significant federal investment in ambitious scientific research; 2) a dedicated effort to addressing antimicrobial resistance; 3) global scientific partnerships; and 4) enhanced disease surveillance capabilities, including pathogen genomics.

Apr 29, 2021 - On the World Bank blog, Enis Baris, MD, PhD, MSc, argues that antimicrobial resistance may qualify as a population-wide side effect or long-term sequela of COVID-19.

Apr 28, 2021 - In the Pharmaceutical Journal, R. Andrew Seaton, MBChB, MD, describes discrepancies between antibiotic use and indications for prescribing during the pandemic, highlighting scenarios in which antibiotic use should be considered for COVID-19 patients.

Apr 26, 2021 - For Project Syndicate, Loice Achieng Ombajo, MBChB, MMed, discusses concerns related to hospital antibiotic use and rising over-the-counter sales of antibiotics during the COVID-19 pandemic, particularly in countries where access to healthcare workers is limited, highlighting her experience with drug-resistant infections as an infectious-diseases clinician in Kenya and calling on governments, hospitals, and individuals to take action against antimicrobial resistance.

Apr 20, 2021 - In a Global Antibiotic Research and Development Partnership profile, Chelsea Kruger, MBBS, describes her experiences in trying to treat drug-resistant infections in COVID-19 patients in an Australian hopsital.

Apr 19, 2021 - In support of Medical Laboratory Professional Week, a bioMérieux Connection article highlights the impact of the COVID-19 pandemic on clinical laboratory professionals, particularly as it relates to testing volume, work-life balance, and workforce shortages.

Apr 18, 2021 - On The Wire, Kamini Walia, PhD, MPH, provides an overview of human health and environmental antimicrobial resistance potentially worsened by the COVID-19 pandemic, highlighting ways in which antimicrobial stewardship programs can work across sectors to address the problem collaboratively.

Apr 13, 2021 - The Global Fund published a report on the impact of COVID-19 on services and systems that target HIV, tuberculosis, and malaria, noting the sizeable contribution of drug-resistant tuberculosis to overall antimicrobial resistance and the importance of ensuring prompt and thorough diagnosis and treatment.

Apr 1, 2021 - Microbiologist Siouxsie Wiles, PhD, was named a Kiwibank New Zealander of the Year Award Ngā Tohu Pou Kōhure o Aotearoa 2021 winner for her work on antimicrobial resistance and in widely communicating the science of the COVID-19 pandemic.

Mar 31, 2021 - On Infection Control Today, Frank Diamond interviews Priya Nori, MD, about the need for a greater emphasis on an integrated approach to infection prevention, antimicrobial stewardship, regulatory awareness and advocacy, and surveillance of drug resistance and healthcare-associated infections following the COVID-19 pandemic.

Mar 26, 2021 - In a medRxiv preprint, Alexandra Tsitsiklis, PhD, et al evaluate lower respiratory tract host immune responses and microbiome dynamics associated with the risk of developing ventilator-associated pneumonia in 28 COVID-19 patients.

Mar 24, 2021 - The Infectious Diseases Society of America published a statement on the impact of the COVID-19 pandemic on global tuberculosis services and co-infection, highlighting efforts to encourage greater US leadership and dedicated resources to improving access to tuberculosis testing and treatment.

Mar 24, 2021 - The Global Fund features commentary on the drop in testing for tuberculosis that occurred during the pandemic, also highlighting ways in which India and Bangladesh were able to increase testing and treatment for tuberculosis patients, including a program in India that tests people for COVID-19 and tuberculosis at the same time.

Mar 23, 2021 - In news from the Longitude Prize, Ruth Neale, MChem, provides a list of recommendations for learning from or adapting the tools used during the COVID-19 pandemic to advance technologies, regulations, and and research related to antimicrobial resistance.

Mar 22, 2021 - The International Society for Infectious Diseases summarizes global efforts and pandemic-related setbacks to the goal of tuberculosis elimination by 2035, highlighting the work of Oman's surveillance-centered tuberculosis program and its focus on public-private partnerships, patient-centered care, screening of high-risk groups, and accounting for the ways in which the pandemic has affected health services access among migrants and refugees.

Mar 21, 2021 - In The Times, Tom Whipple describes the potential for the UK's coronavirus sequencing infrastructure to be repurposed for antimicrobial resistance surveillance.

Mar 11, 2021 - On Belfast Live, Shauna Corr reports on infections caused by glycopeptide-resistant enterococci among COVID-19 patients hospitalized in a Northern Ireland intensive care unit.

Mar 10, 2021 - The Pew Charitable Trusts features an interview with Emily Heil, PharmD, about how the University of Maryland Medical Center's antibiotic stewardship program adapted to the effects of COVID-19 and the need to "prioritize high-quality research, even during the height of a crisis like COVID-19."

Mar 10, 2021 - On the Michigan Health Lab blog, Kelly Malcom describes how members of the Michigan Medicine Antimicrobial Stewardship Program came together in spring 2020 to develop evidence-based therapeutic guidelines for COVID-19, noting that the website housing the guidelines has been accessed more than 30,000 times from 150 countries.

Mar 7, 2021 - On Contagion, John Parkinson speaks with Kenneth Thorpe, PhD, MA, about efforts that the Partnership to Fight Infectious Disease is taking to work with the US Congress on antimicrobial resistance issues during the COVID-19 pandemic.

Mar 5, 2021 - On the Vanderbilt University School of Medicine blog, David Cohen describes the work of Vanderbilt Master of Public Health student Milner Staub, MD, who worked with the VA Tennessee Valley Healthcare System’s Infection Prevention Team to develop comprehensive COVID 19 prevention algorithms and understand supply chains for medical equipment, noting that the experience was essential to Dr. Staub's future endeavors to pursue antimicrobial stewardship.

Mar 4, 2021 - In a perspective piece for Pfizer, Susan Rienow, MBA, lists simple actions that anyone can take to advocate for actions that mitigate antimicrobial resistance and change how antibiotics are used during the COVID-19 pandemic.

Mar 4, 2021 - In the Daily Maverick, Christi Nortier highlights points made by Marc Mendelson, MBBS, PhD, Joanne Liu, MDCM, and Manica Balasegaram, BM BS, MSc, on how to immediately address the threat posed by antimicrobial resistance during and following the COVID-19 pandemic in a webinar hosted by the Global Antibiotic Research & Development Partnership.

Mar 3, 2021 - In a commentary for Stat, Michelle McMurry-Heath, MD, PhD, proposes considerations for integrating antimicrobial resistance and development concerns into the Biden administration's pandemic planning agenda.

Mar 2, 2021 - In Pharmacy Times, Alana Hippensteele, MA, summarizes highlights from a presentation on the complexity of healthcare-assoicated infections and antibiotic use among COVID-19 patients given by Kalvin Yu, MD, during a webinar hosted by the American Hospital Association.

Feb 25, 2021 - ReAct lists four considerations for addressing antimicrobial resistance through pandemic preparedness, highlighting the importance of a research agenda driven by public health, global rules-based governance for access to life-saving supplies, efforts to improve coverage of diagnostics and preventative measures, and an integrated One Health approach where possible.

Feb 24, 2021 - In a MedRxiv preprint, Imran Sulaiman, MBBS, PhD, et al assess bacterial and fungal culture data from 589 critically ill subjects with COVID-19 requiring mechanical ventilation in New York from Mar 3 to Jun 18, 2020, finding that, though isolation of a hospital-acquired respiratory pathogen was not associated with mortality, enrichment of the lower airway microbiota with an oral commensal (Mycoplasma salivarium) was associated with mortality and with ventilation for more than 28 days.

Feb 24, 2021 - The Center for Disease Dynamics, Economics and Policy issued a report on infectious diseases in Southeast Asia, focusing on the health and economic burdens of tuberculosis, malaria, typhoid and enteric pathogens, antimicrobial resistance and healthcare-acquired infections, and HIV and sexually transmitted infections. The report also looks at COVID-related disruptions to infectious disease control, as well as the need for urgent attention to this area once COVID vaccination becomes more widespread. 

Feb 18, 2021 - On Devex, Harsh Vardhan, MBBS, and Lucica Ditiu, MD, describe the need to prioritize focus on ending tuberculosis during the COVID-19 pandemic, also discussing efforts that India has taken to continue tuberculosis surveillance and contact tracing linked to COVID-19 tracing.

Feb 17, 2021 - In Knowable, Mohan Joshi, MBBS, MD, MSc, describes the potential for public health improvements that can target both COVID-19 and rising antimicrobial resistance, including investment in appropriate personal protective equipment for healthcare workers; robust antibiotic stewardship programs; and a society-wide emphasis on surveillance, education, and research.

Feb 16, 2021 - On Contagion, Krutika Kuppalli, MD, and Syra Madad, DHSc, MSc, describe the status of emerging infectious diseases—Ebola, vaccine-preventable diseases like diphtheria and pertussis, multidrug-resistant organisms like Candida auris and Acinetobacter baumannii—in the context of global resource inequities and the structural changes prompted by the COVID-19 pandemic.

Feb 16, 2021 - On the Nesta Challenges blog, Abdul Ghafur, MD, describes his perspectives on the policy, investment, and patient engagement aspects of antimicrobial resistance and use during the pandemic from the point of view of a clinician and a COVID-19 patient.

Feb 16, 2021 - On Health Europa, Rosemary Lobley interviews Arlene Brailey, BPharm, about the importance of listening to many voices and stories when advocating for targeted research against antimicrobial resistance during the COVID-19 pandemic, also addressing the nuances of engagement and policy work during a time of exhaustion and low resources.

Feb 15, 2021 - In a Wealth of Nations podcast and post, Ravi Mehta describes antimicrobial resistance across India and the potential of Indian pharmaceutical and biotech companies to support antimicrobial innovation during the COVID-19 pandemic.

Feb 15, 2021 - In a Harvard Science in the News blog post, Molly Sargen provides an overview of how the COVID-19 pandemic may negatively affect antimicrobial resistance while also providing opportunities to improve infection prevention, One Health approaches to global issues, and immunization uptake.

Feb 15, 2021 - The World Health Organization Regional Office for Europe describes the enthusiasm and innovation expressed across Europe during World Antibiotic Awareness Week 2020, noting that social media and interdisciplinary partnerships were key to engaging people and spreading awareness about antimicrobial resistance during the pandemic.

Feb 15, 2021 - In The Guardian, Laura Spinney discusses the implications of antibiotic overuse during COVID-19, describes how a pandemic of antimicrobial resistance would look similar to and different than the COVID-19 pandemic, and highlights novel anti-infectives as one way of preventing a surge of chronic and untreatable illness.

Feb 12, 2021 - In a commentary for the American Council on Science and Health, David Shlaes, MD, PhD, questions whether drastic change is needed to invest in research for new antibiotics on the scale of COVID-19 vaccine development.

Feb 9, 2021 - In an article for Next Avenue, Stephenie Overman, MA, describes the potential threat of drug-resistant infections during the COVID-19 pandemic, highlighting a series of questions provided by Muhammad Zaman, PhD, that one can ask to protect loved ones from COVID-19 and antimicrobial resistance in long-term care facilities.

Feb 9, 2021 - In a commentary for Gavi, Priya Joi, MSc, discusses One Health methods for addressing the antimicrobial resistance implications of high antibiotic use during the pandemic.

Feb 9, 2021 - On the blog of the Royal College of Pathologists, Dr. Francesca Heard describes her experiences as an infectious diseases and microbiology trainee in the UK during the COVID-19 pandemic, including reflections on the role of the microbiology lab in encouraging appropriate antimicrobial use for COVID-19 patients.

Feb 8, 2021 - On Contagion, Deanna J. Buehrle, PharmD, reviews global data on disparities between antibiotic use and bacterial infections in COVID-19 patients, also highlighting unanswered questions that require further research.

Feb 4, 2021 - In Contemporary Pediatrics, Bob Kronemyer highlights perspectives from Mark R. Schleiss, MD, and Ateev Mehrotra, MD, MPH, on the issues underlying the over-prescription of antibiotics to children during the COVID-19 pandemic.

Feb 4, 2021 - In a Mott Macdonald commentary, Toby Leslie, PhD, MSc, describes the response of the Fleming Fund to COVID-19 and antimicrobial resistance (AMR), particularly with regard to surveillance across sub-Saharan Africa and Southeast Asia, highlighting the need for a long-term One Health mindset in managing AMR.

Feb 3, 2021 - On the Nesta Challenges blog, Daniel Berman, MIA, describes the impact of the COVID-19 pandemic on cancer care, particularly as it relates to the threat of drug-resistant infections and the future viability of chemotherapy.

Jan 29, 2021 - In Inside Dentistry, Rebekah Lucier Pryles, DMD, discusses antimicrobial stewardship considerations and antibiotic overprescribing associated with delays in dental care during the COVID-19 pandemic.

Jan 27, 2021 - In The New York Times, Matt Richtel, MS, discusses outbreaks of drug-resistant organisms during the pandemic, uncertainties about the effects of COVID-19 on antimicrobial resistance, and changes to standard infection control and prevention.

Jan 26, 2021 - In a medRxiv preprint, Camille d'Humieres, PharmD, et al assess the prevalence of bacterial co-infection in 197 patients with COVID-19 treated in a French intensive care unit from Jan 29, 2020, to May 31, 2020, finding that 44.7% of patients had at least one co-infection during their stay, with 77 patients diagnosed with bacterial pneumonia and 31 patients experiencing a bloodstream infection. The authors note two peculiarities: 1) an unusual persistence of bacteria in the respiratory samples of patients with ventilator-associated pneumonia despite adequate antibiotic therapy, and 2) more than half of bloodstream infections (17/31) appearing to originate from a digestive or oro-pharyngeal source.

Jan 25, 2021 - In a commentary for the World Economic Forum Davos Agenda 2021, Lars Rebien Sorensen, MSc, describes developments in antimicrobial resistance research and opportunities for accelerated policy on antimicrobial development associated with the COVID-19 pandemic.

Jan 20, 2021 - On the Devpolicy blog, Suman Majumdar, BMed, MPH&TM, and Mark Rice, MPA, discuss challenges and trends outlined in the World Health Organization's Global TB Report 2020, along with the impact of COVID-19 and the opportunities presented by the pandemic related to progress toward ending tuberculosis.

Jan 19, 2021 - In a Choosing Wisely Viewpoint, Jeremy Friedman, MBChB, brings attention to the need for diagnostic and antibiotic stewardship for children during the COVID-19 pandemic.

Jan 19, 2021 - The Nesta Challenges blog highlights a story from Pranav Johri as part of the Nesta AMR Voices project about the experience of a difficult-to-treat infection managed with phage therapy and the implications of COVID-19 on global travel and specialized experimental treatment that provide therapeteutic options to people with drug-resistant infections.

Jan 15, 2021 - In a medRxiv preprint, Chiagozie O. Pickens, MD, et al found that 21% of 133 ventilated COVID-19 patients who received bronchoscopic bronchoalveolar lavage (BAL) had a superinfection, most commonly caused by methicillin-sensitive Staphylococcus aureus or a Streptococcus species, within 48 hours of intubation, finding also that BAL-based treatment reduced antibiotic use compared with guideline-recommended care.

Jan 15, 2021 - In a medRxiv preprint, George P. Drewett, MBBS, et al found in a study of 166 patients with COVID-19 hospitalized in Australia that higher levels of procalcitonin were associated with antibiotic use, as well as a shorter time to de-escalation to oral therapy.

Jan 14, 2021 - In a commentary for the Pew Charitable Trusts, David Hyun, MD, outlines four priorities for managing antimicrobial resistance in 2021, highlighting how lessons learned from COVID-19 can be applied to innovation in collaborative antimicrobial development, funding sources, public health infrastructure, and a global view of infectious disease preparedness.

Jan 12, 2021 - In a medRxiv preprint, Nosheen Nasir, MD, MSc, et al found that risk factors for bacterial infection in patients hospitalized with moderate-to-severe COVID-19 in Pakistan from February to June 2020 included severe or critical COVID-19 at presentation and use of steroids.

Jan 6, 2021 - In a bioRxiv preprint, Yingyi Guo et al found in a study of 146 patients with COVID-19 hospitalized in south China from Jan 11 to Feb 22, 2020, that only three had a co-infection upon admission, and 16 patients developed a secondary infection.

Jan 5, 2021 - On Slate, Charles Kenny, PhD, MA, discusses ways in which the Biden administration could learn from the COVID-19 pandemic to establish improved mechanisms to carry out surveillance on antimicrobial use and resistance, limit medically important antimicrobials in animal agriculture, implement strong evaluation of progress, and sustainably fund antimicrobial development.

Dec 28, 2020 - The Financial Times editorial board describe the necessity of preparing to tackle antimicrobial resistance after the COVID-19 pandemic, particularly in the arenas of agricultural antimicrobial use and government involvement in antimicrobial development incentives.

Dec 22, 2020 - In a medRxiv preprint, Alysa J. Martin, PharmD, et al found that, among 198 patients with COVID-19 hospitalized in a US medical center from March through May 2020, 83% received at least one course of antibiotics, and respiratory cultures were obtained in only 32% of patients.

Dec 15, 2020 - On the Nesta Challenges blog, Ranj Singh, MBBS, discuss the interplay between diagnosis and prescribing for COVID-19 and/or bacterial infections in children, noting the importance of advocating for the prevention of difficult-to-treat infections other than COVID-19 that affect children.

Dec 15, 2020 - In a blog post for the USAID/Management Sciences for Health Medicines, Technologies, and Pharmaceutical Services (MTaPS) program, Javier Guzman, MD, MSc, MBA, and Kwesi Eghan, BPharm, MSc, MBA, discuss ways in which the COVID-19 pandemic has highlighted the importance of effective treatments and testing capabilities, including those that optimize antimicrobial treatment, in the context of robust pharmaceutical systems that are moving toward Universal Health Coverage in low- and middle-income countries.

Dec 14, 2020 - In a medRxiv preprint, Peter W. Horby, MD, PhD, et al describe the lack of benefit of azithromycin in patients hospitalized with COVID-19 and recommend that it be used only when there is a clear indication for antimicrobial therapy. The authors also made a statement about the results on the website of the RECOVERY (Randomised Evaluation of COVID-19 Therapy) trial.

Dec 13, 2020 - In Scientific American, Seth Berkley, MD, and Ramanan Laxminarayan, PhD, MPH, describe the relationship between the COVID-19 pandemic and the threat of increasing antimicrobial resistance, advocating for a collaborative approach to antibiotic development on the scale of efforts to manufacture and create access to COVID-19 vaccines.

Dec 11, 2020 - In an interview for Nature Reviews Drug Discovery, Asher Mullard speaks with Executive Director of the European Medicines Agency Emer Cooke, BSc(Pharm), MSc, MBA, about the long-term impacts of the COVID-19 pandemic on regulation of medical products and market issues affecting antimicrobial resistance.

Dec 9, 2020 - In a Global Antibiotic Research & Development Partnership REVIVE Antimicrobial Viewpoint, Rachael Ngozi Osagie, PhD, MSc, describes lessons learned from infection prevention and control efforts during COVID-19 for the mitigation of antimicrobial resistance in rural Nigerian communities, particularly related to surveillance, strong partnerships with local providers, and a focus on long-term behavior change.

Dec 8, 2020 - In Financial Times, Amy Kazmin, MSc, describes how COVID-19 has hindered efforts to curtail antimicrobial resistance at the government and hospital levels across India, citing impediments to the progress of integrated antimicrobial stewardship, disease surveillance, and immunization programs.

Dec 7, 2020 - In a medRxiv preprint, Adriana Yock-Corrales, MD, MSc, et al assess 990 pediatric COVID-19 and/or multisystem inflammatory syndrome (MIS-C) cases across Argentina, Colombia, Costa Rica, Mexico, and Peru, finding that the prevalence of antibiotic use was 24.5%.

Dec 7, 2020 - In a medRxiv preprint, Samuel Ebiowei Fanifini Orubu, BPharm, PhD, MSc, MBA, et al measure antibiotic sales in Pakistan from January to April 2020, finding that total antibiotic sales decreased during the early months of the pandemic compared with the previous year, although macrolide consumption increased from February to April 2020.

Dec 7, 2020 - On the Principles for Responsible Investment blog, Fiona Reynolds discusses lessons learned from the COVID-19 pandemic that may apply to driving investment in actions to mitigate antimicrobial resistance.

Dec 2, 2020 - On ScienceNorway, Erik Martiniussen, MA, and Sigurd Høye, MD, describe factors that may have contributed to the reduction in antibiotic prescribing in Norway during strict COVID-19 containment measures.

Dec 1, 2020 - In a Research Square preprint, Sarah Denny, MBBS, et al describe findings of significantly fewer-than-expected bloodstream infections caused by Enterobacterales and an historic high of bloodstream infections caused by coagulase-negative staphylococci across six London hospitals during the peak of the COVID-19 pandemic.

Dec 1, 2020 - In a commentary for Health Europa, Mariano Votta, MSc, and Neda Milevska-Kostova, MPharm, PhD, MSc, MCPPM, discuss antimicrobial resistance (AMR) during the COVID-19 pandemic as a patients' rights issue and a chance to advocate for patient-centered AMR prevention and awareness.

Nov 30, 2020 - In Green European Journal, Claas Kirchhelle, DPhil, MA, describes the history of pandemics, particularly cholera pandemics, and their relationship with cooperative efforts to invest in public health infrastructure, also stressing the danger of ignoring antimicrobial stewardship during the COVID-19 pandemic and the need for a global antimicrobial commons.

Nov 27, 2020 - In The Standard, James Marcomic Maragia describes the interplay between laboratory systems, national governance, and members of the public in mitigating antimicrobial resistance levels in Kenya during the pandemic.

Nov 27, 2020 - In an interview for Contagion, Kevin Kunzmann speaks with Neil Clancy, MD, about the US Food and Drug Administration's suggested revisions to ranking antimicrobials based on their importance in human medicine and how the COVID-19 pandemic has affected progress toward agricultural antimicrobial stewardship.

Nov 24, 2020 - In a commentary for WaterAid Australia, Alison Macintyre, MPH, discusses the importance of water quality and access to COVID-19 prevention and response efforts and the potential to improve a multi-sector santitation-focused response to antimicrobial resistance.

Nov 24, 2020 - In The Parliament Magazine, Martin Banks highlights remarks made on antibiotic development, investment in vaccines, antimicrobial shortages, and global cooperation at the European Policy Centre conversation on “Antimicrobial resistance in the COVID-19 era—What solutions for halting its spread?” 

Nov 24, 2020 - On DownToEarth, Dusan Jasovsky, MPharm, MSc, Jyotsna Singh, and Leena Menghaney, PhD, LLB, describe methods of integrating antimicrobial stewardship in COVID-19 response in India, particularly as it affects laboratory capacity and sustainable access to essential antibiotics.

Nov 24, 2020 - The Longitude Prize published "AMR Voices," a report that highlights stories on the intersection of COVID-19 and antimicrobial resistance from people who have experienced drug-resistant infections and clinicians in India, South Africa, the UK, and the US.

Nov 24, 2020 - In a blog post for the African Population and Health Research Center, Abdhalah K. Ziraba, MBBS, PhD, MSc, and Elvis Wambiya, MSc, describe One Health efforts in Kenya to manage antimicrobial resistance during the COVID-19 pandemic.

Nov 23, 2020 - In The Irish Times, Niamh Cahill reports on substantial primary-care reductions in antibiotic use in Ireland during the COVID-19 pandemic.

Nov 22, 2020 - In The News on Sunday, Qadeer Ahsan, MD, discusses concerns regarding antibiotic use during the COVID-19 pandemic, as well as multisectoral governance to manage antimicrobial resistance in Pakistan.

Nov 20, 2020 - In The New York Times, Maria Varenikova reports on an increase in both prescribed and non-prescribed over-the-counter sales of antibiotics in Ukraine during the COVID-19 pandemic.

Nov 20, 2020 - In a report from the Access to Medicine Foundation, Francesca Chiara, PhD, Moska Hellamand, MSc, and Margo Warren, MA, describe how lessons about drug resistance surveillance learned during the COVID-19 pandemic illuminate the importance of pharmaceutical companies' decisions to share their surveillance datasets and promote greater transparency in private-sector data on antimicrobial resistance.

Nov 20, 2020 - The Fleming Fund highlights insights from Dame Sally Davies, MBChB, MSc, Mirfin Mpundu, BPharm, MPH, MBA, Hanan Balkhy, MD, Keith Sumption, Vet MB, PhD, MA, and Charles Mwansambo, MBChB, on antimicrobial resistance during the COVID-19 response and opportunities to improve clinical engagement and diagnostic use.

Nov 18, 2020 - On Health Policy Watch, Raisa Santos provides in-depth coverage of Wellcome's launch event to discuss a new report on global progress toward antimicrobial resistance goals and the effects of the emergence of SARS-CoV-2.

Nov 18, 2020 - The Global Antibiotic Research & Development Partnership (GARDP) published a report on lessons from COVID-19 that can be applied to antimicrobial resistance (AMR), focusing onfive measures that governments can take to ensure the development and access to medical countermeasures.

Nov 18, 2020 - News from the World Health Organization describes the importance of ensuring that increases in antimicrobial resistance are not a consequence of the COVID-19 pandemic, highlighting insights from Fabio Soldani, MD, on the difficulty of restricting antibiotic use during the COVID-19 surge this spring in northern Italy.

Nov 18, 2020 - In news from the American Academy of Pediatrics, Athena P. Kourtis, MD, PhD, MPH, discusses considerations for optimizing antibiotic prescribing for children during the COVID-19 pandemic.

Nov 17, 2020 - In a bioMérieux Connection interview, Debra Goff, PharmD, describes the relevance of the COVID-19 pandemic in communicating the dangers of untreatable infections and the threat of antimicrobial resistance, also highlighting the importance of international engagement of pharmacist leaders in antimicrobial stewardship.

Nov 17, 2020 - On Project Syndicate, Thomas Cueni, MS, describes lessons learned from systemic responses to COVID-19 and how those lessons can be applied to innovation for antibiotic development and associated legislation.

Nov 16, 2020 - Wellcome launched a report that analyzes global activities on antimicrobial resistance (AMR) and evaluates lessons learned from COVID-19 to propose a path for global AMR response now and beyond 2030.

Nov 13, 2020 - On the Royal Society of Tropical Medicine & Hygiene blog, Adam Roberts, PhD, asserts the importance of maintaining focus on preventing antimicrobial resistance during the COVID-19 pandemic, particularly as it relates to the fragility of healthcare systems and innovation in vaccine development, also highlighting the connections between behavior changes associated with the pandemic and antibiotic prescribing rates.

Nov 13, 2020 - The Infectious Diseases Society of America released a statement critiquing the US Senate Labor, Health and Human Services Appropriations bill for failing to include the the investment necessary to respond to COVID-19 and antimicrobial resistance.

Nov 12, 2020 - In a Global Antibiotic Research & Development Partnership REVIVE Antimicrobial Viewpoint, Venkatasubramanian Ramasubramanian, MD, discusses the context of antibiotic overuse in India during the COVID-19 pandemic.

Nov 11, 2020 - On the BMC On Health blog, Kevin Kavanagh, MD, MS, describes how the COVID-19 pandemic might transform healthcare, highlighting the need for advances in surveillance, infection prevention, and community engagement to stop the spread of multidrug resistance in the US.

Nov 9, 2020 - The UW-Madison BerbeeWalsh Department of Emergency Medicine announced that Michael Pulia, MD, MS, will partner with Barry Fox, MD, Director of Antibiotic Stewardship at the Wisconsin Department of Health Services, to improve antibiotic prescribing in urgent care clinics and emergency departments throughout Wisconsin.

Nov 9, 2020 - In Stat, Jowa (Zhuo) Shi and Ateev Mehrotra, MD, MPH, describes concerns regarding a possible increase in antibiotic prescribing in the US this winter associated with COVID-19, more care-seeking for treatment of symptoms related to acute respiratory infections, and higher use of telemedicine.

Nov 8, 2020 - In a profile for Churchill College Cambridge, Chioma Achi, DVM, PhD, MSc, describes her journey to studying antimicrobial stewardship in veterinary settings, and the importance of focusing on antibiotic use during the COVID-19 pandemic, saying “The beauty of science is that one thing ties to another. You can’t address Covid in isolation without looking at the increase in use of antimicrobials."

Nov 4, 2020 - In an article for RTE Ireland, Dearbháile Morris, PhD, describes factors that could lead to increases in antimicrobial resistance during the COVID-19 pandemic.

Nov 4, 2020 - In a commentary for the British Society for Antimicrobial Chemotherapy (BSAC), Ashley Hammond, PhD, MSc, describes the decline in diagnoses of urinary tract infections and the reduction in requests for urinary samples to culture in the UK during the COVID-19 pandemic, highlighting challenges to managing antibiotic use and resistance when primary care is not sought or is not performing testing to guide therapy.

Nov 3, 2020 - The Southern African Centre for Infectious Disease Surveillance Foundation for One Health published a report on "COVID-19 and Africa's Volatile Changing Epidemics Landscape," which describes how ongoing work to enhance surveillance for respiratory diseases and antimicrobial resistance has affected capacity to respond to COVID-19 across Africa.

Nov 2, 2020 - In a Research Square preprint, Tat Ming Ng, PharmD, describe the effect of an existing antimicrobial stewardship program on antimicrobial prescribing during the COVID-19 pandemic at a Singapore hospital, despite the re-deployment or reduction in dedicated antimicrobial stewardship team members and resources.

Oct 30, 2020 - The Special Inspector General for Afghanistan Reconstruction Quarterly Report to the United States Congress warns of the potential for increases in antimicrobial resistance exacerbated by COVID-19 in Afghanistan, highlighting in particular the availability and self-prescription of antibiotics. 

Oct 28, 2020 - In an article for the Association of Health Care Journalists, Bara Vaida discusses current knowledge, experience, and observation on the threat of rising antimicrobial resistance (AMR) during COVID-19, also offering story ideas for reporters interested in the diverse aspects of AMR and antibiotic use during the pandemic.

Oct 27, 2020 - In a post for ISGlobal (the Barcelona Institute for Global Health), Marina Tarrús, MSc, describes the Superbug Awareness for Education (SAFE) program, which launched in January 2020 as a way to provide service-learning workshops on antimicrobial resistance and microbiology for high school and university students in southern Europe, and has adapted to the COVID-19 pandemic by creating digital awareness campaigns.

Oct 27, 2020 - In a medRxiv preprint, Vadsala Baskaran, BMBS, et al describe limited evidence for community-acquired bacterial infections, but a high rate of gram-negative bacterial infection acquired associated with the duration of time spent in the intensive care unit (ICU), among patients critically ill with COVID-19 across seven ICUs in England from the start of the pandemic to May 18.

Oct 25, 2020 - In a medRxiv preprint, Alysa J. Martin, PharmD, et al describe risk factors associated with increased antibiotic use and receipt of more than one course of antibiotics in COVID-19 patients in a US hospital.

Oct 22, 2020 - In a medRxiv preprint, Amal A. Gharamti, MD, et al discuss the use of a ferritin-to-procalcitonin ratio (F/P) to differentiate patients with COVID-19 from patients with bacterial pneumonia at two hospitals in the US and one hospital in China, finding that the median F/P was significantly higher in patients with COVID-19 and that an F/P greater than or equal to 877 increased the likelihood of a COVID-19 pneumonia diagnosis.

Oct 22, 2020 - In Discover, Sara Novak speaks with Valerie Vaughn, MD, MSc, about her experience trying to treat a drug-resistant Clostridioides difficile infection in a patient who had COVID-19, also discussing the issue of antibiotic overuse and development during the pandemic with Stephen Trent, PhD.

Oct 22, 2020 - In Investment Week, Abigail Herron, MSt, discusses issues associated with possible increases in antimicrobial resistance during the COVID-19 pandemic, focusing particularly on hospital and pharmaceutical industry wastewater, also highlighting opportunities for investors to become involved in ensuring access to effective antibiotics.

Oct 21, 2020 - In a Nature Outlook piece, Kristina Campbell, MSc, describes observations and research on the links between the COVID-19 pandemic, enhanced focus on infection prevention, reduced rates of healthcare-associated drug-resistant bacterial infections, and behavior change.

Oct 20, 2020 - In a Research Square preprint, Natasha N. Pettit, PharmD, et al describe the effect of a guideline for antibiotic initiation and discontinuation on the duration of empirical therapy for community-acquired bacterial pneumonia among COVID-19 patients.

Oct 20, 2020 - The Pioneer Institute published a report by patient advocate Gunnar Esiason on lessons learned from the COVID-19 pandemic that can be applied to market, legislative, and educational structures affecting antibiotic research and development.

Oct 19, 2020 - On AMR Insights, Sabiha Y. Essack, BPharm, MPharm, PhD, describes the need to apply lessons learned from the COVID-19 pandemic to policies affecting antimicrobial resistance, particular as they affect infection prevention in community settings and progress toward the sustainable development goals.

Oct 18, 2020 - In the Financial Times, Clive Cookson describes a collaboration between the Financial Times and Wellcome Trust to hold a workshop that looked at the challenges in communicating about antimicrobial resistance (AMR) during and beyond the COVID-19 pandemic, followed by a video for the public that highlights the problem of AMR and possible solutions.

Oct 16, 2020 - On The Hill, Chia-Yi Hou, PhD, MA, describes possible contributors to antimicrobial resistance during the COVID-19 pandemic, highlighting work on phage therapy, diagnostics development and training, biomarker use, racial disparities in antibiotic use, and resource allocation.

Oct 16, 2020 - In a viewpoint for the Global Antibiotic Research & Development Partnership REVIVE website, Markus Heep, MD, Esther Bettiol, MD, PhD, Tanyaporn Wansom, MD, PhD, MPP, and Hilary Johnstone, MBChB, MSc, discuss the process of running a phase 3 trial for zoliflodacin for gonorrhea across the Netherlands, South Africa, Thailand, and the US during the COVID-19 pandemic.

Oct 14, 2020 - In a commentary for United Hospital Fund, Pooja Kothari, RN, MPH, discusses uncertainty about the need for antibiotic prescribing during the COVID-19 pandemic, highlighting evidence-informed practices that may address the issue from an administrative or educational standpoint.

Oct 14, 2020 - The TB Alliance highlights challenges to tuberculosis prevention, healthcare access, and appropriate treatment for drug-resistant infections during the COVID-19 pandemic, noting the need for greater resource allocation, prioritized short all-oral therapies, and full funding of a portfolio of treatments, vaccines, and diagnostics.

Oct 9, 2020 - In a medRxiv preprint, Monira Parveen, MD, MBBS, et al provides an overview of antimicrobial resistance and inappropriate antibiotic use in Bangladesh during the COVID-19 pandemic, highlighting potential mitigation strategies that include restrictions on over-the-counter antimicrobial sales, biomarker testing, provider and patient education, and the effective use of telemedicine.

Oct 6, 2020 - In news from the University of Maryland School of Pharmacy, Malissa Carroll, MA, highlights comments made by Emily Heil, PharmD, during the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) public meeting on the role of antimicrobial stewardship in helping to improve patient care and mitigate supply chain disruptions during the COVID-19 pandemic.

Oct 6, 2020 - On the Global Antibiotic Research & Development Partnership REVIVE website, John Rex, MD, discusses how lessons learned from COVID-19 support the importance of non-inferiority trials for new antimicrobial agents, particularly agents used to treat infections in critical care.

Oct 1, 2020 - Devex features an interview with Dr. Saurabh Rane, a survivor of extensively drug-resistant tuberculosis, about the need to increase access to treatment for people living with tuberculosis during the COVID-19 pandemic and the potential of a decentralized and local emphasis on delivery of care.

Sep 28, 2020 - BusinessMirror highlights perspectives from Maria Rhona G. Bergantin, MD, MSc, and Cesar Recto II, MD, on the links between COVID-19, bacterial co-infection, and antimicrobial resistance in the Philippines.

Sep 26, 2020 - In Forbes, Madhukar Pai, MD, PhD, highlights aspects of a recently released World Health Organization Global Tuberculosis Programme report ("Progress towards achieving global tuberculosis targets and implementation of the UN Political Declaration on Tuberculosis"), and its conclusion that urgent action and investment are needed to assuage the impact of the COVID-19 pandemic on tuberculosis services, referring to COVID-19 and tuberculosis as a "syndemic that feeds on social inequities and poverty."

Sep 24, 2020 - On the blog of the UK Research and Innovation (UKRI) Arts and Humanities Research Council, Colin MacDuff, RMN, RGN, PhD, MSc, describes the contribution of the arts and humanities to understanding and innovating for antimicrobial resistance, COVID-19, and general interdisciplinary work.

Sep 24, 2020 - In a commentary for the London School of Hygiene & Tropical Medicine, Clare Chandler, PhD, MSc, and Claas Kirchhelle, DPhil, MA, entertain the idea of antibiotics as an infrastructure that sets expectations for what is possible, highlighting what COVID-19 has revealed about the need for innovation in addressing structural factors that drive antibiotic use, equitable regulation, and an international commitment driven by data that transforms practice.

Sep 23, 2020 - In a commentary for the BMJ blog, Buddha Basnyat, MD, MSc, Olawale Salami, MD, PhD, Abhilasha Karkey, PhD, MSc, Catrin Moore, DPhil, MBA, MSc, Abhishek Giri, MD, and Piero Olliaro, MD, PhD, MA, describe the impact of COVID-19 on health delivery and research in South Asia, highlighting the need for a plan to implement antimicrobial stewardship guidelines for COVID-19 patients and improve diagnostics for febrile illnesses.

Sep 23, 2020 - On PMLiVE, Lara Meyer, MSc, discusses the links between COVID-19 and antimicrobial resistance from the perspective of healthcare workers' concerns and observations expressed on social media.

Sep 22, 2020 - In The Guardian, Tom Kibasi discusses the need for a global foundation to health security in the light of the COVID-19 pandemic and the assertion that the current global architecture is insufficient to prevent or respond to future crises, asserting that a new global institution could lead efforts to combat antimicrobial resistance.

Sep 18, 2020 - REFORM published an assessment of the UK's efforts to manage antimicrobial resistance, exploring seven "key ideas" to encourage innovation in antimicrobial stewardship and governance in the light of experiences with testing, surveillance, and clinical practice during the COVID-19 pandemic.

Sep 17, 2020 - As part of Mediaplanet's 2020 Global Cause Infectious Diseases campaign, Haileyesus Getahun Gebreone, MD, PhD, MPH, asserts the importance of antimicrobial access as a key part of universal health coverage, noting how the COVID-19 pandemic has revealed close links between health and economic development that can be applied to the need for enhanced governance and national and grassroots efforts to mitigate drug shortages and increase equitable access.

Sep 17, 2020 - As part of Mediaplanet's 2020 Global Cause Infectious Diseases campaign, Jinkou Zhao, PhD, MSc, describes the importance of innovative responses to data collection and sharing in mitigating negative impacts of the COVID-19 pandemic on the management of tuberculosis, HIV, and malaria.

Sep 16, 2020 - In Open Access Government, Josep Figueras, MD, PhD, MPH, and Anna Sagan, MSc, describe the need to maintain prevention of antimicrobial resistance during the COVID-19 pandemic, noting the importance of investment in public-private initiatives and resilient health systems.

Sep 16, 2020 - In Forbes, Rodney Rohde, PhD, describes the ways in which the COVID-19 pandemic may accelerate antimicrobial resistance, highlighting the need for improved public health/university funding and speaking with Timothy P. Gauthier, PharmD, about how antimicrobial stewardship plays a fundamental role across COVID-19 response.

Sep 16, 2020 - On the blog of the African Institute for Development Policy, Victory Kamthunzi, MA, Levi Kalitsilo, MSc, Claire Jensen, MSW, and Paul Kawale, PhD, MPH, discuss the relationship between COVID-19, sepsis, and antimicrobial resistance, highlighting multidisciplinary efforts to strengthen the ability of health systems to address the triple threat.

Sep 16, 2020 - A coalition of stakeholders in tuberculosis prevention and care—including the Stop TB Partnership, McGill University, and the Global TB Caucus—released "The Impact of COVID-19 on the TB Epidemic: A Community Perspective," which details findings and calls to action from a global survey of civil society organizations and communities affected by tuberculosis.

Sep 16, 2020 - In an opinion piece for Wellcome, Gemma Buckland Merrett, PhD, MSc, describes the need for more research and reliable data on the effects of COVID-19 on drug resistance, also calling for ideas on systems that might work to gather, generate, and use data around the world.

Sep 14, 2020 - In ICU Management & Practice, Michael Mansour, MD, PhD, discusses procalcitonin-guided antibiotic stewardship in COVID-19 patients, especially in the inflammatory phase of SARS-CoV-2 infection, and the difficulty in estimating the toll of secondary bacterial infections during the course of the disease.

Sep 14, 2020 - In the European Respiratory Journal, Martin Duerden, MBBS, discusses the issue of antibiotic over-prescribing for sore throat and the opportunity presented by COVID-19 to improve prescribing guidelines, address regional discrepancies in recommendations, and ensure that people have access to evidence-informed symptom-based treatment.

Sep 14, 2020 - On the AMR Solutions blog, John H. Rex, MD, summarizes a chat with Sumathi Nambiar, MD, PhD, and Marco Cavaleri, PhD, during the AMR conference about regulatory activities related to guidance updates, anti-infective development for rare pathogens, the challenges of running trials during COVID-19, and more.

Sep 10, 2020 - On Axios, Eileen Drage O'Reilly, MA, highlights perspectives from Arjun Srinivasan, MD, and Amy Mathers, MD, on the possibility that the COVID-19 pandemic may not be fueling a substantial increase in drug-resistant infections.

Sep 9, 2020 - In The Guardian, Sheldon Chanel and Ben Doherty, MS, discuss the threat posed by antimicrobial resistance (AMR) in the context of COVID-19 across the Pacific region, focusing on trends in drug-resistant infections in Fiji and partnerships between researchers in Fiji and Australia to enhance One Health AMR surveillance in the region.

Sep 9, 2020 - In Dermatology Advisor, Linda Peckel summarizes how dermatologic diagnoses and prescribing play a role in antimicrobial resistance (AMR) during the COVID-19 pandemic, speaking with Adam Friedman, MD, about considering the risk of AMR when prescribing for acne and other chronic skin conditions.

Sep 6, 2020 - In the Bloomberg Coronavirus Daily, Emma Court reports on how the shortage of supplies for COVID-19 testing in the US has limited testing for bacterial pathogens and could be affecting identification of disease-causing pathogens and appropriate antibiotic use.

Sep 2, 2020 - In an interview with the Pew Charitable Trusts, Manica Balasegaram, BM BS, MSc, speaks about his work as the executive director of the Global Antibiotic Research & Development Partnership, the role of nonprofits in helping to address challenges faced by antibiotic developers, and the impact of global mobilization to confront the COVID-19 pandemic on the future of antibiotic research and development policy.

Sep 1, 2020 European Biotechnology features a summary of the 4th AMR Conference, which highlighted the impact of the COVID-19 pandemic on antibiotic use and the importance of diagnostics, improvement of market conditions for antibiotics through innovative pull incentives, the work of Indian government officials to build a framework to address antimicrobial resistance and COVID-19, among other issues.

Aug 31, 2020 - In USA Today, John Fauber and Daphne Chen profile the work of 91-year-old Calvin Kunin, MD, to warn other clinicians of the danger of over-prescribing antibiotics during the COVID-19 pandemic, highlighting Kunin's work to learn about and prevent antibiotic resistance during the 1957-58 influenza pandemic.

Aug 31, 2020 - On Contagion, Saskia Popescu, PhD, MPH, MA, highlights recent research on the interplay between antibiotic use and the presence of community-onset bacterial co-infections in COVID-19 patients.

Aug 27, 2020 - In advance of World Sepsis Day (Sep 13), ReAct highlights issues affecting the management of sepsis, including broad-spectrum antibiotic use, co-occurence with COVID-19, cancer care, and neonatal health.

Aug 26, 2020 - In a post for the Microbiology Society, Michael Devlin, MA, discusses research that delves into the potential of antimicrobial resistance to change drastically in response to changes wrought by the COVID-19 pandemic, particularly as those changes have affected water, sanitation, and hygiene in low- and middle-income regions.

Aug 25, 2020 - In a commentary for the ISGlobal (Barcelona Institute for Global Health) Antimicrobial Resistance Initiative, Clara Ballesté, PhD, and Jordi Vila, MD, PhD, describe concerns around the use of antibiotics, such as teicoplanin and azithromycin, as alternative or combination therapies for COVID-19, along with possible effects on antimicrobial resistance associated with telemedicine prescribing and biocide use during the pandemic.

Aug 25, 2020 - In a commentary for the British Society for Antimicrobial Chemotherapy (BSAC), Eva M. Krockow, PhD, describes how communication about the threat of antimicrobial resistance falls short in describing its importance and empowering people to take action, especially in the light of terms used to discuss HIV/AIDS and COVID-19.

Aug 20, 2020 - In Clinical Lab Manager, Miriam Bergeret, MSc, summarizes conflicting research on the possibility of procalcitonin testing to guide antibiotic use in COVID-19 patients.

Aug 19, 2020 - In Nature, Maryn McKenna, MSJ, describes the unique challenges faced by pharmaceutical and biotechnology companies that manufacture antibiotics, also providing insight into antibiotic supply and demand issues that have accompanied the COVID-19 pandemic.

Aug 10, 2020 - On Somatosphere, Rachel Irwin, PhD, explores the use of the "Dark Ages" metaphor for the growth of antimicrobial resistance, popular fascination with scientific dystopias, and possibilities for thinking and creating a liveable and equitable future in a potential post-antibiotic era.

Aug 7, 2020 - In an interview hosted by the Longitude Prize, Robyn Meurant describes regulatory considerations for the development of rapid point-of-care diagnostic tests, particularly regarding issues of market entry into south and east African countries, also discussing the effect of COVID-19 on changes to diagnostics pathways and the possible impact these changes may have on antimicrobial resistance and test availability.

Aug 4, 2020 - On The Conversation, Lara Marks, DPhil, and Ankur Mutreja, PhD, MSc, discuss how the burden of antimicrobial resistance may fall on low- and middle-income countries where health services and supplies have been disrupted during COVID-19 lockdowns, discussing also the development of a cheap and portable diagnostic kit that can determine an isolate's antibiotic susceptibility without identifying the pathogen.

Aug 4, 2020 - In Forbes, Louis Metzger IV, PhD, summarizes the ongoing history of antimicrobial resistance and the myriad considerations for development of new antibiotic therapies, along with efforts to provide incentives and collaborative environments for antibiotic research.

Aug 3, 2020 - In The New York Times, Apoorva Mandavilli considers the effect of the COVID-19 pandemic on global rates of tuberculosis, highlighting the risk of rising drug resistance amid overwhelmed infrastructures and medical supply chain disruptions.

Jul 28, 2020 - In Infection Control Today, Jan Dyer describes the effect of the COVID-19 pandemic on surveillance for healthcare-associated infections, along with the impact on antimicrobial stewardship and infection control programs.

Jul 23, 2020 - In Chemistry World, Phillip Broadwith, DPhil, PhD, MSci, describes the need to apply lessons learned from the COVID-19 pandemic to improving the funding and interdisciplinary collaboration environment needed to address climate change and antimicrobial resistance.

Jul 13, 2020 - In Financial Times, Emma Walmsley, MA, describes the need for a greater array of pull incentives for antibiotic development to prepare for possible increases in drug-resistant infections following the COVID-19 pandemic.

Jul 13, 2020 - On HealthWire, Raghwendra Shukla interviews Patrick R. Murray, PhD, about the relationship between COVID-19 and antimicrobial resistance.

Jul 10, 2020 - On Somatosphere, Danny de Vries, PhD, MA, Karlijn Hofstraat, MSc, and Vera Spaan discuss demographic, economic, and sociocultural similarities between how societies view and respond to COVID-19 and antimicrobial resistance, also noting links and differences between the effect of both on the symbolic role of modern medicine and how causality and blame are framed.

Jul 10, 2020 - On the Deloitte Centre for Health Solutions blog, Samrina Bhatti, MRPharmS, discusses the UK government's response to antimicrobial resistance in the context of possible increases following the COVID-19 pandemic, also describing the possible roles of healthcare professionals, digital technologies, and industry.

Jul 9, 2020 - In The Telegraph, Dame Sally Davies, MBChB, MSc, and Thomas Cueni, MS, describe the threat of antimicrobial resistance in the wake of the COVID-19 pandemic, along with the need for clarity about the risks faced by society and modern medicine.

Jul 8, 2020 - In a policy brief for the South Centre, Mirfin Mpundu, BPharm, MPH, MBA, Caline Mattar, MD, and Mirza Alas, MPH, discuss the roles of surveillance, new technologies, and infection prevention and control in building health system capacity to respond to antimicrobial resistance and COVID-19 in low- and middle-income countries.

Jul 7, 2020 - In a feature story for Al Jazeera, Amir Khan, MBBS, describes the potential links between the COVID-19 pandemic and rising antimicrobial resistance.

Jul 3, 2020 - On DownToEarth, Rajeshwari Sinha, PhD, MSc, discusses the World Health Organization's concern regarding personal and environmental biocides as a potential contributor to antimicrobial resistance during the COVID-19 pandemic.

Jun 21, 2020 - In interviews for Canada's CBC News, Amina Zafar, MMJC, discusses concerns raised by Eric Brown, PhD, about long-term effects from antibiotic overuse during the COVID-19 pandemic.

Jun 17, 2020 - In the Philadelphia Inquirer, Kasra Zarei describes factors that may contribute to the risk of drug-resistant bacterial infections in COVID-19 patients.

Jun 16, 2020 - In commentary for the United States Pharmacopeial Convention (usp), Carly Ching, PhD, and Muhammad Hamid Zaman, PhD, describe concerns around substandard and falsified antibiotics and the rise of antimicrobial resistance during the COVID-19 pandemic.

Jun 16, 2020 - In The Telegraph, Georgina Hayes, MA, discusses the relationship between antibiotic overprescribing and a lack of access to testing during the COVID-19 pandemic, particularly in the light of unavailable testing for viral causes of pneumonia in community settings.

Jun 11, 2020 - In a perspective piece for the British Society for Antimicrobial Chemotherapy (BSAC), Laura Seeney describes how the COVID-19 pandemic may provide an opportunity for students to use their voices at home, on social media, and eventually at colleges and universities to inspire and educate people about antimicrobial resistance.

Jun 11, 2020 The Hindu reports on a webinar hosted by India's Centre for Science and Environment to discuss connections between the COVID-19 pandemic, antimicrobial resistance, and industrial agriculture.

Jun 9, 2020 - On The Conversation, David W. Graham, PhD, MASc, and Peter Collignon, MBBS, PhD, discuss the possibility of increased antimicrobial resistance following the COVID-19 pandemic, focusing on efforts to reduce antibiotic use through water, sanitation, and hygiene improvements and governance around pollution and wastewater management in low- and middle-income countries.

Jun 9, 2020 - On DownToEarth, Vibha Varshney, PhD, discusses the need for governments and clinicians to advocate for judicious use of broad-spectrum antibiotics during the COVID-19 pandemic.

Jun 4, 2020 - In the New York Times, Andrew Jacobs offers insight into the perspectives and decisions of clinicians attempting to educate others on lessons learned from antibiotic over-prescribing during the COVID-19 pandemic.

Jun 2, 2020 - In news from the World Economic Forum, Linda Lacina, MA, discusses points made during a World Health Organization media briefing on COVID-19 and other emergent disease threats, noting a reference to antimicrobial resistance as "the most urgent challenge of our time."

Jun 1, 2020 - In a news release, the World Health Organization (WHO) noted the large number of countries currently monitoring and reporting on antimicrobial resistance via the Global Antimicrobial Resistance and Surveillance System (GLASS). GLASS now aggregates data from more than 64,000 surveillance sites with more than 2 million patients enrolled from 66 countries.  In the statement, the WHO also expressed concern regarding increased use of antibiotics during the COVID-19 pandemic.

Jun 1, 2020 - In a post for the American Council on Science and Health, David Shlaes, MD, PhD, evaluates high rates of antibiotic use during the COVID-19 pandemic through the lens of his experiences with antimicrobial resistance as an attending physician on a medical intensive care unit.

May 29, 2020 - The Fleming Fund articulated its intent to continue supporting low- and middle-income countries as they strengthen antimicrobial resistance (AMR) surveillance systems and establish the effect of COVID-19 on AMR.

May 29, 2020 - In a commentary for the Pew Charitable Trusts, Kathy Talkington, MPA, highlights news items that delve into the impact of the COVID-19 pandemic on the availability of effective antibiotics.

May 27, 2020 - A perspective piece from ReAct describes shortcomings of the World Health Assembly COVID-19 response resolution, which mentions the need for prudent antibiotic use but fails to address structural changes to water, sanitation, infections prevention, and equitable access to antibiotics.

May 27, 2020 - News from the Carolina Antimicrobial Stewardship Program at the University of North Carolina School of Medicine features insight from Nicolaos Mavrogiorgos, MD, and Lindsay Daniels, PharmD, about how they have adapted a telemedicine program to carry out antimicrobial stewardship interventions during the COVID-19 pandemic.

May 26, 2020 - In The Parliament, Nicolae Ștefănuță, MPM, MA, discusses the threat of AMR during the COVID-19 pandemic, exploring a proposal for a results-based AMR fund that would provide incentives for accountable action across EU member states.

May 25, 2020 - In Infection Control Today, Frank Diamond interviews Katherine Perez, PharmD, about how the COVID-19 pandemic might affect future antimicrobial stewardship efforts and the connections between hospital antimicrobial stewardship and infection control teams.

May 19, 2020 - In a commentary for the British Society for Antimicrobial Chemotherapy, Liz Wilson discusses the experience of developing a COVID-19 Virtual Ward at a UK hospital and the future potential for the program in reducing the transmission of antimicrobial resistance.

May 14, 2020 - In an NPR interview, Susan Brink speaks with Muhammad Hamid Zaman, PhD, about Zaman's recent book, Biography of Resistance: The Epic Battle Between People and Pathogens, and One Health approaches to thinking about the concurrent problems of COVID-19 and antimicrobial resistance.

May 13, 2020 - On the Global Antibiotic Research & Development Partnership REVIVE blog, Stephan Harbarth, MD, MS, discusses the possible effects that the COVID-19 pandemic could have on antimicrobial resistance, highlighting experiences in Geneva and several scenarios in which the effect of COVID-19 on antimicrobial resistance is up for debate.

May 13, 2020 - In commentary for the Royal Australian College of General Practitioners, Doug Hendrie, PhD, discusses international efforts to determine the links between co-infections, antimicrobial resistance, and COVID-19 mortality.

May 12, 2020 - On Medscape, Will Boggs, MD, summarizes research on the low rates of microbial co-infection in people hospitalized with COVID-19 and other coronaviruses, along with high observed rates of empirical antimicrobial prescribing.

May 12, 2020 - On Healio, Trevor Van Schooneveld, MD, describes data on the increasing rates of antibiotic use during the COVID-19 pandemic.

May 12, 2020 - On MedPage Today, Ryan Basen, MA, describes clinical perspectives on antibiotic overuse and reductions during the COVID-19 pandemic, highlighting that antimicrobial stewardship is "difficult, but doable."

May 12, 2020 - In a perspective piece for the British Society for Antimicrobial Chemotherapy, Ronan McCarthy, PhD, describes the potential for a rise in antimicrobial resistance (AMR) associated with the COVID-19 pandemic, calling for a unified global effort, industry incentives, and large-scale funding to address AMR.

May 11, 2020 - In commentary for Gavi, the Vaccine Alliance, Stephen Sosler, PhD, discusses the importance of maintaining routine immunization programs in combating the threat of rising antimicrobial resistance during the COVID-19 pandemic.

May 7, 2020 - In commentary for the Fresh Approaches to the Study of Antimicrobials in Society project at the London School of Hygiene & Tropical Medicine, Faith Kandiye describes the status of work on antimicrobial resistance during the COVID-19 lockdown in Zimbabwe.

May 5, 2020 - In an opinion piece for the University of Copenhagen School of Global Health, Gloria Cordoba, MD, PhD, MPH, discusses questions surrounding connections between antimicrobial resistance and COVID-19, given the high variation in mortality rates across countries, and highlights the need to maintain momentum on antibiotic stewardship, development of diagnostic tests, and international efforts that take a One Health stance.

May 5, 2020 - In the Tribune Review, Cornelius Clancy, MD, describes the connections between the need for new antibiotics and the care of COVID-19 patients.

May 4, 2020 - In the Financial Times, Donato Paolo Mancini describes possible lessons learned from efforts to contain and manage the COVID-19 pandemic and their applications to how the general public and antibiotic researchers view the problem of antimicrobial resistance.

Apr 28, 2020 - In commentary for the British Society for Antimicrobial Chemotherapy, Andrew Singer, PhD, discusses the implications of high quantities of antibiotics used during the COVID-19 pandemic on the spread of antimicrobial resistance genes in the environment.

Apr 27, 2020 - In an article for the Pew Charitable Trusts, Kathy Talkington, MPA, highlights recently published commentary on the nexus of COVID-19 and antibiotic stewardship.

Apr 23, 2020 - ReAct highlights possible effects of COVID-19 on vaccine-preventable diseases, particularly those that affect children, and global antibiotic resistance.

Apr 23, 2020 - In Wired, Maryn McKenna, MSJ, describes the possibility that global antibiotic resistance may rise substantially during and after the COVID-19 pandemic, summarizing current research efforts to determine and predict the extent of the problem and changes in practice that may entail empirical antibiotic administration for situations that previously had not required therapy.

Apr 22, 2020 - On The Conversation, Ronan McCarthy, PhD, discusses the risk of secondary bacterial infections during viral pandemics, both historically and in light of clinical experiences during the COVID-19 pandemic, highlighting the potential for increases in antimicrobial resistance and the need for new antibiotics.

Apr 22, 2020 - In Forbes, Nicole Fisher, MPP, describes what people should know about antimicrobial resistance, "superbugs," and antibiotic use in the context of COVID-19.

Apr 22, 2020 - On Medium, Lance B. Price, PhD, describes the importance of continuing to track and study antibiotic-resistant bacteria during the COVID-19 pandemic, with attention to the risk of transmission of resistance mechanisms in crowded hospitals that may lack protective supplies, along with the intensified threat that the lack of antibiotic access poses to healthcare in resource-limited settings.

Apr 20, 2020 - In news from the International Livestock Research Institute, Ekta Patel, PhD, and Arshnee Moodley, PhD, explore the link between COVID-19 and antibiotic resistance in low- and middle-income countries, particularly as it affects testing and antibiotic use in rural areas of sub-Saharan Africa.

Apr 20, 2020 - On The Conversation, Lori L. Burrows, PhD, describes the public health and economic risk posed by antibiotic resistance, citing lessons learned from addressing the COVID-19 pandemic and how they can be applied to improvements in antibiotic development, vaccination, and the use of antibacterial products.

Apr 16, 2020 - In Science, Sara Reardon, MS, describes the experiences of several infectious diseases clinicians as they make decisions regarding antibiotic therapy for COVID-19 patients and address fears surrounding the development of antibiotic resistance, along with a summary of the US Department of Defense's plan to assemble a group of medical centers to study secondary bacterial and fungal infections and antimicrobial use in COVID-19 patients.

Apr 16, 2020 - On The Hill, Jessie Hellmann, MA, describes how increased demand for azithromycin following the US president's promotion of the antibiotic as a COVID-19 treatment has led to shortages that may particularly affect the care of patients with sexually transmitted infections.

Apr 16, 2020 - In Scientific American, Oliver Schacht, PhD, describes the need to enhance testing for bacterial and fungal infections in patients hospitalized with COVID-19.

Apr 16, 2020 - The Joint Programming Initiative on Antimicrobial Resistance describes the need to prepare for increasing antimicrobial resistance attributed to heightened antibiotic use and bacterial infections secondary to COVID-19, also noting that the potential spread of antimicrobial resistance via hospital wastewater requires a community-oriented approach.

Apr 15, 2020 - In an article for the Pew Charitable Trusts, Kathy Talkington, MPA, describes the important role that antibiotics play in caring for COVID-19 patients and patients with other life-threatening or immune-compromising conditions, outlining five priorities to ensure a sustainable system for effective antibiotics.

Apr 9, 2020 - In US News & World Report, Daniel Levine describes how clinicians can address patients' demands for antibiotics to prevent or treat COVID-19 and the risk of antimicrobial resistance associated with inappropriate antibiotic use during the pandemic, providing perspective on patient education methods from Gary LeRoy, MD, and Jeffrey A. Linder, MD. 

Apr 7, 2020 - For Endpoints News, Natalie Grover, MSc, reports on the possible links between COVID-19 and antibiotic-resistant secondary bacterial infections, citing limited data from studies of antibiotic use in COVID-19 patients, perspectives from infectious diseases clinicians and biotechnology professionals, the global surge in demand for antibiotics, and the need for meaningful change in how incentives are applied to antibiotic development.

Apr 7, 2020 - On Norway Today, Alethea Ellingsen reports on perspectives among Norwegian clinicians about the link between COVID-19 mortality and antibiotic consumption and resistance in southern European countries. 

Apr 6, 2020 - On the Infectious Diseases Society of America Global Health "Science Speaks" blog, Neil J. Clancy, MD, discusses available data on the associations between COVID-19 and bacterial and fungal superinfections, highlighting the need for an economic model that both encourages sustainable drug development and appropriate use, particularly for broad-spectrum agents.

Apr 6, 2020 - On Phrma's The Catalyst forum, Andrew Powaleny interviews Julie Gerberding, MD, MPH, about the connections between COVID-19, secondary bacterial infections, and antimicrobial resistance, along with the immediacy of addressing market failures in antibiotic research and development.

Apr 4, 2020 - ReAct outlines current knowledge on the relationship between COVID-19 disease outcomes and antimicrobial resistance, also noting the potential for drug shortages and the possibility for new approaches to antibiotic development.

Apr 3, 2020 - On the Global Antibiotic Research & Development Partnership REVIVE blog, Manica Balasegaram, BM BS, MSc, describes the link between COVID-19 and drug-resistant infections, along with the urgent need to protect global access to antibiotics.

Apr 1, 2020 - In a Scientific American opinion piece, Claas Kirchhelle, DPhil, MA, Adam Roberts, PhD, and Andrew C. Singer, PhD, describe how antibiotic resistance could be a significant contributor to COVID-19 mortality, pleading that "the global unity of purpose and research that is tackling COVID-19 become a roadmap for solving one of the most pernicious and long-running crises in global medicine—the issue of increasing antibiotic resistance and a stuttering pipeline of solutions."

Apr 1, 2020 - In The Globe and Mail, Andrew Morris, MD, MS, and Gerry Wright, PhD, discuss possible effects on global rates of antimicrobial resistance associated with increased antibiotic use for patients with COVID-19, the need to re-affirm the principles of antimicrobial stewardship, and the formation of an interdisciplinary Canadian network to bring issues related to antimicrobial resistance into public discourse.

Apr 1, 2020 - For BBC Future, Martha Henriques, MSci, explores possible reasons behind the variance in COVID-19 death rates between different countries, delving into the effects of country-level testing strategies, determining the cause of death when multiple comorbidities are present, and the implications of high antimicrobial resistance rates in Italy.

Mar 31, 2020 - On FierceHealthcare, Kenneth Thorpe, PhD, MA, describes how antibiotic resistance has become a greater threat amidst the COVID-19 pandemic, arguing for greater attention to antimicrobial stewardship and innovative methods to spur antibiotic development.

Mar 24, 2020 - On Swissinfo, Jessica Davis Plüss highlights concerns related to supply and demand of antibiotics during the global response to COVID-19, including the need for more information on antibiotics being used to treat secondary bacterial infections in patients who have COVID-19 and bottlenecks related to procurement of active pharmaceutical ingredients across Asia. 

Mar 23, 2020 - In Stat, Julie Gerberding, MD, MPH, discusses the connections between COVID-19, bacterial co-infections, and antibiotic resistance, also highlighting the need to address how hospitals are reimbursed for antibiotics.

Mar 9, 2020 - On Vox, Jen Kirby, MS, provides perspectives on the possibility that the global COVID-19 outbreak and response may have on drug shortages in the US, highlighting the fragile global supply chain responsible for antibiotic manufacture and procurement of active pharmaceutical ingredients.

Mar 2, 2020 - In Forbes, Victoria Forster, PhD, discusses the impact of COVID-19 on antibiotic shortages in the US and the concentration in China of medical drug manufacturing facilities and raw ingredients for drugs made elsewhere.

Published Literature

Studies, commentaries, or reports on COVID-19, bacterial coinfection, antimicrobial resistance, and antimicrobial stewardship interventions published in peer-reviewed journals

Abdel-Aziz M, Azab N. Acute invasive fungal rhinosinusitis and coronavirus disease 2019. J Craniofac Surg 2021 (published online Sep 220

Abdela SG, Liesenborghs L, Tadese F, et al. Antibiotic overuse for COVID-19: are we adding insult to injury? Am J Trop Med Hyg 2021 (published online Oct 29)

Abdollahi A, Aliramezani A, Salehi M, et al. Co-infection of ST2 IP carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital. BMC Infect Dis 2021 (published online Sep 8)

Abelenda-Alonso G, Padulles A, Rombauts G, et al. Antibiotic prescription during the COVID-19 pandemic: a biphasic pattern. Infect Control Hosp Epidemiol 2020 (published online Jul 30)

Abouelkhair MA. Non-SARS-CoV-2 genome sequences identified in clinical samples from COVID-19 infected patients: evidence for co-infections. PeerJ 2020 (published online Nov 2)

Abu-Rub LI, Abdelrahman HA, Johar ARA, et al. Antibiotics prescribing in intensive care settings during the COVID-19 era: a systematic review. Antibiotics (Basel) 2021 (published online Aug 2)

Adalbert JR, Varshney K, Tobin R, et al. Clinical outcomes in patients co-infected with COVID-19 and Staphylococcus aureus: a scoping review. BMC Infect Dis 2021 (published online Sep 21)

Adams B, Beaney A. Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy. J Glob Antimicrob Resist 2021 (published online Nov 12)

Adebisi YA, Jimoh ND, Ogunkola IO, et al. The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries. Trop Med Health 2021 (published online Jun 23)

Adebisi YA, Alaran AJ, Okereke M, et al. COVID-19 and antimicrobial resistance: a review. Infect Dis (Auckl) 2021 (published online Jul 31)

Adeiza SS, Shuaib AB, Shuaibu GM. Random effects meta-analysis of COVID-19/S. aureus partnership in co-infection. GMS Hyg Infect Control 2020 (published online Nov 27)

Afshinnekoo E, Bhattacharya C, Burguete-García A, et al. COVID-19 drug practices risk antimicrobial resistance evolution. Lancet Microbe 2021 (published online Feb 24)

Agrawal S, Phulware RH. COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman. Autops Case Rep 2021 (published online Aug 20)

Ahn SY, Park JY, Lim IS, et al. Changes in the occurrence of gastrointestinal infections after COVID-19 in Korea. J Korean Med Sci 2021 (published online Jun 21)

Akagi E, Sharma M, Johnson LB, et al. Clinical features and risk factors for community onset bloodstream infections among COVID-19 patients. Infect Control Hosp Epidemiol 2021 (published online Mar 12)

Akhtar H, Akhtar S, Rahman FU, et al. Treatment options used for management of COVID-19 in Pakistan: timeline, reality, and challenges. JMIR Public Health Surveill 2021 (published online May 2)

Akhtar Z, Mah-E-Muneer S, Rashid MM, et al. Antibiotics use and its knowledge in the community: a mobile phone survey during the COVID-19 pandemic in Bangladesh. Antibiotics (Basel) 2021 (published online Aug 29)

Al-Azzam S, Mhaidat NM, Banat HA, et al. An assessment of the impact of coronavirus disease (COVID-19) pandemic on national antimicrobial consumption in Jordan. Antibiotics (Basel) 2021 (published online Jun 9)

Aldawood F, El-Saed A, Al Zunitan M, et al. Central line-associated blood stream infection during COVID-19 pandemic. J Infect Public Health 2021 (published online Feb 9)

Alegre-González D, Herrera S, Bernal J, et al. Disseminated Cryptococcus neoformans infection associated to COVID-19. Med Mycol Case Rep. 2021 (published online Oct 22)

Alfonso-Sanchez JL, Agurto-Ramirez A, Chong-Valbuena MA, et al. The influence of infection and colonization on outcomes in inpatients with COVID-19: are we forgetting something? Front Public Health 2021 (published online Nov 10)

Al-Hadidi SH, Alhussain H, Hadi HA, et al. The spectrum of antibiotic prescribing during COVID-19 pandemic: a systematic literature review. Microb Drug Resist 2021 (published online Jun 1)

Al-Hatmi AMS, Mohsin J, Al-Huraizi A, et al. COVID-19 associated invasive candidiasis. J Infect 2020 (published online Aug 6)

Alhumaid S, Al Mutair A, Al Alawi Z, et al. Coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2: a systematic review and meta-analysis. Pathogens 2021 (published online Jun 25)

Ali GA, Husain A, Salah H, et al. Trichosporon asahii fungemia and COVID-19 co-infection: an emerging fungal pathogen; case report and review of the literature. IDCases 2021 (published online Aug 3)

Alied M. Antimicrobial resistance, COVID-19 and self-medication in Syria: a potential boost for an already escalating problem. JAC Antimicrob Resist 2021 (published online Jul 18)

Aljuhani O, Al Sulaiman K, Alshabasy A, et al. Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: a multicenter, retrospective cohort study. BMC Infect Dis 2021 (published online Nov 1)

Allam C, Gaymard A, Descours G, et al. Co-infection with Legionella and SARS-CoV-2, France, March 2020. Emerg Infect Dis 2021 (published online Sep 1)

Allegretti JR, Nije C, McClure E, et al. Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 2019. JGH Open 2021 Mar 30;5(5):622-5

Allou N, Larsen K, Dubernet A, et al. Co-infection in patients with hypoxemic pneumonia due to COVID-19 in Reunion Island. Medicine (Baltimore) 2021 (published online Jan 29)

Alloush TK, Mansour O, Alloush A, et al. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital. Neurol Sci 2021 (published online Nov 17)

Alobaid K, Yousuf B, Al-Qattan E, et al. Pulmonary aspergillosis in two COVID-19 patients from Kuwait. Access Microbiol 2021 (published online Feb 11)

Álvarez-Moreno, Valderrama-Beltrán S, Rodriguez AJ. Implications of antibiotic use during the COVID-19 pandemic: the example of associated antimicrobial resistance in Latin America. Antibiotics (Basel) 2021 (published online Mar 20)

Alvi MZ, Sattar M, Cheema FA, et al. COVID-19 and emergence of antimicrobial resistance: a most neglected aspect of health emergency in Pakistan. Diabetes Metab Syndr 2021 (published online Jun 17)

Amarsy R, Jacquier H, Munier AL, et al. Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: another nightmare. Am J Infect Control 2021 (published online Jul 14)

Amarsy R, Trystram D, Cambau E, et al. Surging bloodstream infections and antimicrobial resistance during the first wave of COVID-19: a study in a large multihospital institution in the Paris region. Int J Infect Dis 2021 (published online Oct 21)

Amin-Chowdhury Z, Aiano F, Mensah A, et al. Impact of the COVID-19 pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with SARS-CoV-2: prospective national cohort study, England. Clin Infect Dis 2020 (published online Nov 16)

Andrews A, Budd EL, Hendrick A, et al. Surveillance of antibacterial usage during the COVID-19 pandemic in England, 2020. Antibiotics (Basel) 2021 (published online Jul 10)

Angell KE, Lawler JV, Hewlett AL, et al. Antibacterial use in the age of SARS-CoV-2. JAC Antimicrob Resist 2021 (published online Jun 9)

Ansari S, Hays JP, Kemp A, et al. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective. JAC-Antimicrobial Resistance 2021 (published online Apr 8)

Anton-Vazquez V, Clivillé R. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19. Eur J Clin Microbiol Infect Dis 2021 (published online Jan 19)

Apisarnthanarak A, Weber DJ. Strategy to limit multi-drug resistant Acinetobacter baumannii transmission in cohort COVID-19 critical care unit. Infect Control Hosp Epidemiol 2021 (published online Jun 24)

Apoorva M, Kumar GY. Antimicrobial prescribing in dental practice during COVID 19: its impact on antimicrobial resistance. Indian J Pharmacol 2021 Mar-Apr;53(2):180-1

Aranjani JM, Manuel A, Razack HIA, et al. COVID-19-associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLoS Negl Trop Dis 2021 (pubished online Nov 18)

Arastehfar A, Carvalho A, Nguyen MH, et al. COVID-19–associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions? J Fungi (Basel) 2020 (published online Oct 8)

Arcari G, Raponi G, Sacco F, et al. Klebsiella pneumoniae infections in COVID-19 patients: a two-month retrospective analysis in an Italian hospital. Int J Antimicrob Agents 2020 (published online Nov 27)

Armitage R, Nellums LB. Antibiotic prescribing in general practice during COVID-19. Lancet Infect Dis 2020 (published online Dec 1)

Armstrong-James D, Youngs J, Bicanic T, et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J 2020 (published online Oct 1)

Arora S, Bhatnagar A, Singh GK, et al. Hansen's disease in the era of COVID-19: an observation on a series of six patients with co-infection. Dermatol Ther 2021 (published online Feb 2)

Arora S, Hemmige VS, Mandke C, et al. Online registry of COVID-19–associated mucormycosis cases, India, 2021. Emerg Infect Dis 2021 (published online Aug 27)

Arshad A, Ijaz F, Siddiqui M, et al. COVID-19 pandemic and antimicrobial resistance in developing countries. Discoveries 2021 (published online Nov 10)

Arshad M, Mahmood SF, Khan M, et al. Covid -19, misinformation, and antimicrobial resistance. BMJ 2020 (published online Nov 24)

Arteaga-Livias K, Pinzas-Acosta K, Perez-Abad L, et al. A multidrug resistant Klebsiella pneumoniae outbreak in a Peruvian hospital. Another threat from the COVID-19 pandemic. Infect Control Hosp Epidemiol 2021 (published online Jan 5)

Arun AB, Hasan MM, Rackimuthu S, et al. Antifungal drug shortage in India amid surfeit of invasive fungal functions during COVID-19. Infect Control Hosp Epidemiol 2021 (published online Sep 23)

Ashiru-Oredope D, Kerr F, Hughes S, et al. Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom. Antibiotics (Basel) 2021 (published online Jan 23)

Asmarawati TP, Rosyid AN, Suryantoro SD, et al. The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya. F1000Res 2021 (published online Feb 15)

Assefa D, Melaku T. Commercial hand sanitizers use amid COVID-19 pandemic: the concerns of antimicrobial resistance. Infect Drug Resist 2021 Jun 10;14:2183-5

Assi M, Abbas S, Nori P, et al. Infection prevention and antimicrobial stewardship program collaboration during the COVID-19 pandemic: a window of opportunity. Curr Infect Dis Rep 2021 (published online Aug 18)

Assi M, Doll M, Pryor R, et al. Impact of COVID-19 on healthcare-associated infections: an update and perspective. Infect Control Hosp Epidemiol 2021 (published online Mar 12)

Aurilio C, Sansone P, Paladini A, et al. Multidrug resistence prevalence in COVID area. Life 2021 (published online Jun 23)

Auxiliadora Parreiras Martins M, Fonseca de Madeiros A, Dias Carneiro de Almeida C, et al. Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview. Drugs Ther Perspect 2020 (published online Jul 31)

Ayad S, Alyacoub R, Gergis K, et al. Invasive pneumococcal disease in a patient with COVID-19: a case report. Cureus 2021 (published online Feb 25)

Ayerbe L, Risco-Risco C, Forgnone I, et al. Azithromycin in patients with COVID-19: a systematic review and meta-analysis. J Antimicrob Chemother 2021 (published online Nov 17)

Ayoubzadeh SI, Isabel S, Coomes EA, et al. Enteric fever and COVID-19 co-infection in a teenager returning from Pakistan. J Travel Med 2021 (published online Feb 8)

Aznar ML, Espinosa-Pereiro J, Saborit N, et al. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis 2021 (published online Apr 27)

Baccolini V, Migliara G, Isonne C, et al. The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study. Antimicrob Resist Infect Control 2021 (published online Jun 4)

Baddley JW. COVID-19 associated pulmonary aspergillosis: do we have the CAPAcity to improve outcomes? Clin Infect Dis 2021 (published online Mar 23)

Baddley JW, Thompson III GR, Chen SCA, et al. COVID-19-associated invasive fungal infection. Open Forum Infect Dis 2021 (published online Nov 16)

Baghdadi JD, Coffey KC, Adediran T, et al. Antibiotic use and bacterial infection among inpatients in the first wave of COVID-19: a retrospective cohort study of 64,691 patients. Antimicrob Agents Chemother 2021 (published online Sep 7)

Baiou A, Elbuzidi AA, Bakdach D, et al. Clinical characteristics and risk factors for the isolation of multidrug-resistant gram-negative bacteria from critically ill patients with coronavirus disease 2019. J Hosp Infect 2021 (published online Feb 6)

Baker MA, Sands KE, Huang SS, et al. The impact of COVID-19 on healthcare-associated infections. Clin Infect Dis 2021 (published online Aug 9)

Baldwin AJ, Jackowski A, Jamal A, et al. Risk of surgical site infection in hand trauma, and the impact of the SARS-CoV-2 pandemic: a cohort study. J Plast Reconstr Aesthet Surg 2021 (published online Jul 1)

Bandyopadhyay A, Palepu S, Bandyopadhyay K, et al. COVID-19 and tuberculosis co-infection: a neglected paradigm. Monaldi Arch Chest Dis 2020 (published online Sep 4)

Bardi T, Pintado V, Gomez-Rojo M, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis 2021 (published online Jan 3)

Bashir A, Abdullah MS, Momin NR, et al. Prevalence of primary bacterial co-infections among patients with COVID-19 in Brunei Darussalam. Western Pac Surveill Response J 2021 Sep 8;12(3):65-70

Baskara MA, Makrufardi F, Dinisari A. COVID-19 and active primary tuberculosis in a low-resource setting: a case report. Ann Med Surg (Lond) 2021 (published online Jan 12)

Baskaran V, Lawrence H, Lansbury LE, et al. Co-infection in critically ill patients with COVID-19: an observational cohort study from England. J Med Microbiol 2021 (published online Apr 16)

Battista Migliori G, Thong PM, Akkerman O, et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020. Emerg Infect Dis 2020 (published online Sep 11)

Bayram N, Ozsaygılı C, Sav H, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol 2021 (published online May 31)

Bearman G. From the year of the coronavirus disease 2019 (COVID-19) pandemic, the rise of Antimicrobial Stewardship and Healthcare Epidemiology (ASHE): reflections and future priorities. Antimicrobial Stewardship & Healthcare Epidemiology 2021 (published online Jun 23)

Belen Guisado-Gil A, Infante-Dominguez C, Penalva G, et al. Impact of the COVID-19 pandemic on antimicrobial consumption and hospital-acquired candidemia and multidrug-resistant bloodstream infections. Antibiotics (Basel) 2020 (published online Nov 17)

Belvisi V, Del Borgo C, Vita S, et al. Impact of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) pandemic on carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) prevention and control program: convergent or divergent action? J Hosp Infect 2020 (published online Dec 15)

Bendala Estrada AD, Calderón Parra J, Fernández Carracedo E, et al. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis 2021 (published online Nov 8)

Bengoechea JA, Bamford CGG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med 2020 (published online May 26)

Bentivegna E, Alessio G, Spuntarelli V, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control 2020 (published online Oct 5)

Beovic B, Dousak M, Ferreira-Coimbra J, et al. Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother 2020 (published online Aug 7)

Ber Lucien MA, Canarie MF, Kilgore PE, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int J Infect Dis 2021 (published online Jan 9)

Bhargava A, Riederer K, Sharma M, et al. High rate of multidrug-resistant organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission. Am J Infect Control 2021 (published online Aug 17)

Bhatia M. The rise of mucormycosis in Covid-19 patients in India. Expert Rev Ant Infect Ther 2021 (published online Jul 26)

Bhatt K, Agolli A, Patel MH, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova) 2021 (published online Mar 31)

Bhatt PJ, Shiau S, Brunetti L, et al. Risk factors and outcomes of hospitalized patients with severe COVID-19 and secondary bloodstream infections: a multicenter, case-control study. Clin Infect Dis 2020 (published online Nov 20)

Bhattacharyya A, Sarma P, Sharma DJ, et al. Rhino-orbital-cerebral-mucormycosis in COVID-19: a systematic review. Indian J Pharmacol Jul-Aug 2021;53(4):317-27

Bhotla HK, Balasubramanian B, Meyyazhagan A, et al. Opportunistic mycoses in COVID-19 patients/survivors: epidemic inside a pandemic. J Infect Public Health 2021 (published online Oct 15)

Biswas SS, Awal SS, Awal SK. COVID-19 and pulmonary tuberculosis—a diagnostic dilemma. Radiol Case Rep 2021 (published online Aug 2)

Bogdanová K, Doubravská L, Vágnerová I, et al. Clostridioides difficile and vancomycin-resistant enterococci in COVID-19 patients with severe pneumonia. Life (Basel) 2021 (published online Oct 22)

Bogossian EG, Taccone FS, Izzi A, et al. The acquisition of multidrug-resistant bacteria in patients admitted to COVID-19 intensive care units: a monocentric retrospective case control study. Microorganisms 2020 (published online Nov 19)

Bolker A, Coe K, Smith J, et al. Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagn Microbiol Infect Dis 2021 (published online Sep 30)

Boretti A. Steroids induced black fungus infection in India during the May 2021 COVID-19 outbreak. Indian J Otolaryngol Head Neck Surg 2021 (published online Nov 15)

Borges do Nascimento IJ, von Groote TC, O'Mathúna DP, et al. Clinical, laboratory and radiological characteristics and outcomes of novel coronvirus (SARS-CoV-2) infection in humans: a systematic review and series of meta-analyses. PLoS One 2020 (published online Sep 17)

Bork JT, Leekha S, Claeys K, et al. Change in hospital antibiotic use and acquisition of multidrug resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol 2020 (published online Dec 10)

Bourgoin P, Soliveres T, Barbaresi A, et al. CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department. Cytometry A 2021 (published online Jan 21)

Boyd S, Martin-Loeches I. Rates of Aspergillus co-infection in COVID patients in ICU not as high as previously reported. Clin Infect Dis 2021 (published online Jan 8)

Brikman S, Dori G, Kasher C, et al. Candida bloodstream infection, a dire complication in hospitalized COVID-19 patients: three cases from a single center in northern Israel. Isr Med Assoc J 2021 Oct;23(10):615-7

Broadhurst AGB, Lalla U, Taljaard JJ, et al. The diagnostic challenge of pneumocystis pneumonia and COVID-19 co-infection in HIV. Respirol Case Rep 2021 (published online Feb 22)

Bruggemann FJ, van de Veerdonk FL, Verweij PE. The challenge of managing COVID-19 associated pulmonary aspergillosis. Clin Infect Dis 2020 (published online Aug 18)

Buehler PK, Zinkernagel AS, Hofmaenner DA, et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med 2021 (published online Mar 14)

Buehrle DJ, Decker BK, Wagener MM, et al. Antibiotic consumption and stewardship at a hospital outside of an early coronavirus disease 2019 epicentre. Antimicrob Agents Chemother 2020 (published online Aug 19)

Buehrle DJ, Nguyen MH, Wagener MM, et al. Impact of the coronavirus disease 2019 pandemic on outpatient antibiotic prescriptions in the United States. Open Forum Infect Dis 2020 (published online Dec 22)

Buehrle DJ, Wagener MM, Nguyen MH, et al. Trends in outpatient antibiotic prescriptions in the United States during the COVID-19 pandemic in 2020. JAMA Netw Open 2021 (published online Sep 22)

Buil JB, van Zanten ARH, Bentvelsen RG, et al. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021. Euro Surveill 2021 (published online Jun 10)

Burstein B, Anderson G, Yannopoulos A. Prevalence of serious bacterial infections among febrile infants 90 days or younger in a Canadian urban pediatric emergency department during the COVID-19 pandemic. JAMA Netw Open 2021 (published online Jul 13)

Buse C, Brown N, Nettleton S, et al. Caring through distancing: spatial boundaries and proximities in the cystic fibrosis clinic. Soc Sci Med 2020 (published online Nov 17)

Butler CC, Yu LM, Dorward J, et al. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med 2021 (published online Jul 27)

Cafardi J, Haas D, Lamarre T, et al. Opportunistic fungal infection associated with COVID-19. Open Forum Infect Dis 2021 (published online Jan 18)

Calderón M, Li A, Bazo-Alvarez JC, et al. Evaluation of procalcitonin-guided antimicrobial stewardship in patients admitted to hospital with COVID-19 pneumonia. JAC Antimicrob Resist 2021 (published online Aug 20)

Calderón-Parra J, Muino-Miguez A, Bendala-Estrada AD, et al. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One 2021 (published online May 11)

Calderwood MS, Deloney VM, Anderson DJ, et al. Policies and practices of SHEA Research Network hospitals during the COVID-19 pandemic. Infect Control Hosp Epidemiol 2020 Oct;41(10):1127-35

Cama J, Leszczynski R, Tang PK, et al. To push or to pull? In a post-COVID world, supporting and incentivizing antimicrobial drug development must become a governmental priority. ACS Infect Dis 2021 (published online Feb 19)

Cambier S, Metzemaekers M, Carvalho AC, et al. Atypical response to bacterial co-infection and persistent neutrophilic broncho-alveolar inflammation distinguish critical COVID-19 from influenza. JCI Insight 2021 (published online Nov 18)

Caméléna F, Moy AC, Dudoignon E, et al. Performance of a multiplex polymerase chain reaction panel for identifying bacterial pathogens causing pneumonia in critically ill patients with COVID-19. Diagn Microbiol Infect Dis 2020 (published online Aug 21)

Campitelli MA, Bronskill SE, Maclagan LC, et al. Comparison of medication prescribing before and after the COVID-19 pandemic among nursing home residents in Ontario, Canada. JAMA Netw Open 2021 (published online Aug 2)

Cantón R, Gijón D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic. Curr Opin Crit Care 2020 (published online Jul 27)

Casanova C, Küffer M, Leib SL, et al. Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021. Emerg Microbes Infect 2021 (published online Nov 1)

Cassidy SS, Sanders DJ, Wade J, et al. Antimicrobial surfaces: a need for stewardship? PLoS Pathog 2020 (published online Oct 15)

Castro-Lopes A, Correia S, Leal C, et al. Increase of antimicrobial consumption in a tertiary care hospital during the first phase of the COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Jun 25)

Cataldo MA, Tetaj N, Selleri M, et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: an alarming "collateral effect." J Glob Antimicrob Resist 2020 (published online Oct 29)

Cataño-Correa JC, Cardona-Arias JA, Mancilla JPP, et al. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS One 2021 (published online Jul 13)

Chalker VJ, Adler H, Ball R, et al. Fatal co-infections with SARS-CoV-2 and Legionella pneumophila, England. Emerg Infect Dis 2021 Nov;27(11)2950-2

Chamieh A, Zgheib R, El-Sawalhi S, et al. Trends of multidrug-resistant pathogens, difficult to treat bloodstream infections, and antimicrobial consumption at a tertiary care center in Lebanon from 2015–2020: COVID-19 aftermath. Antibiotics (Basel) 2021 (published online Aug 21)

Chang CT, Lee M, Lee JCY, et al. Public KAP towards COVID-19 and antibiotics resistance: a Malaysian survey of knowledge and awareness. Int J Environ Res Public Health 2021 (pubished online Apr 9)

Chang CY, Chan KG. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics. J Infect 2020 (published online Jul 3)

Charalampous T, Alcolea-Medina A, Snell LB, et al. Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units. Genome Med 2021 (published online Nov 17)

Chaudhry R, Sreenath K, Batra P, et al. Atypical bacterial co-infections among patients with COVID-19: a study from India. J Med Virol 2021 (published online Sep 7)

Chaudhry R, Sreenath K, Vinayaraj EV, et al. Mycoplasma pneumoniae co-infection with SARS-CoV-2: a case report. Access Microbiol 2021 (published online Mar 10)

Chauhan K, Soni D, Sarkar D, et al. Mucormycosis after COVID-19 in a patient with diabetes. Lancet 2021 (published online Aug 4)

Chaurasia S, Thimmappa M, Chowdhury S. Case Report: Chronic Cavitatory Pulmonary Aspergillosis after COVID-19. Am J Trop Med Hyg 2021 (published online Nov 24)

Chedid M, Waked R, Haddad E, et al. Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy. J Infect Public Health 2021 (published online Feb 9)

Chen HH, Chung GWT, Wu JE, et al. Antibiotic stewardship algorithm to rationalise antibiotic use among hospitalised COVID-19 patients. Ann Acad Med Singap 2021 Apr;50(4):366-8

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020 (published online Jan 30)

Chen Z, Guo J, Jiang Y, et al. High concentration and high dose of disinfectants and antibiotics used during the COVID-19 pandemic threaten human health. Environ Sci Eur 2021 (published online Jan 29)

Cheng F, Li Q, Han Y, et al. Analysis of influencing factors and pharmaceutical care of patients with COVID-19 in Fangcang Shelter Hospital. Infect Drug Resist 2020 Oct 6;13:3443-50

Cheng K, He M, Shu Q, et al. Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital. Risk Manag Healthc Policy 2020 (published online Nov 13)

Cheng LSK, Chau SKY, Tso EYK, et al. Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster. Ther Adv Infect Dis 2020 (published online Dec 7)

Chen S, Zhu Q, Xiao Y, et al. Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: an observational study. Clin Respir J 2021 (published online Apr 5)

Chibabhai V, Duse AG, Perovic O, et al. Collateral damage of the COVID-19 pandemic: exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes? S Afr Med J 2020 Jun 2;110(7):572-3

Chirumbolo S, Simonetti V, Franzini M, et al. Estimating COVID-19-caused deaths in hospitals and healthcare units: did hospital acquired infections play the utmost role? Comments with a proposal. Infect Control Hosp Epidemiol 2021 (published online Mar 19)

Chong WH, Neu KP. The incidence, diagnosis, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect 2021 (published online Apr 20)

Chong WH, Saha BK, Ramani A, et al. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 2021 (published online Mar 11)

Choubey A, Sagar D, Cawley P, et al. Retrospective review analysis of COVID-19 patients co-infected with Mycoplasma pneumoniae. Lung India 2021 Mar;38(7):22-6

Choudhary NK, Jain AK, Soni R, et al. Mucormycosis: a deadly black fungus infection among COVID-19 patients in India. Clin Epidemiol Glob Health 2021 (published online Nov 1)

Chowdhary A, Sharma A. The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic. J Glob Antimicrob Resist 2020 (published online Jun 12)

Chowdhary A, Tarai B, Singh A, et al. Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020. Emerg Infect Dis 2020 (published online Aug 27)

Chua KP, Volerman A, Conti RM. Prescription drug dispensing to US children during the COVID-19 pandemic. Pediatrics 2021 (published online Aug 2)

Chukwu EE, Musa AZ, Enwuru C, et al. Determinants of antimicrobial use for Covid-19 related symptoms among Nigerians. West Afr J Med 2021 (published online Mar 22)

Chumbita M, Puerta-Alcalde P, Garcia-Pouton N, et al. COVID-19 and fungal infections: etiopathogenesis and therapeutic implications. Rev Esp Quimioter 2021 Sep;34(suppl 1):72-5

Cimolai N. The complexity of co-infections in the era of COVID-19. SN Compr Clin Med 2021 (published online Apr 23)

Clancy CJ, Buehrle DJ, Nguyen MH. PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates. JAC–Antimicrobial Resistance 2020 (published online Jul 17)

Clancy CJ, Nguyen MH. COVID-19, superinfections and antimicrobial development: what can we expect? Clin Infect Dis 2020 (published online May 1)

Clancy CJ, Schwartz IS, Kula B, et al. Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies. Open Forum Infect Dis 2021 (published online Feb 4)

Codina-Jiménez C, Marin S, Álvarez M, et al. Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case–control study. Eur J Hosp Pharm 2021 (published online Aug 16)

Coenen S, de la Court JR, Buis DTP, et al. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study. Antimicrob Resist Infect Control 2021 (published online Oct 30)

Cohen R, Finn T, Babushkin F, et al. High rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients. Infect Dis (Lond) 2021 (published online Oct 4)

Colaneri M, Valsecchi P, Vecchia M, et al. What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie. J Glob Antimicrob Resist 2021 (published online Jun 9)

Cole J, Barnard E. The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms. Am J Infect Control 2020 (published online Oct 1)

Collignon P, Beggs JJ. CON: COVID-19 will not result in increased antimicrobial resistance prevalence. JAC–Antimicrobial Resistance 2020 (published online Jul 17)

Comber SDW, Upton M, Lewin S, et al. COVID-19, antibiotics and One Health: a UK environmental risk assessment. J Antimicrob Chemother 2020 (published online Aug 12)

Cona A, Tavelli A, Renzelli A, et al. Incidence, risk factors and impact on clinical outcomes of bloodstream infections in patients hospitalised with COVID-19: a prospective cohort study. Antibiotics (Basel) 2021 (published online Aug 24)

Cong W, Narayan Poudel A, Alhusein N, et al. Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: a scoping review. Antibiotics (Basel) 2021 (published online Jun 19)

Contou D, Claudinon A, Pajot O, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 2020 (published online Sep 7)

Copaja-Corzo C, Hueda-Zavaleta M, Benites-Zapata VA, et al. Antibiotic use and fatal outcomes among critically ill patients with COVID-19 in Tacna, Peru. Antibiotics (Basel) 2021 (published online Aug 9)

Coşkun AS, Durmaz SO. Fungal infections in COVID-19 intensive care patients. Pol J Microbiol 2021 Sep;70(3):395-400

Courtenay M, Burnett E, Castro-Sanchez E, et al. Preparing nurses for COVID-19 response efforts through involvement in antimicrobial stewardship programmes. J Hosp Infect 2020 (published online Jun 9)

Cox MJ, Loman N, Bogaert D, et al. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe 2020 (published online Apr 24)

Coz Yataco AO, Simpson SQ. COVID-19 sepsis—a nudge toward antimicrobial stewardship. Chest 2020 (published online Jul 21)

Crabtree SJ, Cohen SH. The role of multidisciplinary infection prevention teams in identifying community transmission of SARS-CoV-2 in the United States. Infect Control Hosp Epidemiol 2020 (published online Jul 23)

Crane MA, Popovic A, Panaparambil R, et al. Reporting of infectious diseases in the United States during the COVID-19 pandemic. Clin Infect Dis 2021 (published online Jun 7)

Croser D. Antimicrobial stewardship and COVID-19. BDJ In Practice 2020 (published online Nov 9)

Cruz Soriano M, Vaquero C, Ortiz-Fernandez A, et al. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J Infect 2020 (published online Sep 18)

Cucchiari D, Pericás JM, Riera J, et al. Pneumococcal superinfection in COVID-19 patients: a series of 5 cases. Med Clin (Barc) 2020 (published online Jun 5)

Cuevas LE, Santos VS, Lima SVMA, et al. Systematic review of pooling sputum as an efficient method for Xpert MTB/RIF tuberculosis testing during the COVID-19 pandemic. Emerg Infect Dis 2021 (published online Feb 22)

Cultrera R, Barozzi A, Libanore M, et al. Co-infections in critically ill patients with or without COVID-19: a comparison of clinical microbial culture findings. Int J Environ Res Public Health 2021 (published online Apr 20)

Cusumano JA, Dupper AC, Malik Y, et al. Staphylococcus aureus bacteremia in patients infected with COVID-19: a case series. Open Forum Infect Dis 2020 (published online Nov 12)

Dahal D, Sundar S, Kullar R, et al. Antimicrobial resistance during the COVID-19 pandemic: the missing patient perspective. JAC–Antimicrobial Resistance 2021 (published online Mar 22)

Daix T, Jeannet R, Hernandez Padilla AC, et al. Immature granulocytes can help the diagnosis of pulmonary bacterial infections in patients with severe COVID-19 pneumonia. J Intensive Care 2021 (published online Sep 20)

Damonti L, Kronenberg A, Marschall J, et al. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Crit Care. 2021 (published online Nov 22)

Danion F, Letscher-Bru V, Guitard J, et al. COVID-19 associated mucormycosis in France: a rare but deadly complication. Open Forum Infect Dis 2021 (published online Nov 6)

Dara M, Kuchukhidze G, Yedilbayev A, et al. Early COVID-19 pandemic’s toll on tuberculosis services, WHO European Region, January to June 2020. Euro Surveill 2021 Jun 17;26(24)

Darvishnia D, Sadeghi M, Sharifpour A, et al. Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin's lymphoma history from north of Iran. Infect Disord Drug Targets 2021 (published online Feb 3)

Das R, Kotra K, Singh P, et al. Alternative treatment strategies for secondary bacterial and fungal infections associated with COVID-19. Infect Dis Ther 2021 (published online Nov 22)

da Silva Ramos FJ, de Freitas FGR, Machado FR. Sepsis in patients hospitalized with coronavirus disease 2019: how often and how severe? Curr Opin Crit Care 2021 (published online Jul 20)

da Silva Ramos FJ, de Freitas FGR, Machado FR. Sepsis in patients hospitalized with coronavirus disease 2019: how often and how severe? Curr Opin Crit Care 2021 Oct;27(5):474-9

Davis MW, McManus D, Koff A, et al. Re-purposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients. Infect Control Hosp Epidemiol 2020 (published online Jun 8)

de Carvalho Hessel Dias VM, Tuon FF, de Jesus Capelo P, et al. Trend analysis of carbapenem-resistant gram-negative bacteria and antimicrobial consumption in the post-COVID-19 era, an extra challenge for healthcare institutions. J Hosp Infect 2021 (published online Nov 19)

Declan Gallacher S, Seaton A. Meningococcal meningitis and COVID-19 co-infection. BMJ Case Rep 2020 (published online Aug 25)

De Francesco MA, Poiesi C, Gargiulo F, et al. Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features. J Infect 2021 (published online Jan 18)

Delliere S, Dudoignon E, Fodil S, et al. Risk factors associated with Covid-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect 2020 (published online Dec 11)

de Lusignan S, Joy M, Sherlock J, et al. PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study. BJGP Open 2021 (published online Jul 26)

Del Pozo JL. Respiratory co-and superinfections in COVID-19. Rev Esp Quimioter 2021 Sep;34(suppl 1):69-71

de Marcellus C, Dupic L, Roux CJ, et al. Case report: cerebrovascular events associated with bacterial and SARS-CoV-2 infections in an adolescent. Front Neurol 2021 (published online Apr 8)

Denny S, Abdolrasouli A, Elamin T, et al. A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave. J Infect 2021 (published online Feb 17)

Denny S, Rawson TM, Hart P, et al. Bacteraemia variation during the COVID-19 pandemic; a multi-centre UK secondary care ecological analysis. BMC Infect Dis 2021 (published online Jun 11)

de Oliveira Ferreira E, Penna B, Yates EA. Should we be worried about Clostridioides difficile during the SARS-CoV-2 pandemic? Front Microbiol 2020 (published online Sep 29)

Desai A, Santonocito OG, Caltagirone G, et al. Effectiveness of Streptococcus pneumoniae urinary antigen testing in decreasing mortality of COVID-19 co-infected patients: a clinical investigation. Medicina (Kaunas) 2020 (published online Oct 29)

Desai EJ, Pandya A, Upadhya I, et al. Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients. Indian J Otolaryngol Head Neck Surg 2021 (published online Aug 15)

De Santis V, Corona A, Vitale D, et al. Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study. Infection 2021 (published online Jul 14)

Despotovic A, Milosevic B, Cirkovic A, et al. The impact of COVID-19 on the profile of hospital-acquired infections in adult intensive care units. Antibiotics (Basel) 2021 (published online Sep 23)

Devi S. No time to lower the guard on AMR. Lancet Microbe 2020 Sep 1;1(5):E198

DeVoe C, Segal MR, Wang L, et al. Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with COVID-19. Infect Control Hosp Epidemiol 2021 (published online Sep 9)

De Waele JJ, Derde L, Bassetti M. Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s? Intensive Care Med 2020 (published online Oct 17)

Dewi IM, Janssen NA, Rosati D, et al. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol 2021 (published online May 22)

d'Humières C, Patrier J, Lortat-Jacob B, et al. Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France. PLoS One 2021 (published online Apr 29)

Diaz Högberg L, Vlahović-Palčevski V, Pereira C, et al. Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020. Euro Surveill 2021 (published online Nov 18)

Dieringer TD, Furukawa D, Graber CJ, et al. Inpatient antibiotic utilization in the Veterans Administration during the COVID-19 pandemic. Infect Control Hosp Epidemiol 2020 (published online Oct 20)

Di Gennaro F, Gualano G, Timelli L, et al. Increase in tuberculosis diagnostic delay during first wave of the COVID-19 pandemic: data from an Italian infectious disease referral hospital. Antibiotics (Basel) 2021 (published online Mar 8)

Di Guardo G. COVID-19: measles and antibiotic resistance are a matter of concern. Pathogens 2021 (published online Apr 9)

Dilworth TJ, Brummitt CF. Reduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the COVID-19 pandemic. Infect Control Hosp Epidemiol 2020 (published online Sep 28)

Ding W, Li Y, Bai Y, et al. Estimating the effects of the COVID-19 outbreak on the reductions in tuberculosis cases and the epidemiological trends in China: a causal impact analysis. Infect Drug Resist 2021 (published online Nov 6)

Di Pilato V, Codda G, Ball L, et al. Molecular epidemiological investigation of a nosocomial cluster of C. auris: evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J Fungi 2021 (published online Feb 15)

Doan T, Hinterworth A, Arzika AM, et al. Reduction of coronavirus burden with mass azithromycin distribution. Clin Infect Dis 2020 (published online May 19)

Dockree S, Brook J, James T, et al. A pregnancy-specific reference interval for procalcitonin. Clin Chim Acta 2020 (published online Dec 8)

Dolci A, Robbiano C, Aloisio E, et al. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients. Clin Chem Lab Med 2020 Nov 19;59(2):433-40

Dona D, Di Chiara C, Sharland M. Multidrug resistant infections in the COVID-19 era, a framework for considering the potential impact. J Hosp Infect 2020 (published online May 17)

Douglas M, Moy S, Hernandez N. Impact of COVID-19 on outpatient antimicrobial prescribing patterns in New York City. Infect Dis Clin Pract 2021 Nov;29(6):e352-5

Dubey P, Thakur B, Reddy S, et al. Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women—a systematic review and meta-analysis. BMC Pregnancy Childbirth 2021 (published online Mar 24)

Dudoignon E, Camelena F, Deniau B, et al. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis 2020 (published online Jun 16)

Duffy E, Thomas M, Hills T, et al. The impacts of New Zealand's COVID-19 epidemic response on community antibiotic use and hospitalisation for pneumonia, peritonsillar abscess and rheumatic fever. Lancet Regional Health—Western Pacific 2021 (published online Jun 9)

Dumitru IM, Dumitrascu M, Vlad ND, et al. Carbapenem-resistant Klebsiella pneumoniae associated with COVID-19. Antibiotics (Basel) 2021 (published online May 11)

Duncan EM, Goulao B, Clarkson J, et al. 'You had to do something': prescribing antibiotics in Scotland during the COVID-19 pandemic restrictions and remobilisation. Br Dent J 2021 (published online Nov 23)

Dykstra MP, Baitchman EJ. A call for One Health in medical education: how the COVID-19 pandemic underscores the need to integrate human, animal, and environmental health. Acad Med 2021 (published online Mar 23)

Egyir B, Obeng-Nkrumah N, Kyei GB. COVID-19 pandemic and antimicrobial resistance: another call to strengthen laboratory diagnostic capacity in Africa. Afr J Lab Med 2020 (published online Sep 23)

Elbeddini A, Prabaharan T, Almasalkhi S, et al. Pharmacists and COVID-19. J Pharm Policy Pract 2020 (published online Jun 19)

Elhamamsy S, Bayer T, Al-Kaffas M, et al. Rhino-orbital cerebral mucormycosis in non-diabetic patients with COVID-19. R I Med J 2021 Oct 1;104(8):19-21

El-Kholy NA, El-Fattah AMA, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity. Laryngoscope 2021 (published online May 19)

Elliott TM, Hurst C, Doidge M, et al. Unexpected benefit of COVID-19 hospital restrictions: reduction in patients isolating with multidrug resistant organisms after restrictions were lifted. Infect Dis Health 2021 (published online Aug 18)

Essack S, Bell J, Burgoyne D, et al. Point-of-care testing for pharyngitis in the pharmacy. Antibiotics (Basel) 2020 (published online Oct 28)

Estella Á, Vidal-Cortés P, Rodríguez A, et al. Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU. Med Intensiva 2021 (published online Apr 30)

Estrada ADB, Parra JC, Carracedo EF, et al. Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. BMC Infect Dis 2021 (published online Nov 8)

The European Society of Intensive Care Medicine (ESICM), The Global Sepsis Alliance (GSA), The Society of Critical Care Medicine (SCCM). Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic? Intensive Care Med 2021 (published online Jun 16)

Evans TJ, Davidson HC, Low JM, et al. Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters? J Infect Prev 2020 (published online Dec 10)

Fabre V, Karaba S, Amoah J, et al. The role of procalcitonin in antibiotic decision-making in Covid-19 infection. Infect Control Hosp Epidemiol 2021 (published online Apr 19)

Fakih MG, Bufalino A, Sturm L, et al. COVID-19 Pandemic, CLABSI, and CAUTI: the urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol 2021 (published online Feb 19)

Fakih MG, Sturm LK, Thyagarajan RV, et al. Is it time for us to account for the impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections? Infect Control Hosp Epidemiol 2021 (published online Nov 8)

Falcone M, Tiseo G, Giordano C, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother 2020 (published online Dec 29)

Farfour E, Lecuru M, Dortet L, et al. Carbapenemase-producing Enterobacterales outbreak: another dark side of COVID-19. Am J Infect Control 2020 (published online Oct 1) 

Farias da Silva C, Deutschendorf C, Marcio Nagel F, et al. Impact of the pandemic on antimicrobial consumption patterns. Infect Control Hosp Epidemiol 2020 (published online Sep 23)

Farrel Cortes M, Leal de Almeida B, Sanchez Espinosa EP, et al. Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients. Diagn Microbiol Infect Dis 2021 (published online Feb 12)

Farrell JM, Zhao CY, Tarquinio KM, et al. Causes and consequences of COVID-19-associated bacterial infections. Front Microbiol 2021 (published online Jul 20)

Fattorini L, Creti R, Palma C, et al. Bacterial coinfections in COVID-19: an underestimated adversary. Ann Ist Super Sanita 2020 Jul-Sep;56(3):359-64

Fazeli MA, Rezaei L, Javadirad E, et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: an observational study. Mycoses 2021 (published online Jul 12)

Fekkar A, Lampros A, Mayaux J, et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med 2021 Feb 1;203(3)

Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan) 2021 (published online Apr 25)

Fierens J, De Bus L, Colpaert K, et al. Antimicrobial prescription in severe COVID-19 and CAP: a matched case-control study. Acta Clin Belg 2021 (published online Oct 28)

Fjelltveit EB, Cox RJ, Kittang BR, et al. Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. Infect Dis (Lond) 2021 (published online Sep 16)

Fontana C, Favaro M, Minelli S, et al. Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test. Sci Rep 2021 (published online Aug 11)

Foschi C, Zignoli A, Gaibani P, et al. Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: conventional culture vs BioFire FilmArray pneumonia plus panel. J Microbiol Methods 2021 (published online May 29)

Fouad YA, Abdelaziz TT, Askoura A, et al. Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic. Front Med (Lausanne) 2021 (published online May 28)

Founou RC, Blocker AJ, Noubom M, et al. The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA 2021 (published online Jun 10)

Frías-De-León MG, Pinto Almazán R, Hernández-Castro R, et al. Epidemiology of systemic mycoses in the COVID-19 pandemic. J Fungi (Basel) 2021 (published online Jul 13)

Frost HM, Sebastian T, Durfee J, et al. Ophthalmic antibiotic use for acute infectious conjunctivitis in children. J AAPOS 2021 (published online Nov 1)

Furukawa D, Graber CJ. Antimicrobial stewardship in a pandemic: picking up the pieces. Clin Infect Dis 2020 (published online Aug 28)

Gagliotti C, Buttazzi R, Ricchizzi E, et al. Community use of antibiotics during the COVID-19 lockdown. Infect Dis 2020 (published online Oct 19)

Gaibani P, Viciani E, Bartoletti M, et al. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep 2021 (published online May 12)

Gangneux JP, Dannaoui E, Fekkar A, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 2021 (published online Nov 26)

Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, et al. Incidence of co-infections and superinfections in hospitalised patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect 2020 (published online Jul 30)

Garg R, Bharangar S, Gupta S, et al. Post Covid-19 infection presenting as rhino-orbital mycosis. Indian J Otolaryngol Head Neck Surg 2021 (published online Jul 14)

Garg S. Antibiotic misuse during COVID-19 pandemic: a recipe for disaster. Indian J Crit Care Med 2021 Jun;25(6):617-9

Garrigos ZE, Wingler MJB, Svoronos PA, et al. Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic. Infect Control Hosp Epidemiol 2021 (published online Jun 24)

Gaspar GG, Ferreira LR, Feliciano CS, et al. Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital. Rev Soc Bras Med Trop 2021 (published online Jul 23)

Gaspari R, Spinazzola G, Teofili L, et al. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections. Eur J Clin Invest 2021 (published online Oct 2)

Gasperini B, Cherubini A, Lucarelli M, et al. Multidrug-resistant bacterial infections in geriatric hospitalized patients before and after the COVID-19 outbreak: results from a retrospective observational study in two geriatric wards. Antibiotics 2021 (published online Jan 19)

Gerstein S, Khatri A, Roth N, et al. Coronavirus disease 2019 and extra-pulmonary tuberculosis co-infection—a case report and review of literature. J Clin Tuberc Other Mycobact Dis 2021 (published online Jan 7)

Gerver SM, Guy R, Wilson K, et al. National surveillance of bacterial and fungal co- and secondary infection in COVID-19 patients in England—lessons from the first wave. Clin Microbiol Infect 2021 (published online Jun 8)

Getahun H, Smith I, Trivedi K, et al. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ 2020 Jul;98(7)

Ghafur A. COVID-19 pandemic, superbugs, and the oncologists! Cancer Res Stat Treat 2021;4:8-9

Gharamti AA, Mei F, Jankousky KC, et al. Diagnostic utility of a ferritin-to-procalcitonin ratio to differentiate patients with COVID-19 from those with bacterial pneumonia: a multicenter study. Open Forum Infect Dis 2021 (published online Mar 14)

Ghazanfari M, Arastehfar A, Davoodi L, et al. Pervasive but neglected: a perspective on COVID-19-associated pulmonary mold infections among mechanically ventilated COVID-19 patients. Front Med (Lausanne) 2021 (published online Jun 14)

Ghosh A, Sarkar A, Paul P, et al. The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19. Fungal Biol Rev 2021 (published online Sep 17)

Ghosh S, Bornman C, Zafer MM. Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand? J Infect Public Health 2021 (published online Mar 5)

Giacobbe DR, Ball L, Magnasco L, et al. Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario. Front Biosci 2021 (published online Sep 30)

Giacobbe DR, Battaglini D, Enrile EM, et al. Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: a multicenter study. J Clin Med 2021 (published online Feb 3)

Giacobbe DR, Russo C, Martini V, et al. Use of ceftaroline in hospitalized patients with and without COVID-19: a descriptive cross-sectional study. Antibiotics (Basel) 2021 (published online Jun 23)

Giamarellos-Bourboulis EJ, Daikos GL, Gargalianos P, et al. The role of macrolides for the management of community-acquired pneumonia and pneumonia by the novel coronavirus SARS-CoV-2 (COVID-19): a position paper by four medical societies from Greece. Infect Dis Ther 2021 (published online Jun 16)

Gillies MB, Burgner DP, Ivancic L, et al. Changes in antibiotic prescribing following COVID-19 restrictions: lessons for post-pandemic antibiotic stewardship. Br J Clin Pharmacol 2021 (published online Aug 17)

Ginsburg AS, Klugman KP. COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health 2020 (published online Nov 11)

Girvin B, Hsia Y, Turner W. Antimicrobial stewardship in Northern Ireland during COVID‐19. Prescriber 2021 (published online Apr 21)

Godman B, Egwuenu A, Haque M, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life 2021 (published online Jun 7)

Goff DA, Ashiru-Oredope D, Cairns KA, et al. Global contributions of pharmacists during the COVID-19 pandemic. J Am Coll Clin Pharm 2020 (published online Sep 20)

Goldstein EJC, Tillotson G, Redell M. Antimicrobial management of respiratory infections in SARS-CoV-2 patients: clinical and ASP conundrums. Open Forum Infect Dis 2020 (published online Oct 26)

Gomez-Simmonds A, Annavajhala MK, McConville TH, et al. Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital. J Antimicrob Chemother 2020 (published online Nov 17)

Goncalves Mendes Neto A, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol 2020 (published online Aug 18)

Gonzalez-Zorn B. Antibiotic use in the COVID-19 crisis in Spain. Clin Microbiol Infect 2020 (published online Nov 18)

Górski A, Borysowski J, Międzybrodzki R. Sepsis, phages, and COVID-19. Pathogens 2020 (published online Oct 15)

Gouin KA, Creasy S, Beckerson M, et al. Trends in prescribing of antibiotics and drugs investigated for COVID-19 treatment in U.S. nursing home residents during the COVID-19 pandemic. Clin Infect Dis 2021 (published online Mar 10)

Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med 2020 (published online Apr 17)

Granata G, Bartoloni A, Codeluppi M, et al. The burden of Clostridioides difficile infection during the COVID-19 pandemic: a retrospective case-control study in Italian hospitals (CloVid). J Clin Med 2020 (published online Nov 27)

Granata G, Petrosillo N, Al Moghazi S, et al. The burden of Clostridioides difficile infection in COVID-19 patients: a systematic review and meta-analysis. Anaerobe 2021 (published online Nov 26)

Grasselli G, Cattaneo E, Florio G. Secondary infections in critically ill patients with COVID-19. Crit Care 2021 (published online Aug 31)

Grau S, Echevarria-Esnal D, Gómez-Zorrilla S, et al. Evolution of antimicrobial consumption during the first wave of COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Jan 29)

Grau S, Hernández S, Echeverría D, et al. Antimicrobial consumption among 66 acute care hospitals in Catalonia: impact of the COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Aug 4)

Gregorova M, Morse D, Brignoli T, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring AMR bacterial pneumonia. Elife 2020 (published online Dec 17)

Gupta G, S R, Singh Y, et al. Emerging cases of mucormycosis under COVID-19 pandemic in India: misuse of antibiotics. Drug Dev Res 2021 (published Jul 29)

Gupta NK, Kapre M, Gupta H, et al. Risk based decision algorithms for management of COVID-19 associated rhino-orbital mucormycosis. Indian J Otolaryngol Head Neck Surg 2021 (published online Jul 30)

Gupta R, Kesavadev J, Krishnan G, et al. COVID-19 associated mucormycosis: a descriptive multisite study from India. Diabetes Metab Syndr 2021 (published online Oct 27)

Guzmán-Castro S, Chora-Hernandez LD, Trujillo-Alonso G, et al. COVID-19 associated mucormycosis, diabetes and steroid therapy: experience in a single centre in western Mexico. Mycoses 2021 (published online Oct 21)

Gysin M, Acevedo CT, Haldimann K, et al. Antimicrobial susceptibility patterns of respiratory gram-negative bacterial isolates from COVID-19 patients in Switzerland. Ann Clin Microbiol Antimicrob 2021 (published online Sep 7)

Haeusler GM, De Abreu Lourenco R, Bakos C, et al. Managing low-risk febrile neutropenia in children in the time of COVID-19: what matters to parents and clinicians. J Paediatr Child Health 2021 (published online Feb 3)

Haglund A, Christensen S, Kristensen L, et al. Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19. Med Mycol Case Rep 2020 (published online Dec 5)

Han SM, Greenfield G, Majeed A, et al. Impact of remote consultations on antibiotic prescribing in primary healthcare: systematic review. J Med Internet Res 2020 (published online Oct 2)

Hanson BM, Dinh AQ, Tran TT, et al. Candida auris invasive infections during a COVID-19 case surge. Antimicrob Agents Chemother 2021 (published online Aug 2)

Haqqi A, Awan UA, Ahmed H, et al. Antimicrobial resistance vs COVID-19: a bigger challenge in the post-pandemic era! J Formos Med Assoc 2021 (published online Mar 14)

Haque M, Meyer JC, Godman B. Potential ways to address antimicrobial resistance across India and wider exacerbated by COVID-19. J App Pharm Sci, 2021 Oct;11(10)

Harita S, Hamaguchi J, Shimizu K, et al. Respiratory extracorporeal membrane oxygenation and central-line–associated bloodstream infection: experience at a tertiary-care center during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021 (published online Aug 2)

Harring N, Jagers SC, Lofgren A. COVID-19: large-scale collective action, government intervention, and the importance of trust. World Dev 2020 (published online Oct 17)

Hashmi F, Atif N, Malik UR, et al. In pursuit of COVID-19 treatment strategies; are we triggering antimicrobial resistance? Disaster Med Public Health Prep 2020 (published online Dec 22)

Hawes AM, Desai A Patel PK. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Anaerobe 2021 (published online May 22)

Hayat F, Roitt I, Afzali M, et al. Increased antimicrobial resistance due to COVID-19 pandemic, a reality or myth: a comprehensive review. Int J Innov Sci Res Rev 2021 Mar;3(3):984-9

Hazel K, Skally M, Glynn E, et al. The other ‘C’: hospital-acquired Clostridioides difficile infection during the COVID-19 pandemic. Infect Control Hosp Epidemiol 2021 (published online Jan 13)

Hazra D, Abhilash KP, Gunasekharan K, et al. Eschar: an indispensable clue for the diagnosis of scrub typhus and COVID-19 co-infection during the ongoing pandemic. J Postgrad Med 2021 (published online Apr 8)

He F, Xia X, Nie D, et al. Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients. Diagn Microbiol Infect Dis 2020 (published online Sep 3)

He S, Liu W, Jiang M, et al. Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: a multi-center study. PLoS One 2021 (published online Apr 5)

Heaney AK, Head JR, Broen K, et al. Coccidioidomycosis and COVID-19 co-infection, United States, 2020. Emerg Infect Dis 2021 (published online Mar 22)

Heard KL, Hughes S, Mughal N, et al. COVID-19 and fungal superinfection. Lancet Microbe 2020 (published online Jul 1)

Heer RS, Mandal AKJ, Kho J, et al. EXPRESS: Elevated procalcitonin levels in severe Covid-19 may not reflect bacterial co-infection. Ann Clin Biochem 2021 (published online May 21)

Heer RS, Mandal AKJ, Szawarski P, et al. Procalcitonin is a biomarker for disease severity rather than bacterial co-infection in COVID-19. Eur J Emerg Med 2021 (published online Sep 21)

Heesom L, Rehnberg L, Nasim-Mohi M, et al. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care. J Glob Antimicrob Resist 2020 (published online Jul 24)

Henig O, Kehat O, Meijer SE, et al. Antibiotic use during the COVID-19 pandemic in a tertiary hospital with an ongoing antibiotic stewardship program. Antibiotics (Basel) 2021 (published online Aug 31)

Hezam IM, Foul A, Alrasheedi A. A dynamic optimal control model for COVID-19 and cholera co-infection in Yemen. Adv Differ Equ 2021 (published online Feb 15)

Hills T, Ritchie S, Thomas M, et al. Non-pharmaceutical interventions targeting COVID-19 were associated with large reductions in community antibiotic dispensing but no increase in severe morbidity from severe common bacterial infections. N Z Med J 2021 (published online Oct 22)

Hinks TSC, Cureton L, Knight R, et al. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir Med 2021 (published online Jul 9)

Hirabayashi A, Kajihara T, Yahara K, et al. Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance. J Hosp Infect 2021 (published online Sep 22)

Hodgkins P. Providing community intravenous therapy during the COVID-19 pandemic. Br J Nurs 2021 (published online Nov 1)

Hoenigl M. Invasive fungal disease complicating COVID-19: when it rains it pours. Clin Infect Dis 2020 (published online Sep 5)

Hosoda T, Harada S, Okamoto K, et al. COVID-19 and fatal sepsis caused by hypervirulent Klebsiella pneumoniae, Japan, 2020. Emerg Infect Dis 2020 (published online Dec 15)

Hou C, Hu Y, Yang H, et al. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank. BMC Med 2021 (published online Nov 16)

Houghton R, Moore N, Williams R, et al. C-reactive protein-guided use of procalcitonin in COVID-19. JAC Antimicrob Resist 2021 (published online Nov 28)

Howard LM. Is there an association between SARS-CoV-2 and Streptococcus pneumoniae? Clin Infect Dis 2020 (published online Dec 4)

Hsu J. How covid-19 is accelerating the threat of antimicrobial resistance. BMJ 2020 (published online May 18)

Huang CP, Tsai CS, Su PL, et al. Respiratory etiological surveillance among quarantined patients with suspected lower respiratory tract infection at a medical center in southern Taiwan during COVID-19 pandemic. J Microbiol Immunol Infect 2021 (published online Sep 1)

Huang G, Furukawa D, Yang BD, et al. Bacterial coinfections with coronavirus disease 2019 (COVID-19). Antimicrob Steward Healthc Epidemiol 2021 (published online Nov 10)

Hughes S, Mughal N, Moore LSP. Procalcitonin to guide antibacterial prescribing in patients hospitalised with COVID-19. Antibiotics (Basel) 2021 (published online Sep 17)

Hughes S, Troise O, Donaldson H, et al. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary care setting. Clin Microbiol Infect 2020 (published online Jun 26)

Hullegie S, Schilder AGM, Marchisio P, et al. A strong decline in the incidence of childhood otitis media during the COVID-19 pandemic in the Netherlands. Front Cell Infect Microbiol 2021 (published online Nov 1)

Hussain S, Baxi H, Riad A, et al. COVID-19-associated mucormycosis (CAM): an updated evidence mapping. Int J Environ Res Public Health 2021 (published online Sep 30)

Hussain S, Riad A, Singh A, et al. Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis. J Fungi (Basel) 2021 (published online Nov 18)

Huttner B, Catho G, Pano-Pardo JR, et al. COVID-19: don't neglect antimicrobial stewardship principles! Clin Microbiol Infect 2020 (published online Apr 30)

Ianiro G, Mullish BH, Kelly CR, et al. Reorganisation of faecal microbiota tranplant services during the COVID-19 pandemic. Gut 2020 Sep;69(9):1555-63

Intra J, Sarto C, Beck E, et al. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected. Am J Infect Control 2020 (published online Jun 24)

Ioannou P, Karakonstantis S, Mathioudaki A, et al. Knowledge and perceptions about COVID-19 among health care workers: evidence from COVID-19 hospitals during the second pandemic wave. Trop Med Infect Dis 2021 (published online Jul 19)

Ippolito M, Misseri G, Catalisano G, et al. Ventilator-associated pneumonia in patients with COVID-19: a systematic review and meta-analysis. Antibiotics (Basel) 2021 (published online May 7)

Ishiguro T, Kobayashi Y, Shimizu Y, et al. Frequency and significance of coinfection in patients with COVID-19 at hospital admission. Intern Med 2021 (published online Sep 18)

Ismail M, Kapadia NN, Usman S. The role of emergency departments for antimicrobial stewardship in COVID-19 pandemic; the time is now. Pak J Med Sci 2021 (published online Nov 11)

Iwu CJ, Jordan P, Jaja IF, et al. Treatment of COVID-19: implications for antimicrobial resistance in Africa. Pan Afr Med J 2020 Jul 20;35(2):119

Jain A, Taneja S. Post-COVID fungal infections of maxillofacial region: a systematic review. Oral Maxillofac Surg 2021 (published online Oct 7)

Janssen NAF, Nyga R, Vanderbeke L, et al. Multinational observational cohort study of COVID-19–associated pulmonary aspergillosis. Emerg Infect Dis 2021 (published online Sep 14)

Jin LS, Fisher D. MDRO transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis 2021 (published online May 19)

Johnson T. A trade-off: antimicrobial resistance and COVID-19. Bioethics 2021 (published online Aug 31)

Jolobe OMP. A more appropriate use of antibiotics in covid-19 infection. QJM 2021 (published online Sep 6)

Jones KA, Watson M, Jacob JT, et al. Antimicrobial stewardship interventions to minimize healthcare worker exposure to SARS-CoV-2. Infect Control Hosp Epidemiol 2020 (published online Jun 19)

Jose A, Singh S, Roychoudhury A, et al. Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review. J Maxillofac Oral Surg 2021 (published online Jun 16)

Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerg Infect Dis 2021 (published online Sep 29)

Kamel AM, Monem MSA, Sharaf NA, et al. Efficacy and safety of azithromycin in Covid-19 patients: a systematic review and meta-analysis of randomized clinical trials. Rev Med Virol 2021 (published online Jun 2)

Kaminsky LW, Dalessio S, Al-Shaikhly T, et al. Penicillin allergy label increases risk of worse clinical outcomes in COVID-19. J Allergy Clin Immunol Pract 2021 (published online Jul 19)

Kampmeier S, Tonnies H, Correa-Martinez CL, et al. A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit. Antimicrob Resist Infect Control 2020 (published online Sep 22)

Kanungo R. Antimicrobial resistance and the COVID -19 pandemic: a double threat. Indian J Med Microbiol 2021 (published online Jun 22)

Karaba SM, Jones G, Helsel T, et al. Prevalence of co-infection at the time of hospital admission in COVID-19 patients, a multicenter study. Open Forum Infect Dis 2020 (published online Dec 21)

Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in the Netherlands. Infect Dis (Lond) 2020 (published online Oct 24)

Karataş M, Yaşar-Duman M, Tünger A, et al. Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study. Ann Clin Microbiol Antimicrob 2021 (published online Aug 5)

Karruli A, Boccia F, Gagliardi M, et al. Multidrug-resistant infections and outcome of critically ill patients with coronavirus disease 2019: a single center experience. Microb Drug Resist 2021 (published online Feb 17)

Kasugai D, Jingushi N, Omote N, et al. The mystery of futility of appropriate antibiotics for co-infection in COVID-19. Am J Respir Crit Care Med 2021 (published online Sep 21)

Katz SE, Spencer H, Zhang M, et al. Impact of the COVID-19 pandemic on infectious diagnoses and antibiotic use in pediatric ambulatory practices. J Pediatric Infect Dis Soc 2020 (published online Oct 16)

Kayaaslan B, Eser F, Kalem AK, et al. Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence, and higher mortality rates compared to non-COVID-19 patients. Mycoses 2021 (published online Jun 4)

Kayarat B, Khanna P, Sarkar S. Superadded coinfections and antibiotic resistance in the context of COVID-19: where do we stand? Indian J Crit Care Med 2021 Jun;25(6):699-703

Kazemian N, Kao D, Pakpour S. Fecal microbiota transplantation during and post-COVID-19 pandemic. Int J Mol Sci 2021 (published online Mar 16)

Keating JA, McKinley L, Safdar N. COVID-19 and antibiotic stewardship: using a systems engineering approach to maintain patient safety. Infect Control Hosp Epidemiol 2020 (published online Oct 12)

Kerguelen C, Merchán A, León J, et al. Effect of COVID-19 pandemic on catheter-related bloodstream infections: control measures should not be relaxed. Infect Control Hosp Epidemiol 2021 (published online May 27)

Khanna S, Kraft CS. The interplay of SARS-CoV-2 and Clostridioides difficile infection. Future Microbiol 2021 (published online Apr 13)

Khanna S, Tande A, Rubin DT, et al. Fecal microbiota transplantation for recurrent C difficile infection during the COVID-19 pandemic: experience and recommendations. Mayo Clin Proc 2021 (published online Jun 1)

Kharrat A, Neish A, Diambomba Y, et al. Non-COVID co-morbidity: potential indirect consequences of the SARS-CoV-2 pandemic in a neonatal intensive care unit. J Hosp Infect 2020 (published online Dec 19)

Khatri A, Malhotra P, Izard S, et al. Hospital-acquired bloodstream infections in patients hospitalized with SARS Cov-2 (COVID-19) infection: association with immunosuppressive therapies. Open Forum Infect Dis 2021 (published online Jun 30)

Khor WP, Olaoye O, D'Arcy N, et al. The need for ongoing antimicrobial stewardship during the COVID-19 pandemic and actionable recommendations. Antibiotics (Basel) 2020 (published online Dec 14)

Khurana S, Singh P, Sharad N, et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol 2021 Apr;39(2):147-53

Kim CS, Lynch JB, Cohen S, et al. One academic health system's early (and ongoing) experience responding to COVID-19: recommendations from the initial epicenter of the pandemic in the United States. Acad Med 2020 Aug;95(8):1146-8

King LM, Lovegrove MC, Shehab N, et al. Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic. Clin Infect Dis 2020 (published online Dec 29)

Kitano T, Brown KA, Daneman N, et al. The impact of COVID-19 on outpatient antibiotic prescriptions in Ontario, Canada; an interrupted time series analysis. Open Forum Infect Dis 2021 (published online Oct 30)

Kleinert S, Horton R. Can COVID-19 help accelerate and transform the diagnostics agenda? Lancet 2021 (published online Oct 6)

Knight BD, Shurgold J, Smith G, et al. The impact of COVID-19 on community antibiotic use in Canada: an ecological study. Clin Microbiol Infect 2021 (published online Oct 29)

Knight GM, Glover RE, Finn McQuaid C, et al. Antimicrobial resistance and COVID-19: intersections and implications. Elife 2021 (published online Feb 16)

Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2020 (published online Dec 14)

Kokkoris S, Papachatzakis I, Gavrielatou E, et al. ICU-acquired blood stream infections in critically ill patients with coronavirus disease- 19. J Hosp Infect 2020 (published online Nov 17)

Kolenda C, Ranc AG, Boisset S, et al. Assessment of respiratory bacterial co-infections among SARS-CoV-2 positive patients hospitalized in intensive care units using conventional culture and BioFire FilmArray Pneumonia Panel plus assay. Open Forum Infect Dis 2020 (published online Oct 22)

Kost GJ. Geospatial spread of antimicrobial resistance, bacterial and fungal threats to COVID-19 survival, and point-of-care solutions. Arch Pathol Lab Med 2020 (published online Jul 29)

Kow CS, Hasan SS. Macrolides for patients with COVID-19 and concurrent pertussis infection. Diagn Microbiol Infect Dis 2020 (published online Oct 16)

Kubin CJ, Loo AS, Cheng J, et al. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: challenges and opportunities. Am J Health Syst Pharm 2021 (published online Feb 5)

Kubin CJ, McConville TH, Dietz D, et al. Characterization of bacterial and fungal infections in hospitalized patients with COVID-19 and factors associated with healthcare-associated infections. Open Forum Infect Dis 2021 (published online May 5)

Kula BE, Clancy CJ, Nguyen MH, et al. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe 2021 (published online Jun 23)

Kullar R, Johnson S, McFarland LV, et al. Potential roles for probiotics in the treatment of COVID-19 patients and prevention of complications associated with increased antibiotic use. Antibiotics (Basel) 2021 (published online Apr 9)

Kumar M, Sarma DK, Shubham S, et al. Mucormycosis in COVID-19 pandemic: risk factors and linkages. Curr Res Microb Sci 2021 (published online Aug 8)

Lai CC, Chen SY, Ko WC, et al. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents 2021 (published online Mar 19)

Lai CC, Yu WL. Appropriate use of antimicrobial therapy for COVID-19 co-infection. Immunotherapy 2021 (published online Jun 11)

Lamoth F, Lewis RE, Walsh TL, et al. Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA). J Infect Dis 2021 (published online Mar 26)

Langford BJ, So M, Leung V, et al. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clin Microbiol Infect 2021 (published online Nov 26)

Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021 (published online Jan 4)

Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020 (published online Jul 22)

Lardaro T, Wang AZ, Bucca A, et al. Characteristics of COVID‐19 patients with bacterial co‐infection admitted to the hospital from the emergency department in a large regional healthcare system. J Med Virol 2021 (published online Jan 15)

Laszkowska M, Kim J, Faye AS, et al. Prevalence of Clostridioides difficile and other gastrointestinal pathogens in patients with COVID-19. Dig Dis Sci 2021 (published online Jan 22)

Lawler M, Franklin R, McCallion N, et al. The impact of COVID-19 lockdown on infants' coronavirus exposure and routine healthcare access in Ireland: the CORAL birth cohort study at 6 months. Pediatric Allergy and Immunology 2021 (published online Jul 1)

Le Daré B, Boglione-Kerrien C, Reizine F, et al. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis. Crit Care 2021 (published online Apr 20)

Lehmann CJ, Pho MT, Pitrak D, et al. Community acquired co-infection in COVID-19: a retrospective observational experience. Clin Infect Dis 2020 (published online Jul 1)

Lei JH, Xu Y, Jiang YF, et al. Clustering cases of Chlamydia psittaci pneumonia in COVID-19 screening ward staff. Clin Infect Dis 2020 (published online Nov 5)

Leis JA, Born KB, Theriault G, et al. Using antibiotics wisely for respiratory tract infection in the era of covid-19. BMJ 2020 (published online Nov 13)

Lemenand O, Coeffic T, Thibaut S, et al. Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France. J Infect 2021 (published online Sep 29)

Lepak AJ, Taylor LN, Stone CA, et al. Association of changes in seasonal respiratory virus activity and ambulatory antibiotic prescriptions with the COVID-19 pandemic. JAMA Intern Med 2021 (published online Jun 21)

Lewnard JA, Bruxvoort KJ, Fischer H, et al. Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract. J Infect Dis 2021 (published online Mar 9)

Li HK, Kaforou M, Rodriguez-Manzano J, et al. Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study. Lancet Microbe 2021 (published online Aug 16)

Li J, Wang J, Yang Y, et al. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control 2020 (published online Sep 22)

Li XQ, Liu H, Yin HY, et al. Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: a multi-center retrospective cohort study. J Med Virol 2021 (published online Jul 27)

Li Y, Wang H, Wang F, et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children: a retrospective study. Medicine (Baltimore) 2021 (published online Mar 19)

Liang J, Swanson CS, Wang L, et al. Impact of building closures during the COVID-19 pandemic on Legionella infection risks. Am J Infect Control 2021 (published online Sep 16)

Liew Y, Hui Ling Lee W, Tan L, et al. Antimicrobial stewardship program, a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19). Int J Antimicrob Agents 2020 (published online Aug 27)

Lighter J, Raabe V. Azithromycin should not be used to treat COVID-19. Open Forum Infect Dis 2020 (published online May 30)

Lima dos Santos F, Limirio Sousa LL, Tadashi Inomata Bruce A, et al. Patients’ perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: a qualitative study. PLoS One 2021 (published online Apr 9)

Liu C, Dun Y, Liu P, et al. Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up. Int Immunopharmacol 2020 (published online Nov 3)

Liu C, Wen Y, Wan W, et al. Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19. Int Immunopharmacol 2020 (published online Nov 3) 

Liu HH, Yaron D, Stahl Piraino A, et al. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors. Ann Clin Microbiol Antimicrob 2021 (published online Sep 25)

Liu YX, Liang C, Yang Y, et al. Reduction in antimicrobial use associated with a multifaceted antimicrobial stewardship programme in a tertiary teaching hospital in Shanghai: a segmented regression analysis. Ann Palliat Med 2021 Jul;10(7):7360-9

Livermore DM. Antibiotic resistance during and beyond COVID-19. JAC Antimicrob Resist 2021 (published online Jun 15)

Llor C, Ouchi D, Giner-Soriano M, et al. Correlation between previous antibiotic exposure and COVID-19 severity. A population-based cohort study. Antibiotics (Basel) 2021 (published online Nov 8)

Lobie TA, Roba AA, Booth JA, et al. Antimicrobial resistance: a challenge awaiting the post COVID-19 era. Int J Infect Dis 2021 (published online Sep 8)

Louie JK, Agraz-Lara R, Romo L, et al. Tuberculosis-associated hospitalizations and deaths after COVID-19 shelter-in-place, San Francisco, California, USA. Emerg Infect Dis 2021 (published online Jun 11)

Lo Yan Yam E. COVID-19 will further exacerbate global antimicrobial resistance. J Travel Med 2020 (published online Sep 26)

Lu J, Guo J. Disinfection spreads antimicrobial resistance. Science 2021 (published online Jan 29)

Luyt CE, Sahnoun T, Gautier M, et al. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care 2020 (published online Nov 23)

Lynch C, Mahida N, Gray J. Antimicrobial stewardship: a COVID casualty? J Hosp Infect 2020 (published online Oct 8)

Ma ESK, Kung KH, Chen H. Combating antimicrobial resistance during the COVID-19 pandemic. Hong Kong Med J 2021 (published online Nov 17)

Ma S, Zhang F, Zhou F, et al. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther 2021 (published online May 13)

Maataoui N, Chemali L, Patrier J, et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis 2021 (published online Mar 17)

Macera M, Onorato L, Calò F, et al. The impact of the SARS-Cov2 pandemic on a persuasive educational antimicrobial stewardship program in a university hospital in southern Italy: a pre-post study. Antibiotics 2021 (published online Nov 16)

Maes M, Higginson E, Pereira-Dias J, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care 2021 (published online Jan 11)

Magnasco L, Mikulska M, Giacobbe DR, et al. Spread of carbapenem-resistant gram-negatives and Candida auris during the COVID-19 pandemic in critically ill patients: one step back in antimicrobial stewardship? Microorganisms 2021 (published online Jan 3)

Mahalaxmi I, Jayaramayya K, Venkatesan D, et al. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res 2021 (published online Jul 6)

Mahalmani V, Kumaravel J, Jain M, et al. Antimicrobial resistance: an unseen threat prowling behind the COVID-19 outbreak. Indian J Pharmacol 2021;53:187-91

Mah-E-Muneer S, Hassan MZ, Al Jubayer Biswas MA, et al. Use of antimicrobials among suspected COVID-19 patients at selected hospitals, Bangladesh: findings from the first wave of COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Jun 18)

Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control 2020 (published online Dec 17)

Mahoney AR, Moein Safaee M, Wuest WM, et al. The silent pandemic: emergent antibiotic resistances following the global response to SARS-CoV-2. iScience 2021 (published online Mar 13)

Maison-Fomotar M, Sivasubramanian G. Bordetella hinzii pneumonia and bacteremia in a patient with SARS-CoV-2 infection. Emerg Infect Dis 2021 (published online Aug 13)

Malcolm W, Seaton RA, Haddock G, et al. Impact of the COVID-19 pandemic on community antibiotic prescribing in Scotland. JAC–Antimicrobial Resistance 2020 (published online Dec 8)

Mamun AA, Saatchi A, Xie M, et al. Community antibiotic use at the population level during the SARS-CoV-2 pandemic in British Columbia, Canada. Open Forum Infect Dis 2021 (published online Apr 13)

Manchanda S, Semalti K, Bhalla AS, et al. Revisiting rhino-orbito-cerebral acute invasive fungal sinusitis in the era of COVID-19: pictorial review. Emerg Radiol 2021 (published online Aug 31)

Manda D, Sen I, Thakral P, et al. Invasive fungal infection in COVID-19-recovered patient detected on 18F-FDG-labeled leukocytes PET/CT scan. Clin Nucl Med 2021 (published online Jul 26)

Manea E, Jipa R, Milea A, et al. Healthcare-associated Clostridioides difficile infection during the COVID-19 pandemic in a tertiary care hospital in Romania. Rom J Intern Med 2021 (published online May 29)

Manesh A, Varghese GM. Rising antimicrobial resistance: an evolving epidemic in a pandemic. Lancet Microbe 2021 (published online Jul 1)

Manohar P, Loh B, Nachimuthu R, et al. Secondary bacterial infections in patients with viral pneumonia. Front Med (Lausanne) 2020 (published online Aug 5)

Mansour O, Keller S, Katz M, et al. Outpatient parenteral antimicrobial therapy OPAT in the time of COVID-19: the urgent need for better insurance coverage. Open Forum Infect Dis 2020 (published online Jul 22)

Maqbool M. Impact of Covid-19 pandemic on antimicrobial resistance (AMR): an opinion. Pharmaceutical Drug Regulatory Affairs Journal 2021 (published online Aug 25)

Marcus JE, Sams VG, Barsoumian AE. Elevated secondary infection rates in patients with COVID-19 requiring extracorporeal membrane oxygenation. Infect Control Hosp Epidemiol 2021 (published online Feb 9)

Marinescu AR, Laza R, Musta VF, et al. Clostridium difficile and COVID-19: general data, ribotype, clinical form, treatment—our experience from the largest infectious diseases hospital in western Romania. Medicina (Kaunas) 2021 (published online Oct 13)

Marr KA, Platt A, Tornheim JA, et al. Aspergillosis complicating severe coronavirus disease. Emerg Infect Dis 2020 (published online Oct 21)

Martin AJ, Shulder S, Dobrzynski D, et al. Antibiotic use and associated risk factors for antibiotic prescribing in COVID-19 hospitalized patients. J Pharm Pract 2021 (published online Jul 22)

Martin E, Philbin M, Hughes G, et al. Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic. J Antimicrob Chemother 2020 (published online Oct 4)

Martinecz A, Wojewodzic MW. Could bacteriophages be the answer to the COVID-19 crisis? Expert Rev Anti Infect Ther 2020 (published online Oct 13)

Martinez-Guerra BA, Gonzalez-Lara MF, de-Leon-Cividanes NA, et al. Antimicrobial resistance patterns and antibiotic use during hospital conversion in the COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Feb 11)

Martins AC, Psaltikidis EM, de Lima TC, et al. COVID-19 and invasive fungal coinfections: a case series at a Brazilian referral hospital. J Mycol Med 2021 (published online Jul 14)

Marwitz KK. The pharmacist's active role in combating COVID-19 medication misinformation. J Am Pharm Assoc 2020 (published online Nov 4) 

Mason CY, Kanitkar T, Richardson CJ, et al. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics. J Antimicrob Chemother 2021 (published online Jan 19)

Mastrangelo A, Germinario BN, Ferrante M, et al. Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls. Clin Infect Dis 2020 (published online Oct 30)

Mateen BA, Samanta S, Tullie S, et al. Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients. BMJ Open Gastroenterol 2021 (published online Sep 6)

Mayi BS, Mainville M, Altaf R, et al. A crucial role for antimicrobial stewardship in the midst of COVID-19. J Microbiol Biol Educ 2021 Mar 31;22(1)

May M, Chang M, Dietz D, et al. Limited utility of procalcitonin in identifying community-associated bacterial infections in patients presenting with coronavirus disease 2019. Antimicrob Agents Chemother 2021 (published online Jan 25)

Mazdeyasna H, Nori P, Patel P, et al. Antimicrobial stewardship at the core of COVID-19 response efforts: implications for sustaining and building programs. Curr Infect Dis Rep 2020 (published online Jul 3)

Mazumder P, Kalamdhad A, Chaminda GGT, et al. Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: the blues of post-COVID-19 world. Case Studies in Chemical and Environmental Engineering 2021 Jun;3

Mazzariol A, Benini A, Unali I, et al. Dynamics of SARS-CoV2 infection and multi-drug resistant bacteria superinfection in patients with assisted mechanical ventilation. Front Cell Infect Microbiol 2021 (published online Aug 12)

McCarty T. Candidemia and severe COVID-19—which risk factors are modifiable? Clin Infect Dis 2021 (published online Jul 15)

McCormick DW, Kugeler KJ, Marx GE, et al. Effects of COVID-19 pandemic on reported Lyme disease, United States, 2020. Emerg Infect Dis 2021 (published online Aug 23)

Mc Gann P, Geringer MR, Hall LR, et al. Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19. J Med Microbiol 2021 Aug;70(8)

McIntosh EDG, Feemster K, Rello J. Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2. Hum Vaccin Immunother 2021 (published online Aug 18)

McMillan T, Jones C, O'Connor CJ, et al. Risk factors associated with bloodstream infections among critically ill patients with COVID-19. J Infect 2021 (published online Sep 16)

Meawed TE, Ahmed SM, Mowafy SMS, et al. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. J Infect Public Health 2021 (published online Aug 8)

Mędrzycka-Dąbrowska W, Lange S, Zorena K, et al. Carbapenem-resistant Klebsiella pneumoniae infections in ICU COVID-19 patients—a scoping review. J Clin Med 2021 (published online May 12)

Mendes JC, Casado A. Serratia marcescens outbreak in a COVID-19 intensive care unit—are there any factors specific to COVID-19 units that facilitate bacterial cross-contamination between COVID-19 patients? Am J Infect Control 2021 (published online Oct 20)

Méndez L, Ferreira J, Caneiras C. Hafnia alvei pneumonia: a rare cause of infection in a patient with COVID-19. Microorganisms 2021 (published online Nov 17)

Metsemakers WJ, Zalavras C, Schwarz EM, et al. Antimicrobial resistance, the COVID-19 pandemic, and lessons for the orthopaedic community. J Bone Joint Surg Am 2020 (published online Dec 2)

Mian P, Trof RJ, Beishuizen A, et al. Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis. J Clin Pharm Ther 2021 (published online Aug 25)

Miao Q, Ma Y, Ling Y, et al. Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: a cohort study in Shanghai. J Microbiol Immunol Infect 2021 (published online Apr 6)

Micozzi A, Assanto GM, Cesini L, et al. Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic. JAC Antimicrob Resist 2021 (published online Nov 17)

Milas S, Poncelet A, Buttafuoco F, et al. Antibiotic use in patients with coronavirus disease 2019 (COVID-19): outcomes and associated factors. Acta Clin Belg 2021 (published online Apr 26)

Miltgen G, Garrigos T, Cholley P, et al. Nosocomial cluster of carbapenemase-producing Enterobacter cloacae in an intensive care unit dedicated COVID-19. Antimicrob Resist Infect Control 2021 (published online Oct 21)

Ming DK, Myall AC, Hernandez B, et al. Informing antimicrobial management in the context of COVID-19: understanding the longitudinal dynamics of C-reactive protein and procalcitonin. BMC Infect Dis 2021 (published online Sep 8)

Miranda C, Silva V, Capita R, et al. Implications of antibiotics use during the COVID-19 pandemic: present and future. J Antimicrob Chemother 2020 (published online Aug 24)

Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life 2020 (published online Aug 8)

Mishra Y, Prashar M, Sharma D, et al. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in western India. Diabetes Metab Syndr 2021 (published online Jul 3)

Mitaka H, Kuno T, Takagi H, et al. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis. Mycoses 2021 (published online Apr 25)

Modi P, Khanna R, Reddy N, et al. COVID-19 and tuberculosis co-infection in pregnancy—a case series and review. J Mother Child 2021 (published online Oct 29)

Mody L, Akinboyo IC, Babcok HM, et al. COVID-19 research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol 2021 (published online Jan 25)

Moin S, Farooqi J, Rattani S, et al. C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan. Med Mycol 2021 (published online Oct 8)

Molla MMA, Yeasmin M, Islam MK, et al. Antibiotic prescribing patterns at COVID-19 dedicated wards in Bangladesh: findings from a single center study. Infection Prevention in Practice 2021 Jun;3(2)

Monnet DL, Harbarth S. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Euro Surveill 2020 (published online Nov 12)

Montrucchio G, Corcione S, Sales G, et al. Carbapenem resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: keep an eye on the ball. J Glob Antimicrob Resist 2020 (published online Nov 23)

Moolla MS, Reddy K, Fwemba I, et al. Bacterial infection, antibiotic use and COVID-19: lessons from the intensive care unit. S Afr Med J 2021 (published online Apr 15)

Moore JL, Stroever SJ, Rondain PE, et al. Incidence of secondary bacterial infections following utilization of tocilizumab for the treatment of COVID-19—a matched retrospective cohort study. J Glob Infect Dis 2021 Mar 22;13(2):67-71

Moore SE, Wilde AM, Bohn BC, et al. Antimicrobial stewardship in patients with confirmed COVID-19. Infect Control Hosp Epidemiol 2021 (published online Aug 2)

Moretto F, Sixt T, Devilliers H, et al. Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19? Int J Infect Dis 2021 (published online Jan 24)

Morris SR, Natori Y, Salguero D, et al. Development of a standardized data collection tool for evaluation and management of coronavirus disease 2019. Open Forum Infect Dis (published online Jul 29)

Moseley P, Jackson N, Omar A, et al. Single centre experience of using procalcitonin to guide antibiotic therapy in COVID-19 intensive care patients. J Hosp Infect 2021 (published online Oct 14)

Muflih SM, Al-Azzam S, Karasneh RA, et al. Public health literacy, knowledge, and awareness regarding antibiotic use and antimicrobial resistance during the COVID-19 pandemic: a cross-sectional study. Antibiotics 2021 (published online Sep 13)

Mullié C, Lemonnier D, Adjidé CC, et al. Nosocomial outbreak of monoclonal VIM carbapenemase producing Enterobacter cloacae complex in an intensive care unit during COVID-19 pandemic: an integrated approach. J Hosp Infect 2021 (published online Nov 30)

Murgadella-Sancho A, Coloma-Conde A, Oriol-Bermúdez I. Impact of the strategies implemented by an antimicrobial stewardship program on the antibiotic consumption in the Covid-19 pandemic. Infect Control Hosp Epidemiol 2021 (published online May 21)

Murray AK. The novel coronavirus COVID-19 outbreak: global implications for antimicrobial resistance. Front Microbiol 2020 (published online May 13)

Mustafa L, Tolaj I, Baftiu N, et al. Use of antibiotics in COVID-19 ICU patients. J Infect Dev Ctries 2021 Apr 30;15(4):501-5

Musuuza JS, Watson L, Parmasad V, et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS One 2021 (published online May 6)

Nagano H, Takada D, Shin J, et al. Hospitalization of mild cases of community-acquired pneumonia decreased more than severe ones during the COVID-19 epidemic. Int J Infect Dis 2021 (published online Mar 28)

Narayanan S, Chua JV, Baddley JW, et al. COVID-19 associated mucormycosis (CAM): risk factors and mechanisms of disease. Clin Infect Dis 2021 (published online Aug 22)

Narendrakumar L, Joseph I, Thomas S. Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment. Expert Rev Anti Infect Ther 2020 (published online Dec 16)

Narita M, Hatt G, Gardner Toren K, et al. Delayed tuberculosis diagnoses during the COVID-19 pandemic in 2020—King County, Washington. Clin Infect Dis 2021 (published online May 6)

Nasir N, Rehman F, Omair SF. Risk factors for bacterial infections in patients with moderate to severe COVID-19: a case control study. J Med Virol 2021 (published online Apr 6)

Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, et al. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the community of Castilla y León, Spain. Enferm Infecc Microbiol Clin 2020 (published online Dec 3)

Nehara HR, Puri I, Singhal V, et al. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India. Indian J Med Microbiol 2021 (published online May 26)

Nestler M, Godbout E, Lee K, et al. Fungal superinfection in patients with COVID-19: role of antifungal stewardship? Am J Infect Control 2020 (published online Nov 18)

Nestler M, Godbout E, Lee K, et al. Impact of COVID-19 and pneumonia-focused antibiotic use at an academic medical center. Infect Control Hosp Epidemiol 2020 (published online Jul 23)

Ng TM, Tan SH, Heng ST, et al. Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore. Antimicrob Resist Infect Control 2021 (published online Feb 3)

Nguyen CT, Olson G, Pho MT, et al. Automatic ID consultation for inpatients with COVID-19: point, counterpoint, and a single-center experience. Open Forum Infect Dis 2020 (published online Aug 11)

Nieuwlaat R, Mbuagbaw L, Mertz D, et al. COVID-19 and antimicrobial resistance: parallel and interacting health emergencies. Clin Infect Dis 2020 (published online Jun 16)

Nkengasong JN, Tessema SK. Africa needs a new public health order to tackle infectious disease threats. Cell 2020 Oct 15;183(2):296-300

Nobrega de Almeida Jr J, Moreno L, Francisco EC, et al. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. Mycoses 2021 (published online Jun 5)

Nori P, Cowman K, Chen V, et al. Bacterial and fungal co-infections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol 2020 (published online Jul 24)

Nori P, Patel PK, Stevens MP. Pandemic stewardship: reflecting on new roles and contributions of antimicrobial stewardship programs during COVID-19. Infect Control Hosp Epidemiol 2021 (published online Apr 16)

Nori P, Patel PK, Stevens MP. Rational allocation of COVID-19 vaccines to healthcare personnel and patients: a role for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2020 (published online Dec 16)

Nori P, Szymczak W, Puius Y, et al. Emerging co-pathogens: New Delhi metallo-beta-lactamase producing Enterobacterales infections in New York City COVID-19 patients. Int J Antimicrob Agents 2020 Dec;56(6)

Novy E, Goury A, Thivilier C, et al. Algorithm for rational use of FilmArray Pneumonia Panel in bacterial coinfections of critically ill ventilated COVID-19 patients. Diagn Microbiol Infect Dis 2021 (published online Jul 23)

Nucci M, Barreiros G, Guimaraes LF, et al. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses 2020 (published online Dec 4)

Nzawa Soko R, Burke RM, Feasey HRA, et al. Effects of coronavirus disease pandemic on tuberculosis notifications, Malawi. Emerg Infect Dis 2021 (published online May 26)

Oba J, Silva CA, Katsuya Toma R, et al. COVID-19 and coinfection with Clostridioides (Clostridium) difficile in an infant with gastrointestinal manifestation. Einstein (Sao Paulo) 2020 (published online Dec 7)

Obata R, Maeda T, Rizk D, et al. Increased secondary infection in COVID-19 patients treated with steroids in New York City. Jpn J Infect Dis 2020 (published online Dec 25)

Ochoa-Hein E, González-Lara MF, Chávez-Ríos AR, et al. Surge in ventilator-associated pneumonias and bloodstream infections in an academic referral center converted to treat COVID-19 patients. Rev Invest Clin 2021 (published online May 12)

Ochoa-Hein E, Rajme-Lopez S, Rodriguez-Aldama JC, et al. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients. Am J Infect Control 2020 (published online Dec 18)

Ogawa Y, Ote H, Arai T, et al. Corynebacterium pseudodiphtheriticum as a pathogen in bacterial co-infection in COVID-19 patients with mechanical ventilation. Jpn J Infect Dis 2021 (published online Aug 31)

Ohki R, Fukui Y, Morishita N, et al. Increase of blood culture contamination during COVID-19 pandemic. A retrospective descriptive study. Am J Infect Control 2021 (published online Aug 28)

Oikonomou ME, Gkentzi D, Karatza A, et al. Parental knowledge, attitude, and practices on antibiotic use for childhood upper respiratory tract infections during COVID-19 pandemic in Greece. Antibiotics (Basel) 2021 (published online Jul 1)

O'Kelly B, Cronin C, Connellan D, et al. Antibiotic prescribing patterns in patients hospitalized with COVID-19: lessons from the first wave. JAC Antimicrob Resist 2021 (published online Jun 30)

Oldenburg CE, Pinsky BA, Brogdon J, et al. Effect of oral azithromycin vs placebo on COVID-19 symptoms in outpatients with SARS-CoV-2 infection: a randomized clinical trial. JAMA 2021 (published online Jul 16)

Omame A, Abbas M, Onyenegecha CP. A fractional-order model for COVID-19 and tuberculosis co-infection using Atangana-Baleanu derivative. Chaos Solitons Fractals 2021 (published online Oct 9)

Onal U, Akalin H. Coronavirus disease 2019 and antibiotic stewardship—antibiotic usage in adult patients: is it necessary? When should it be concerned? Balkan Med J 2021 (published online Feb 25)

Ong CCH, Farhanah S, Linn KZ, et al. Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data. Antimicrob Resist Infect Control 2021 (published online Aug 12)

Ortiz-Martinez Y, Mejia-Alzate C, Vega-Vera A, et al. Drug-resistant tuberculosis and COVID-19 co-infection: a systematic review of case reports. Int J Mycobacteriol 2021 Apr-Jun;10(2):214-5

Osman M, Kasir D, Kassem II, et al. Shortage in appropriate diagnostics of antimicrobial resistance in Lebanese clinical settings: a crisis amplified by COVID-19 and economic collapse. J Glob Antimicrob Resist 2021 (published online Sep 4)

Oster Y, Michael-Gayego A, Rivkin M, et al. Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? Clin Microbiol Infect 2020 (published online Dec 19)

Othman AK, Ali MN, Bahar NI, et al. Bacterial pneumonia co-infection in COVID-19 patients. Asian J Med Biomed 2020 Oct 25;4(2):47-52

O'Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect 2021 (published online Jun 6)

Owoicho O, Tapela K, Zune ALD, et al. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Future Microbiol 2021 (published online Jul 28)

Pakdel F, Ahmadikia K, Salahi M, et al. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicenter study from Iran. Mycoses 2021 (published online Jun 7)

Pal C, Przydzial P, Chika-Nwosuh O, et al. Streptococcus pneumoniae coinfection in COVID-19: a series of three cases. Case Rep Pulmonol 2020 (published online Dec 10)

Palanisamy N, Vihari N, Meena DS, et al. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BMC Infect Dis 2021 (published online Sep 8)

Palmer NOA, Seoudi N. The effect of SARS-CoV-2 on the prescribing of antimicrobials and analgesics by NHS general dental practitioners in England. Br Dent J 2021 (published online Jan 21)

Palmore TN, Henderson DK. Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021 (published online Sep 2)

Palou EY, Ramos MA, Cherenfant E, et al. COVID-19 associated rhino-orbital mucormycosis complicated by gangrenous and bone necrosis—a case report from Honduras. Vaccines (Basel) 2021 (published online Jul 27)

Pani A, Lauriola M, Romandini A, et al. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int J Antimicrob Agents 2020 (published online Jun 10)

Para O, Caruso L, Ronchetti M, et al. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship. Intern Emerg Med 2020 (published online Nov 22)

Paramo-Zunzunegui J, Ortega-Fernandez I, Calvo-Espino P, et al. Severe Clostridium difficile colitis as potential late complication associated with COVID-19. Ann R Coll Surg Engl 2020 (published online Aug 17)

Paramythiotou E, Dimopoulos G, Koliakos N, et al. Epidemiology and incidence of COVID-19-associated pulmonary aspergillosis (CAPA) in a Greek tertiary care academic reference hospital. Infect Dis Ther 2021 (published online Jul 14)

Paret M, Lalani K, Hedari C, et al. SARS-CoV-2 among infants <90 days of age admitted for serious bacterial infection evaluation. Pediatrics 2021 (published online Sep 17)

Park HS, Bae PK, Jeong HW, et al. Serological evidence of Coxiella burnetii and SARS-CoV-2 co-infection: a case report. Ann Lab Med 2021 Sep;41(5):510-3

Pasero D, Cossu AP, Terragni P. Multi-drug resistance bacterial infections in critically ill patients admitted with COVID-19. Microorganisms 2021 (published online Aug 20)

Pascale R, Bussini L, Gaibani P, et al. Carbapenem resistant bacteria in intensive care unit during COVID-19 pandemic: multicenter before-after cross sectional study. Infect Control Hosp Epidemiol 2021 (published online Apr 16)

Pascale R, Pasquini Z, Bartoletti M, et al. Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study. JAC Antimicrob Resist 2021 (published online Nov 17)

Patel A. Tackling antimicrobial resistance in the shadow of COVID-19. mBio 2021 (published online Jul 20)

Patel A, Agarwal R, Rudramurthy SM, et al. Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India. Emerg Infect Dis 2021 (published online Jun 4)

Patel A, Emerick M, Cabunoc MK, et al. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg Infect Dis 2021 (published online Feb 10)

Patel PK, Nori P, Stevens MP. Antimicrobial stewardship and bamlanivimab: opportunities for outpatient preauthorization? Infect Control Hosp Epidemiol 2020 (published online Nov 20)

Patel PR, Weiner-Lastinger LM, Dudeck MA, et al. Impact of COVID-19 pandemic on central line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network. Infect Control Hosp Epidemiol 2021 (published online Mar 15)

Pathak L, Gayan S, Pal B, et al. Coronavirus activates an altruistic stem cell–mediated defense mechanism that reactivates dormant tuberculosis. Am J Pathol 2021 (published online Apr 19)

Patrucco F, Airoldi C, Falaschi Z, et al. Mycotic infection prevalence among patients undergoing bronchoalveolar lavage with search of SARS-CoV-2 after two negative nasopharyngeal swabs. J Breath Res 2021 (published online Aug 31)

Payson A, Etinger V, Napky P, et al. Risk of serious bacterial infections in young febrile infants with COVID-19. Pediatr Emerg Care 2021 Apr 1;37(4):232-6

Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control 2021 (published online Jan 29)

Peman J, Ruiz-Gaitan A, Garcia-Vidal C, et al. Fungal co-infection in COVID-19 patients: should we be concerned? Rev Iberoam Micol 2020 (published online Sep 14)

Peñalva G, Benavente RS, Pérez-Moreno MA, et al. Effect of the COVID-19 pandemic on antibiotic use in primary care. Clin Microbiol Infect 2021 (published online Feb 1)

Peng J, Wang Q, Mei H, et al. Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis. Aging (Albany NY) 2021 (published online Mar 19)

Peng Y, Zhang D, Chen T, et al. Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes. J Travel Med 2021 (published online May 5)

Perez S, Innes GK, Spalding Walters M, et al. Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions—New Jersey, February-July 2020. Morb Mortal Wkly Rep 2020 (published online Dec 1)

Pérez-Granda MJ, Sánchez Carrillo C, Rabadán PM, et al. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control. J Hosp Infect 2021 (published online Oct 7)

Permpalung N, Bazemore K, Chiang TPY, et al. Impact of COVID-19 on lung allograft and clinical outcomes in lung transplant recipients: a case-control study. Transplantation 2021 (published online May 28)

Permpalung N, Chiang TPY, Massie AB, et al. COVID-19 associated pulmonary aspergillosis in mechanically ventilated patients. Clin Infect Dis 2021 (published online Mar 9)

Peters C, Williams K, Un EA, et al. Use of procalcitonin for antibiotic stewardship in patients with COVID-19: a quality improvement project in a district general hospital. Clin Med (Lond) 2020 (published online Dec 18)

Petersen FC, Dahle UR, Nicolau B, et al. COVID-19: looking into the overlooked. Front Mol Biosci 2020 (published online Aug 11)

Petrone L, Petruccioli E, Vanini V, et al. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis 2021 (published online Mar 10)

Pettit NN, Nguyen CT, Lew AK, et al. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission. BMC Infect Dis 2021 (published online Jun 2)

Petty LA, Flanders SA, Vaughn VM, et al. Risk factors and outcomes associated with community-onset and hospital-acquired co-infection in patients hospitalized for COVID-19: a multi-hospital cohort study. Infect Control Hosp Epidemiol 2021 (published online Jul 26)

Pickens CO, Gao CA, Cuttica MJ, et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am J Respir Crit Care Med 2021 (published online Aug 19)

Pierce J, Kim J, Deja EN, et al. Electronic distribution of COVID-19 guidelines: a potential tool for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2021 (published online Sep 22)

Pierce J, Stevens MP. COVID-19 and antimicrobial stewardship: lessons learned, best practices and future implications. Int J Infect Dis 2021 (published online Oct 5)

Pink I, Raupach D, Fuge J, et al. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19. Infection 2021 (published online May 22)

Pinxt CMH, Bogie RMM, Hanssen NMJ, et al. COVID-19: a wake-up call for antibiotic overuse in older patients? QJM 2021 (published online Sep 6)

Pippal SK, Kumar D, Ukawat L. Management challenge of rhino-orbito-cerebral mucormycosis in Covid 19 era: a prospective observational study. Indian J Otolaryngol Head Neck Surg 2021 (published online Oct 23)

Polemis M, Mandilara G, Pappa O, et al. COVID-19 and antimicrobial resistance: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance—WHONET-Greece (January 2018–March 2021). Life 2021 (published online Sep 22)

Policar M, Barber P, Malik Y. 383. Increased need for antimicrobial stewardship during a COVID-19 outbreak in New York City. Open Forum Infect Dis 2020 (published online Dec 31)

Polly M, de Almeida BL, Lennon RP, et al. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil. Am J Infect Control 2021 (published online Sep 22)

Ponce-Alonso M, Sáez de la Fuente J, Rincón-Carlavilla A, et al. Impact of the COVID-19 pandemic on nosocomial Clostridioides difficile infection. Infect Control Hosp Epidemiol 2020 (published online Sep 8)

Ponce-Alonso M, Sáez de la Fuente J, Rincón-Carlavilla A, et al. Impact of the COVID-19 pandemic on nosocomial Clostridioides difficile infection—ERRATUM. Infect Control Hosp Epidemiol 2020 (published online Dec 17)

Popp M, Stegemann M, Riemer M, et al. Antibiotics for the treatment of COVID-19. Cochrane Database Syst Rev 2021 (published online Oct 22)

Posteraro B, Cortazzo V, Liotti FM, et al. Diagnosis and treatment of bacterial pneumonia in critically ill patients with COVID-19 using a multiplex PCR assay: a large Italian hospital's five-month experience. Microbiol Spectr 2021 (published online Nov 10)

Posteraro B, De Angelis G, Menchinelli G, et al. Risk factors for mortality in adult COVID-19 patients who develop bloodstream infections mostly caused by antimicrobial-resistant organisms: analysis at a large teaching hospital in Italy. J Clin Med 2021 (published online Apr 17)

Posteraro B, Torelli R, Vella A, et al. Pan-echinocandin–resistant Candida glabata bloodstream infection complicating COVID-19: a fatal case report. J Fungi (Basel) 2020 (published online Sep 6)

Povoa P, Martin-Loeches I, Nseir S. Secondary pneumonias in critically ill patients with COVID-19: risk factors and outcomes. Curr Opin Crit Care 2021;27(5):468-73

Powell N, Howard P, Llewelyn MJ, et al. Use of procalcitonin during the first wave of COVID-19 in the acute NHS hospitals: a retrospective observational study. Antibiotics 2021 May 1;10(5)

Prasetyoputri A. Detection of bacterial coinfection in COVID-19 patients is a missing piece of the puzzle in the COVID-19 management in Indonesia. ACS Infect Dis 2021 (published online Jan 27)

Prestel C, Anderson E, Forsberg K, et al. Candida auris outbreak in a COVID-19 specialty care unit—Florida, July–August 2020. Morb Mortal Wkly Rep 2021 (published online Jan 8)

PRINCIPLE Trial Collaborative Group. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet 2021 (published online Mar 4)

Pulia MS, Wolf I, Schulz LT, et al. COVID-19: an emerging threat to antibiotic stewardship in the emergency department. West J Emerg Med 2020 (published online Aug 7)

Pulia MS, Wolf I, Schwei RJ, et al. Antibiotic prescribing patterns for COVD-19 in two emergency departments with rapid procalcitonin. Infect Control Hosp Epidemiol 2020 (published online Nov 19)

Punjabi C, Madaline T, Gendlina I, et al. Prevalence of MRSA in respiratory cultures and diagnostic performance of the MRSA nasal PCR in patients hospitalized with COVID-19 pneumonia. Infect Control Hosp Epidemiol 2020 (published online Aug 26)

Putot A, Bouiller K, Laborde C, et al. Association between early antibiotic therapy and in-hospital mortality among older patients with SARS-CoV-2 pneumonia. J Gerontol A Biol Sci Med Sci 2021 (published online Jul 17)

Puzniak L, Bauer KA, Yu KC, et al. Effect of inadequate empiric antibacterial therapy on hospital outcomes in SARS-CoV-2-positive and -negative US patients with a positive bacterial culture: a multicenter evaluation from March to November 2020. Open Forum Infect Dis 2021 (published online May 26)

Puzniak L, Finelli L, Yu KC, et al. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis 2021 (published online Feb 27)

Qu J, Cai Z, Liu Y, et al. Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted Pseudomonas aeruginosa chronic colonizer. Front Cell Infect Microbiol 2021 (published online Mar 17)

Quraishi MN, Shabir S, Manzoor SE, et al. The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era. Lancet Microbe 2021 (published online Feb 19)

Rabagliati R, Rodríguez N, Núñez C, et al. COVID-19–associated mold infection in critically ill patients, Chile. Emerg Infect Dis 2021 (published online Mar 24)

Rahman FI, Islam MR, Bhuiyan MA. Mucormycosis or black fungus infection is a new scare in South Asian countries during COVID-19 pandemic: associated risk factors and preventive measures. J Med Virol 2021 (published online Jul 14)

Rahube TO. CEASE approach for combating COVID-19, antimicrobial resistance, and future microbial threats. Can J Microbiol 2021 (published online Oct 14)

Rahube TO. Global impact and implications of Covid-19: call for multi-dimensional perspectives towards sustainable solutions. Microbiol Infect Dis 2021;5(1)

Rajni E, Garg VK, Bacchani D, et al. Prevalence of bloodstream infections and their etiology in COVID-19 patients admitted in a tertiary care hospital in Jaipur. Indian J Crit Care Med 2021 Apr;25(4)

Rajni E, Singh A, Tarai B, et al. A high frequency of Candida auris blood stream infections in COVID-19 patients admitted to intensive care units, north-western India: a case control study. Open Forum Infect Dis 2021 (published online Sep 7)

Ramadan HKA, Mahmoud MA, Aburahma MZ, et al. Predictors of severity and co-infection resistance profile in COVID-19 patients: first report from Upper Egypt. Infect Drug Resist 2020 Oct 5;13:3409-22

Ramalingam S, Gunasekaran K, Arora H, et al. Clostridium difficile and noncirrhotic hyperammonnemia in a patient with COVID-19 infection. Cureus 2021 (published online Apr 17)

Ram Pradeep Rokkam V, Kutti Sridharan G, Vegunta R, et al. Clostridium difficile and COVID-19: novel risk factors for acute portal vein thrombosis. Case Rep Vasc Med 2021 (published online Feb 27)

Ramaswami A, Sahu AK, Kumar A, et al. COVID-19 associated mucormycosis presenting to the emergency department—an observational study of 70 patients. QJM 2021 (published online Jul 12)

Rana MS, Usman M, Salman M, et al. Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan. J Infect 2021 (published online Jul 27)

Randall M, Minahan T, Mesisca M, et al. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia in incarcerated patients with severe COVID-19 infection. Am J Infect Control 2020 (published online Sep 20)

Rangel K, Chagas TPG, De-Simone SG. Acinetobacter baumannii infections in times of COVID-19 pandemic. Pathogens 2021 (published online Aug 10)

Rani KGA, Hamad MA, Zaher DM, et al. Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges. Expert Opin Drug Discov 2020 (published online Dec 28)

Rao VUS, Arakeri G, Madikeri G, et al. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Br J Oral Maxillofac Surg 2021 (published online Jun 29)

Rappuoli R, De Gregorio E, Del Giudice G, et al. Vaccinology in the post−COVID-19 era. Proc Natl Acad Sci U S A 2021 Jan 19;118(3)

Raslan M, Eslam MS, Sara AR, et al. Antimicrobial resistance and second wave of COVID-19: will it impose management protocols deviation? Ann Pharmacol Toxicol 2020 (published online Dec 11)

Rawson TM, Hernandez B, Wilson RC, et al. Supervised machine learning to support the diagnosis of bacterial infection in the context of COVID-19. JAC–Antimicrobial Resistance 2021 (published online Feb 3)

Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections, and COVID-19. Nat Rev Microbiol 2020 Aug;18(8):409-10

Rawson, TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother 2020 (published online May 20)

Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 2020 (published online May 2)

Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect 2020 (published online Sep 22)

Raychaudhuri D, Sarkar M, Roy A, et al. COVID-19 and co-infection in children: the Indian perspectives. J Trop Pediatr 2021 (published online Aug 27)

Razzaque MS. Exacerbation of antimicrobial resistance: another casualty of the covid-19 pandemic? Expert Rev Anti Infect Ther 2020 (published online Dec 23)

RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021 (published online Feb 2)

Regan A, Sweeney S, McKernan C, et al. The impact of the Covid-19 pandemic on food consumers' awareness of antimicrobial resistance, OneHealth, and animal welfare information on food labels. Front Vet Sci 2021 (published online Jun 29)

Rehman Arshad A, Ijaz F, Shan Siddiqui M, et al. COVID-19 pandemic and antimicrobial resistance in developing countries. Discoveries 2021;9(2)

Reus Rodrigues Perez L, Carniel E, Azambuja Narvaez G. Emergence of NDM-producing Pseudomonas aeruginosa among hospitalized patients and impact on antimicrobial therapy during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2021 (published online Jun 28)

Rezaei M, Babamahmoodi A, Marjani M. Tuberculosis and COVID-19 co-infection: a case series from Iran. Int J Mycobacteriol 2021;9(5)

Rezasoltani S, Yadegar A, Hatami B, et al. Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: the global impacts of too much hygiene on AMR. Front Microbiol 2020 (published online Dec 15)

Rezel-Potts E, L'Esperance V, Gullifiord M. Antimicrobial stewardship during the COVID-19 epidemic: population-based cohort study and interrupted time series analysis in the United Kingdom. Br J Gen Pract 2021 (published online Apr 6)

Rhouma M, Tessier M, Aenishaenslin C, et al. Should the increased awareness of the One Health approach brought by the COVID-19 pandemic be used to further tackle the challenge of antimicrobial resistance? Antibiotics (Basel) 2021 (published online Apr 20)

Riad A, Gad A, Hockova B, et al. Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship. Oral Surg 2020 (published online Sep 21)

Riad A, Shabaan AA, Issa J, et al. COVID-19-associated mucormycosis (CAM): case-series and global analysis of mortality risk factors. J Fungi (Basel) 2021 (published online Oct 7)

Richards O, Pallmann P, King C, et al. Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS. Antibiotics (Basel) 2021 (published online Nov 22)

Riou C, Du Bruyn E, Stek C, et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis co-infection. J Clin Invest 2021 (published online May 4)

Ripa M, Galli L, Poli A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect 2020 (published online Oct 23)

Risa E, Roach D, Budak JZ, et al. Characterization of secondary bacterial infections and antibiotic use in mechanically ventilated patients with COVID-19 induced acute respiratory distress syndrome. J Intensive Care Med 2021 (published online Aug 10)

Rivera CG, Mahoney MV, Stevens RW, et al. Out of sight but not out of mind: caring for patients receiving OPAT during the SARS-CoV-2 pandemic. Open Forum Infect Dis 2020 (published online Jul 21)

Rizk NA, Moghnieh R, Haddad N, et al. Challenges to antimicrobial stewardship in the countries of the Arab League: concerns of worsening resistance during the COVID-19 pandemic and proposed solutions. Antibiotics (Basel) 2021 (published online Oct 29)

Rizvi SG, Ahammad SZ. COVID-19 and antimicrobial resistance: a cross-study. Sci Total Environ 2021 (published online Oct 8)

Robinson JC. Funding of pharmaceutical innovation during and after the COVID-19 pandemic. JAMA 2021 (published online Jan 14)

Rocha ICN, Hasan MM, Goyal S, et al. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Trop Med Int Health 2021 (published online Jun 11)

Rodríguez-Álvarez M, López-Vidal Y, Soto-Hernández JL, et al. COVID-19: clouds over the antimicrobial resistance landscape. Arch Med Res 2020 (published online Oct 10)

Rodríguez-Baño J, Rossolini GM, Schultsz C, et al. AMR research in a post-pandemic world: insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist 2021 (published online Mar 1)

Rodríguez-Baño J, Rossolini GM, Schultsz C, et al. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans R Soc Trop Med Hyg 2021 (published online Mar 27)

Rodriguez JY, Le Pape P, Lopez O, et al. Candida auris: a latent threat to critically ill patients with COVID-19. Clin Infect Dis 2020 (published online Oct 18)

Rodríguez-Molinero A. Azithromycin: can its benefit be ruled out in mild COVID-19? Lancet Respir Med 2021 (published online Jul 9)

Rodríguez-Molinero A, Pérez-López C, Gálvez-Barrón C, et al. Observational study of azithromycin in hospitalized patients with COVID-19. PLoS One 2020 (published online Sep 3)

Rojas-Garcia P, Antoñanzas F. Analysis of the prescription of antibiotics during the implementation of COVID-19 personal protection measures in a regional health system. Infect Drug Resist 2021 (published online Nov 15)

Roopa R, Thanthoni M, Warrier AS. COVID-19 coinfection with mucormycosis in a diabetic patient. Cureus 2021 (published online Jun 22)

Rosani Shinohara D, dos Santos Saalfeld SM, Vizzi Martinez H, et al. Outbreak of endemic carbapenem-resistant A. baumannii in a COVID-19-specific intensive care unit. Infect Control Hosp Epidemiol 2021 (published online Mar 9)

Rose AN, Baggs J, Wolford H, et al. Trends in antibiotic use in U.S. hospitals during the COVID-19 pandemic. Open Forum Infect Dis 2021 (published online Jun 3)

Rossato L, Negrao FJ, Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance? Am J Infect Control 2020 (published online Jun 26)

Rossi M, Chatenoud L, Gona F, et al. Characteristics and clinical implications of carbapenemase-producing Klebsiella pneumoniae colonization and infection, Italy. Emerg Infect Dis 2021 (published online Apr 22)

Rota MC, Caporali MG, Scaturro M, et al. Legionella pneumophila and SARS-COV-2 co-infection: the importance of laboratory diagnosis. Letter. Ann Ist Super Sanita 2021 Jul-Sep;57(3):199-200

Rothe K, Feihl S, Schneider J, et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis 2020 (published online Nov 2)

Rothe K, Lahmer T, Rasch S, et al. Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients. Multidiscip Respir Med 2021 (published online Oct 28)

Rothe K, Spinner CD, Panning M, et al. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ). Infection 2021 (published online Oct 23)

Roudbary M, Kumar S, Kumar A, et al. Overview on the prevalence of fungal infections, immune response, and microbiome role in COVID-19 patients. J Fungi 2021 (published online Sep 2)

Roushdy T, Hamid E. A case series of post COVID-19 mucormycosis—a neurological prospective. Egypt J Neurol Psychiatr Neurosurg 2021 (published online Jul 26)

Rouyer M, Strazzulla A, Youbong T, et al. Ventilator-associated pneumonia in COVID-19 patients: a retrospective cohort study. Antibiotics (Basel) 2021 (published online Aug 16)

Rouze A, Martin-Loeches I, Povoa P, et al. Early bacterial identification among intubated patients with COVID-19 or influenza pneumonia: a European multicenter comparative cohort study. Am J Respir Crit Care Med 2021 (published online May 26)

Roy A, Powers HR, Craver CE, et al. Antibiotic stewardship: early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia. J Clin Pharm Ther 2021 (published online Nov 11)

Roy DB, Gupta V, Biswas A, et al. Early surgical intervention followed by antifungals in rhino-orbital mucormycosis in patients with COVID-19 favors clinical outcome: a case series. Cureus 2021 (published online Aug 14)

Rubiano C, Tompkins K, Sellers SA, et al. Pneumocystis and SARS-CoV-2 co-infection: a case report and review of an emerging diagnostic dilemma. Open Forum Infect Dis 2020 (published online Dec 18)

Rudrabhatla PK, Reghukumar A, Thomas SV. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Acta Neurol Belg 2021 (published online Nov 24)

Ruiz J. Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect? J Hosp Infect 2020 (published online Nov 16)

Ruiz-Bastián M, Falces-Romero I, Ramos-Ramos JC, et al. Bacterial co-infections in COVID-19 pneumonia in a tertiary care hospital: surfing the first wave. Diagn Microbiol Infect Dis 2021 (published online Jul 3)

Ruiz-Garbajosa P, Cantón R. COVID-19: impact on prescribing and antimicrobial resistance. Rev Esp Quimioter 2021 Sep;34(suppl 1):63-8

Rusic D, Vilovic M, Bukic J, et al. Implications of COVID-19 pandemic on the emergence of antimicrobial resistance: adjusting the response to future outbreaks. Life 2021 (published online Mar 10)

Russell CD, Fairfield CJ, Drake TM, et al. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe 2021 (published online Jun 2)

Ryu S, Hwang Y, Ali ST, et al. Decreased use of broad-spectrum antibiotics during COVID-19 epidemic in South Korea. J Infect Dis 2021 (published online Apr 15)

Sachdeva K, Saji TA. Adverse drug reaction of antifungals in the management of black fungus: a tertiary care centre experience. Indian J Otolaryngol Head Neck Surg 2021 (published online Sep 1)

Saeed NK, Al-Khawaja S, Alsalman J, et al. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J Virol 2021 (published online Jul 25)

Sahu S, Ditiu L, Singh Sachdeva K, et al. Recovering from the impact of the Covid-19 pandemic and accelerating to achieving the United Nations General Assembly tuberculosis targets. Int J Infect Dis 2021 (published online Mar 11)

Said KB, Alsolami A, Khalifa AM, et al. A multi-point surveillance for antimicrobial resistance profiles among clinical isolates of gram-negative bacteria recovered from major Ha’il hospitals, Saudi Arabia. Microorganisms 2021 (published online Sep 24)

Saidha PK, Kapoor S, Das P, et al. Mucormycosis of paranasal sinuses of odontogenic origin post COVID19 infection: a case series. Indian J Otolaryngol Head Neck Surg 2021 (published online Jun 17)

Saini V, Jain C, Singh NP, et al. Paradigm shift in antimicrobial resistance pattern of bacterial isolates during the COVID-19 pandemic. Antibiotics (Basel) 2021 (published online Aug 7)

Salmanton-García J, Sprute R, Stemler J, et al. COVID-19–associated pulmonary aspergillosis, March–August 2020. Emerg Infect Dis 2021 (published online Feb 4)

Salvesen Blix H, Høye S. Use of antibiotics during the COVID-19 pandemic. Tidsskr Nor Laegeforen 2021 (published online Feb 18)

Sami SA, Marma KKS, Chakraborty A, et al. A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future. Futur J Pharm Sci 2021 (published online Jun 11)

Sandhu AK, LeRose JJ, Garg A, et al. The argument for rapid influenza polymerase chain reaction (PCR) during the COVID-19 pandemic: quicker turnaround times correlated with decreased antimicrobial use, reduced admission rates, and shorter length of stay. Infect Control Hosp Epidemiol 2021 (published online Mar 26)

Sarkar S, Khanna P, Singh AK. Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses. J Med Virol 2020 (published online Dec 17)

Sasson A, Aijaz A, Chernyavsky S, et al. A coronavirus disease 2019 (COVID-19) mystery: persistent fevers and leukocytosis in a patient with severe COVID-19. Open Forum Infect Dis 2020 (published online Dec 18)

Schirmer P, Lucero-Obusan C, Sharma A, et al. Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020. Diagn Microbiol Infect Dis 2021 (published online Jan 20)

Schons MJ, Caliebe A, Spinner CD, et al. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort. Infection 2021 (published online Oct 8)

Schouten J, De Waele J, Lanckohr C, et al. Antimicrobial stewardship in the ICU in COVID times: the known unknowns. Int J Antimicrob Agents 2021 (published online Jul 30)

Scott H, Zahra A, Fernandes R, et al. Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia. Am J Emerg Med 2021 (published online Sep 28)

Seabra G, Ferreira Ventura Mendes R, Vieira Dos Santos Amorim LF, et al. Azithromycin use in COVID-19 patients: implications on the antimicrobial resistance. Curr Top Med Chem 2021 May 3;21(8):677-83

Seagle EE, Jackson BR, Lockhart SR, et al. The landscape of candidemia during the COVID-19 pandemic. Clin Infect Dis 2021 (published online Jun 18)

Seaton RA, Cooper L, Gibbons CL, et al. Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals. JAC Antimicrob Resist 2021 (published online Jun 18)

Seaton RA, Gibbons CL, Cooper L, et al. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals. J Infect 2020 (published online Sep 26) 

Seethalakshmi PS, Charity OJ, Giakoumis T, et al. Delineating the impact of COVID-19 on antimicrobial resistance: an Indian perspective. Sci Total Environ 2021 (published online Nov 16)

Segala FV, Bavaro DF, Di Gennaro F, et al. Impact of SARS-CoV-2 epidemic on antimicrobial resistance: a literature review. Viruses 2021 (published online Oct 20)

Segrelles-Calvo G, de S Araújo GR, Llopis-Pastor E, et al. Candida spp. co-infection in COVID-19 patients with severe pneumonia: prevalence study and associated risk factors. Respir Med 2021 (published online Sep 17)

Sehgal K, Fadel HJ, Tande AJ, et al. Outcomes in patients with SARS-CoV-2 and Clostridioides difficile coinfection. Infect Drug Resist 2021 (published online Apr 28)

Seidel D, Simon M, Sprute R, et al. Results from a national survey on COVID-19 associated mucormycosis in Germany: 13 patients from six tertiary hospitals. Mycoses 2021 (published online Oct 16)

Sender V, Hentrich K, Henriques-Normark B. Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae. Front Cell Infect Microbiol 2021 (published online Mar 22)

Senok A, Alfaresi M, Khansaheb H, et al. Coinfections in patients hospitalized with COVID-19: a descriptive study from the United Arab Emirates. Infect Drug Resist 2021 (published online Jun 21)

Sentís A, Prats-Uribe A, López-Corbeto E, et al. The impact of the COVID-19 pandemic on sexually transmitted infections surveillance data: incidence drop or artefact? BMC Public Health 2021 (published online Sep 7)

Shabrawishi M, AlQarni A, Ghazawi M, et al. New disease and old threats: a case series of COVID-19 and tuberculosis coinfection in Saudi Arabia. Clin Case Rep 2021 (published online May 24)

Shafran N, Shafran I, Ben-Zvi H, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep 2021 (published online Jun 16)

Shah S, Wordley V, Thompson W. How did COVID-19 impact on dental antibiotic prescribing across England? Br Dent J 2020 (published online Nov 13)

Shallal A, Kenney R, Weinman A. Missed vaccine opportunities to S. pneumoniae and influenza in patients admitted during the COVID-19 pandemic. Infect Control Hosp Epidemiol 2020 (published online Oct 26)

Sharifipour E, Shams S, Esmkhani M, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect Dis 2020 (published online Sep 1)

Sharma B, Sreenivasan P, Biswal M, et al. Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: time to adhere to culture-based practices. Qatar Med J 2021 (published online oct 25)

Sharma S, Grover M, Bhargava S, et al. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 2021 (published online Apr 8)

Sharov KS. SARS-CoV-2–related pneumonia cases in pneumonia picture in Russia in March–May 2020: secondary bacterial pneumonia and viral co-infections. J Glob Health 2020 Dec;10(2)

Shbaklo N, Lupia T, De Rosa FG, et al. Infection control in the era of COVID-19: a narrative review. Antibiotics (Basel) 2021 (published online Oct 14)

Sheikh AAE, Sheikh AB, Shah I, et al. COVID-19 and fulminant Clostridium difficile colitis co-infection. Eur J Case Rep Intern Med 2021 (published online Aug 24)

Shimizu M, Chihara Y, Satake S, et al. Co-infection with Legionella and SARS-CoV-2: a case report. JA Clin Rep 2021 (published online Aug 18)

Shin DH, Kang M, Song KH, et al. A call for antimicrobial stewardship in patients with COVID-19: a nationwide cohort study in Korea. Clin Microbiol Infect 2020 (published online Oct 30)

Shukla BS, Warde PR, Knott E, et al. Bloodstream infection risk, incidence, and deaths for hospitalized patients during coronavirus disease pandemic. Emerg Infect Dis 2021 (published online Aug 5)

Sieswerda E, De Boer MGJ, Bonten MMJ, et al. Recommendations for antibacterial therapy in adults with COVID-19—an evidence based guideline. Clin Microbiol Infec 2020 (published online Sep 30)

Silva DL, Lima CM, Magalhães VCR, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect 2021 (published online Apr 11)

Silva TM, Estrela M, Gomes ER, et al. The impact of the COVID-19 pandemic on antibiotic prescribing trends in outpatient care: a nationwide, quasi-experimental approach. Antibiotics (Basel) 2021 (published online Aug 25)

Singh K, Kumar S, Shastri S, et al. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India. Immunogenetics 2021 (published online Oct 1)

Singh V, Upadhyay P, Reddy J, et al. SARS-CoV-2 respiratory co-infections: incidence of viral and bacterial co-pathogens. Int J Infect Dis 2021 (published online Feb 24)

Sipos S, Vlad C, Prejbeanu R, et al. Impact of COVID-19 prevention measures on Clostridioides difficile infections in a regional acute care hospital. Exp Ther Med 2021 Nov;22(5):1215

Skonieczny P, Heleniak Z, Szostakiewicz M, et al. Co-infection of COVID-19 and pneumocystosis in the patient after kidney transplantation. Pol Arch Intern Med 2021 (published online May 11)

Sluggett JK, Dinh YH, Wesselingh SL, et al. National changes in outpatient systemic antibiotic use during the coronavirus disease 2019 pandemic in Australia. Clin Infect Dis 2021 (published online Mar 17)

Smith DRM, Opatowski L. COVID-19 containment measures and incidence of invasive bacterial disease. Lancet Digital Health 2021 Jun 1;3(6):E331-2

Smith L, Karaba SM, Amoah J, et al. Hospital-acquired infections among adult patients admitted for COVID-19. Infect Control Hosp Epidemiol 2021 (published online Apr 13)

Sodhi M, Etminan M. Therapeutic potential for tetracyclines in the treatment of COVID-19. Pharmacother 2020 (published online Apr 8)

Soltani S, Faramarzi S, Zandi M, et al. Bacterial co-infection among COVID-19 patient groups: an update systematic review and meta-analysis. New Microbes New Infect 2021 (published online Jul 1)

Son HJ, Kim T, Lee E, et al. Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: a multicenter study. Am J Infect Control 2021 (published online Jun 16)

Song W, Jia X, Zhang X, et al. Co-infection in COVID-19, a cohort study. J Infect 2020 (published online Oct 8)

Song WM, Zhao JY, Zhang QY, et al. COVID-19 and tuberculosis coinfection: an overview of case reports/case series and meta-analysis. Front Med (Lausanne) 2021 (published online Aug 24)

Soni S, Pudake RN, Jain U, et al. A systematic review on SARS-CoV-2 associated fungal co-infections. J Med Virol 2021 (published online Sep 27)

Sopirala MM. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change? Curr Opin Infect Dis 2021 (published online May 25)

Sosa-Hernández JE, Rodas-Zuluaga LI, López-Pacheco IY, et al. Sources of antibiotics pollutants in the aquatic environment under SARS-CoV-2 pandemic situation. Case Studies in Chemical and Environmental Engineering 2021 (published online Aug 30)

Soto A, Quiñones-Laveriano DM, Valdivia F, et al. Detection of viral and bacterial respiratory pathogens identified by molecular methods in COVID-19 hospitalized patients and its impact on mortality and unfavorable outcomes. Infect Drug Resist 2021 (published online Jul 21)

Spernovasilis N, Ierodiakonou D, Spanias C, et al. Doctors’ perceptions, attitudes and practices towards the management of multidrug-resistant organism infections after the implementation of an antimicrobial stewardship programme during the COVID-19 pandemic. Trop Med Infect Dis 2021 (published online Feb 5)

Spernovasilis N, Kofteridis D. COVID-19 and antimicrobial stewardship: what is the interplay? Infect Control Hosp Epidemiol 2020 (published online May 15)

Spigaglia P. COVID-19 and Clostridioides difficile infection (CDI): possible implications for elderly patients. Anaerobe 2020 (published online Jun 25)

Sreenath K, Batra P, Vinayaraj EV, et al. Coinfections with other respiratory pathogens among patients with COVID-19. Microbiol Spectr 2021 (published online Jul 21)

Starshinova A, Guglielmetti L, Rzhepishevska O, et al. Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case). J Clin Tuberc Other Mycobact Dis 2021 (published online Jul 1)

Staub MB, Beaulieu RM, Graves J, et al. Changes in antimicrobial utilization during the COVID-19 pandemic after implementation of a multispecialty clinical guidance team. Infect Control Hosp Epidemiol 2020 (published online Oct 26)

Staunton S, Rajendran D, Maher P, et al. Discharge-delaying factors for patients suitable for outpatient parenteral antimicrobial therapy (OPAT) in an Irish tertiary hospital during COVID-19. JAC Antimicrob Resist 2021 (published online Oct 14)

Stefanini I, De Renzi G, Foddai E, et al. Profile of bacterial infections in COVID-19 patients: antimicrobial resistance in the time of SARS-CoV-2. Biology (Basel) 2021 (published online Aug 24)

Sterenczak KA, Barrantes I, Stahnke T, et al. Co-infections: testing macrolides for added benefit in patients with COVID-19. Lancet Microbe 2020 (published online Nov 2)

Stevens MP, Patel PK, Nori P. Antimicrobial stewardship programs and convalescent plasma for COVID-19: a new paradigm for pre-authorization. Infect Control Hosp Epidemiology 2020 (published online Sep 9)

Stevens MP, Pierce JW, Pryor R, et al. The coronavirus disease 2019 (COVID-19) delta wave: refocusing effort and remaining resilient in the face of evolving infection prevention and antimicrobial stewardship challenges. Antimicrob Steward Healthc Epidemiol 2021 (published online Nov 18)

Stevens RW, Estes L, Rivera C. Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review. Infect Control Hosp Epidemiol 2020 (published online Apr 15)

Stevens RW, Jensen K, Kooda K, et al. A retrospective antibiotic prescribing assessment and examination of potential antibiotic stewardship targets in patients with COVID-19. JAC Antimicrob Resist 2021 (published online Nov 5)

Stevens RW, Jensen K, O'Horo JC, et al. Antimicrobial prescribing practices at a tertiary care center in patients diagnosed with COVID-19 across the continuum of care. Infect Control Hosp Epidemiol 2020 (published online Jul 24)

Stevenson DR, Sahemey M, Cevallos Morales J, et al. Improving antimicrobial stewardship in critically-ill patients with COVID-19. Clin Infect Dis 2020 (published online Oct 11)

Strathdee SA, Davies SC, Marcelin JR. Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election. Lancet 2020 (published online Sep 29)

Subbarao S, Campbell H, Ribeiro S, et al. Invasive meningococcal disease, 2011–2020, and impact of the COVID-19 pandemic, England. Emerg Infect Dis 2021 (published online Jun 30)

Subramanya SH, Czyż DM, Acharya KP, et al. The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship. Virusdisease 2021 (published online May 25)

Sulis G, Batomen B, Kotwani A, et al. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PLoS Med 2021 (published online Jul 1)

Sundaram N, Bhende T, Yashwant R, et al. Mucormycosis in COVID-19 patients. Indian J Ophthalmol 2021 Dec;69(12):3728-33

Swain S, Ray A, Sarda R, et al. COVID-19 associated sub-acute invasive pulmonary aspergillosis. Mycoses 2021 (published online Sep 19)

Swartwood MJ, Boerneke RA, Kinlaw AC, et al. 483. OPAT delivery during COVID-19. Open Forum Infect Dis 2020 (published online Dec 31)

Szabo BG, Lakatos B, Bobek I, et al. Invasive fungal infections among critically ill adult COVID-19 patients: first experiences from the national centre in Hungary. J Mycol Med 2021 (published online Aug 14)

Takazono T, Mukae H, Izumikawa K, et al. Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: a nationwide survey by the Japanese Respiratory Society. Respir Investig 2021 (published online Oct 7)

Tamuzi JL, Ayele BT, Shumba CS, et al. Implications of COVID-19 in high burden countries for HIV/TB: a systematic review of evidence. BMC Infect Dis 2020 (published online Oct 9)

Tan SH, Ng TM, Tay HL, et al. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19). J Glob Antimicrob Resist 2020 (published online Dec 8)

Tan YX, Wong GW, Tan YH. Superinfection associated with prolonged antibiotic use in non-ventilator associated hospital-acquired pneumonia. Int J Clin Pharm 2021 (published online May 29)

Tande AJ, Stevens RW, Wermers RA, et al. Leveraging existing strategies of medication stewardship to preserve and appropriately use critical supplies. Mayo Clin Proc 2020 Sep;95(9):S29-32

Tang ML, Li YQ, Chen X, et al. Co-infection with common respiratory pathogens and SARS-CoV-2 in patients with COVID-19 pneumonia and laboratory biochemistry findings: a retrospective cross-sectional study of 78 patients from a single center in China. Med Sci Monit 2021 (published online Jan 3)

Tannhäuser R, Nickel O, Lindner M, et al. Bacterial contamination of the smartphones of healthcare workers in a German tertiary-care hospital before and during the COVID-19 pandemic. Am J Infect Control 2021 (published online Oct 16)

Tassi Mousquer G, Peres A, Fiegenbaum M. Pathology of TB/COVID-19 co-infection: the phantom menace. Tuberculosis (Edinb) 2020 (published online Nov 17)

TB/COVID-19 Global Study Group. TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis 2021 Jan 1;25(1):78-80

TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J 2021 (published online Nov 11)

Temperoni C, Caiazzo L, Barchiesi F. High prevalence of antibiotic resistance among opportunistic pathogens isolated from patients with COVID-19 under mechanical ventilation: results of a single-center study. Antibiotics (Basel) 2021 (published online Sep 6)

Tewari S, Vashishth A. Painful trigeminal neuropathy in patients with invasive fungal sinusitis post Covid-19 infection. Pain Pract 2021 (published online Aug 19)

Thaden JT, Maskarinec SA. When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19. Clin Microbiol Infect 2020 (published online Sep 9)

Thelen JM, Buenen AGN, van Apeldoorn M, et al. Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study. BMC Infect Dis 2021 (published online Feb 22)

Thompson GR III, Cornely OA, Pappas PG, et al. Invasive aspergillosis as an underrecognized superinfection in COVID-19. Open Forum Infect Dis 2020 (published online Jun 19)

Thornton HV, Khalid T, Hay AD. Point-of-care testing for respiratory infections during and after COVID-19. Br J Gen Pract 2020 (published online Nov 16)

Tiberi S, Vjecha MJ, Zumla A, et al. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis 2021 (published online Mar 10)

Timbrook TT, Hueth KD, Ginocchio CC. Identification of bacterial co-detections in COVID-19 critically ill patients by BioFire® FilmArray® pneumonia panel: a systematic review and meta-analysis. Diagn Microbiol Infect Dis 2021 (published online Jul 1) 

Tiri B, Sensi E, Marsiliani V, et al. Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant Klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work? J Clin Med 2020 (published online Aug 25)

Tiseo G, Yahav D, Paul M, et al. What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group. Eur J Clin Microbiol Infect Dis 2021 (published online Nov 13)

Toc DA, Costache C, Botan A, et al. Mixed etiology COVID-19 associated pulmonary aspergillosis (CAPA)—a case report and brief review of the literature. J Fungi (Basel) 2021 (published online Oct 18)

Tolossa T, Tsegaye R, Shiferaw S, et al. Survival from a triple co-infection of COVID-19, HIV, and tuberculosis: a case report. Int Med Case Rep J 2021 (published online Sep 2)

Tomczyk S, Taylor A, Brown A, et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother 2021 (published online Sep 2)

Toro-Alzate L, Hofstraat K, de Vries DH. The pandemic beyond the pandemic: a scoping review on the social relationships between COVID-19 and antimicrobial resistance. Int J Environ Res Public Health 2021 (published online Aug 19)

Townsend L, Hughes G, Kerr C, et al. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-Antimicrobial Resistance 2020 (published online Aug 25)

Tsukamoto T, Nakajima N, Sakurai A, et al. Lung pathology of mutually exclusive co-infection with SARS-CoV-2 and Streptococcus pneumoniae. Emerg Infect Dis 2021 (published online Jan 13)

Tyagi N. Prevalence of blood stream infections and their etiology in COVID-19 patients: a tale of two cities. Indian J Crit Care Med 2021 Apr;25(4)

Ukuhor HO. The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics. J Infect Public Health 2020 (published online Dec 9)

Ul Mustafa Z, Saleem MS, Ikram MN, et al. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey. Pathog Glob Health 2021 (published online Nov 16)

Ul Mustafa Z, Salman M, Aldeyab M, et al. Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. SN Compr Clin Med 2021 (published online May 28)

Usman M, Farooq M, Hanna K. Environmental side effects of the injudicious use of antimicrobial in the era of COVID-19. Sci Total Environ 2020 (published online Jul 18)

Vacheron CH, Lepape A, Savey A, et al. Increased incidence of ventilator-acquired pneumonia in coronavirus disease 2019 patients: a multicentric cohort study. Crit Care Med 2021 (published online Sep 22)

Vaillancourt M, Jorth P. The unrecognized threat of secondary bacterial infections with COVID-19. mBio 2020 (published online Aug 7)

van Berkel M, Kox M, Frenzel T, et al. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times. Crit Care 2020 (published online Oct 6)

van de Pol AC, Boeijen JA, Venekamp RP, et al. Impact of the COVID-19 pandemic on antibiotic prescribing for common infections in the Netherlands: a primary care-based observational cohort study. Antibiotics (Basel) 2021 (published online Feb 18)

van Duin D, Barlow G, Nathwani D. The impact of the COVID-19 pandemic on antimicrobial resistance: a debate. JAC–Antimicrobial Resistance 2020 (published online Jul 17)

Vanhomwegen C, Veliziotis I, Malinverni S, et al. Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit. Ir J Med Sci 2021 (published online Jan 16)

Van Laethem J, Wuyts S, Van Laere S, et al. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers. Intern Emerg Med 2021 (published online Jun 29)

Van Laethem J, Wuyts S, Van Laere S, et al. Antibiotic prescriptions targeting bacterial respiratory infections in admitted patients with COVID-19: a prospective observational study. Infect Dis Ther 2021 (published online Sep 16)

Vaughn VM, Dunn GE, Horowitz JK, et al. Duties, resources, and burnout of antibiotic stewards during the coronavirus disease 2019 (COVID-19) pandemic. Antimicrob Steward Healthc Epidemiol 2021 (published online Nov 5)

Vaughn VM, Gandhi T, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis 2020 (published online Aug 21)

Vehreschild MJGT, Tacconelli E, Giske CG, et al. Beyond COVID-19—a paradigm shift in infection management. Lancet Infect Dis 2020 (published online Oct 9)

Velasco-Arnaiz E, Lopez-Ramos MG, Simó-Nebot S, et al. Pediatric antimicrobial stewardship in the COVID-19 outbreak. Infect Control Hosp Epidemiol 2020 (published online Jun 24)

Vélez Pintado M, Camiro-Zúñiga A, Aguilar Soto M, et al. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City. Med Mycol 2021 (published online Mar 16)

Verhasselt HL, Buer J, Dedy J, et al. COVID-19 co-infection with Legionella pneumophila in 2 tertiary-care hospitals, Germany. Emerg Infect Dis 2021 (published online Apr 12)

Verweij PE, Alanio A. Fungal infections should be part of the core outcome set for COVID-19. Lancet Infect Dis 2020 (published online Dec 7)

Vidyarthi AJ, Das A, Chaudhry R. Antimicrobial resistance and COVID-19 syndemic: impact on public health. Drug Discov Ther 2021;15(3):124-9

Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist 2021 May 24;14:1893-903

Villanueva-Lozano H, de J. Trevino-Rangel R, Gonzalez GM, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect 2021 (published online Jan 8)

Visca D, Ong CWM, Tiberi S, et al. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology 2021 (published online Jan 22)

Voona S, Abdic H, Montgomery R, et al. Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre. Anaerobe 2021 (published online Nov 18)

Walker IF. Beyond the military metaphor: comparing antimicrobial resistance and the COVID-19 pandemic in the United Kingdom. Med Anthro Theory 2020 (published online Sep 21)

Wang L, Amin AK, Khanna P, et al. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. J Antimicrob Chemother 2020 (published online Nov 13)

Waqar H, Arshad A, Shera TM, et al. Changing trends of COVID-19 treatment and early use of antibiotics: a case in Pakistan. Asian J Med Biomed 2020 oct 25;4(2):58-63

Wardoyo EH, Suardana IW, Yasa IWPS, et al. Antibiotics susceptibility of Escherichia coli isolates from clinical specimens before and during COVID-19 pandemic. Iran J Microbiol 2021 Apr;13(2):156-60

Waris A, Din M, Iqbal N, et al. Evaluation of serum procalcitonin level as a biomarker for disease severity in Covid-19 patients. New Microbes New Infect 2021 (published online Jul 24)

Wasag DR, Cannings-John R, Hughes K, et al. Antibiotic dispensing during the COVID-19 pandemic: analysis of Welsh primary care dispensing data. Fam Pract 2021 (published online Nov 10)

Wasylyshyn AI, Wasylyshyn GR, Linder KA, et al. COVID-19-associated pulmonary aspergillosis at an academic medical center in the midwestern United States. Mycopathologia 2021 (published online Jun 18)

Watanabe JH, Kwon J, Nan B, et al. Medication use patterns in hospitalized patients with COVID-19 in California during the pandemic. JAMA Netw Open 2021 (published online May 21)

Waterer G, Pickens CI, Wunderink R. Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go away. Respirology 2021 (published online Oct 1)

Weiner-Lastinger LM, Pattabiraman V, Konnor RY, et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2021 (published online Sep 2)

Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021 (published online Apr 7)

Wey EQ, Bristow C, Nandani A, et al. Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19. J Infect 2021 (published online Aug 13)

White PL. Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls. Curr Opin Infect Dis (published online Nov 25)

White PL, Dhillon R, Cordey A, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis 2020 (published online Aug 29)

White PL, Dhillon R, Healy B, et al. Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures. Clin Infect Dis 2020 (published online Oct 18)

Williams EJ, Mair L, de Silva TI, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study. J Hosp Infect 2021 (published online Jan 19)

Williams TGS, Snell LB, Edgeworth JD, et al. COVID-19: stewardship of diagnostic tests for bacterial co-infection. Lancet Microbe 2021 (published online Aug 26)

Wilson LA, Rogers Van Katwyk S, Fafard P, et al. Lessons learned from COVID-19 for the post-antibiotic future. Global Health 2020 (published online Oct 8)

Winders HR, Bailey P, Kohn J, et al. Change in antimicrobial use during COVID-19 pandemic in South Carolina hospitals: a multicenter observational cohort study. Int J Antimicrob Agents 2021 (published online Oct 13)

Wingfield T, Karmadwala F, MacPherson P, et al. Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respir Med 2021 (published online Mar 24)

Witting C, Quaggin-Smith J, Mylvaganam R, et al. Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report. Diagn Microbiol Infect Dis 2020 (published online Nov 20)

Wolfisberg S, Gregoriano C, Schuetz P. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Crit Rev Clin Lab Sci 2021 (published online Sep 13)

Wong A, Cao J, Lyons PG, et al. Quantification of sepsis model alerts in 24 US hospitals before and during the COVID-19 pandemic. JAMA Netw Open 2021 (published online Nov 19)

Wong SC, Lam GKM, Chen JHK, et al. Air dispersal of multidrug-resistant Acinetobacter baumannii: implication in nosocomial transmission during COVID-19 pandemic. J Hosp Infect 2021 (published online Aug 14)

Wu N, Chen LK, Zhu T. Phage therapy for secondary bacterial infections with COVID-19. Curr Opin Virol 2021 (published online Nov 9)

Wu N, Dai J, Guo M, et al. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg Microbes Infect 2021;10(1):612-8

Wu Y, Cheng X, Jiang G, et al. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes 2021 (published online Jul 22)

Yacouba A, Olowo-Okere A, Yunusa I. Repurposing of antibiotics for clinical management of COVID-19: a narrative review. Ann Clin Microbiol Antimicrob 2021 (published online May 21)

Yamamoto S, Saito M, Tamura A, et al. The human microbiome and COVID-19: a systematic review. PLoS One 2021 (published online Jun 23)

Yang M, Feng Y, Yuan L, et al. High concentration and frequent application of disinfection increase the detection of methicillin-resistant Staphylococcus aureus infections in psychiatric hospitals during the COVID-19 pandemic. Front Med 2021 (published online Oct 27)

Yang S, Hua M, Liu X, et al. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit. Microbes Infect 2021 (published online Mar 5)

Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 (published online Feb 24)

Yasmin F, Najeeb H, Naeem A, et al. COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management. Diseases 2021 (published online Sep 22)

Yau YK, Mak WYJ, Lui NSR, et al. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United European Gastroenterol J 2021 (published online Oct 8)

Yildirim Arslan S, Sahbudak Bal Z, Guner Ozenen G, et al. Cervical abscess caused by methicillin-susceptible Staphylococcus aureus in an infant infected with SARS-CoV-2: diagnostic dilemma. J Infect Chemother 2021 (published online Mar 27)

Yin X, Xu X, Li H, et al. Evaluation of early antibiotic use in non-severe COVID-19 patients without bacterial infection: early antibiotic use in non-severe COVID-19. Int J Antimicrob Agents 2021 (published online Oct 23)

Yock-Corrales A, Lenzi J, Ulloa-Gutiérrez R, et al. High rates of Antibiotic prescriptions in children with COVID-19 or Multisystem Inflammatory Syndrome: a multinational experience in 990 cases from Latin America. Acta Paediatr 2021 (published online Mar 19)

Youngs J, Wyncoll D, Hopkins P, et al. Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza. J Infect 2020 (published online Jun 25)

Yu D, Ininbergs K, Hedman K, et al. Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19. PLoS One 2020 (published online Nov 23)

Yusuf I, Sarkinfada F. Gaps in the implementation of COVID-19 mitigation measures could lead to development of new strains of antimicrobial resistant pathogens: Nigerian perspective. Pan Afr Med J 2021 (published online Sep 3)

Zalona Fernandes HM, Mastrobuono G, Costa Conceição E, et al. COVID-19 treatment versus mycobacterial infections: better safe than sorry? Infect Control Hosp Epidemiol 2021 (published online Mar 19)

Zamora Cintas MI, Jiménez López D, Collazos Blanco A, et al. Coinfections among hospitalized patients with COVID-19 in the first pandemic wave. Diagn Microbiol Infect Dis 2021 (published online May 7)

Zeitoun M, Abu-Sittah G, Abu Shomar R, et al. AMR and Covid-19 on the frontline: a call to rethink war, WASH, and public health. Ann Glob Health 2021 (published online Feb 24)

Zembles TN, MacBrayne CE, Mitchell ML, et al. Lessons learned from virtual handshake stewardship during a pandemic. Jt Comm J Qual Saf 2020 (published online Oct 24)

Zhang A, Hobman EV, De Barro P, et al. Self-medication with antibiotics for protection against COVID-19: the role of psychological distress, knowledge of, and experiences with antibiotics. Antibiotics (Basel) 2021 (published online Feb 25)

Zhang D, Acree ME, Ridgway JP, et al. Characterizing coinfection in children with COVID-19: a dual center retrospective analysis. Infect Control Hosp Epidemiol 2020 (published online Sep 23)

Zhang T, Shen X, Liu R, et al. The impact of COVID-19 on primary health care and antibiotic prescribing in rural China: qualitative study. BMC Health Serv Res 2021 (published online Oct 5)

Zhong H, Wang Y, Shi Z, et al. Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients. Cell Discov 2021 (published online Apr 13)

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 (published online Mar 11)

Zhu N, Aylin P, Rawson T, et al. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect 2021 (published online Feb 15)

Zhu NJ, McLeod M, McNulty CAM, et al. Trends in antibiotic prescribing in out-of-hours primary care in England from January 2016 to June 2020 to understand behaviours during the first wave of COVID-19. Antibiotics (Basel) 2021 (published online Jan 1)

Zhu N, Rawson TM, Mookerjee S, et al. Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage. Clin Infect Dis 2021 (published online Oct 1)

Zia M, Goli M. Predisposing factors of important invasive fungal coinfections in COVID-19 patients: a review article. J Int Med Res 2021 (published online Sep 8)

Zubair Hussain A, Paudyal V, Hadi MA. Impact of the COVID-19 pandemic on the prescribing patterns of first-line antibiotics in English primary care: a longitudinal analysis of national prescribing dataset. Antibiotics (Basel) 2021 (published online May 17)

Research Hubs

Websites and databases that bring together available information, tools, literature, and resources on the links between COVID-19, antibiotic use, secondary bacterial and fungal infections, and antimicrobial resistance

Co-Infection and Antimicrobial Stewardship (COVID-19 Real-Time Learning Network) - The resource hub reviews select key literature evaluating the incidence of bacterial and fungal coinfections, as well as antimicrobial use in patients with COVID-19, focusing on the largest studies and those with the highest level of evidence and most generalizable results.

COVID-19 and antimicrobial resistance (London School of Hygiene & Tropical Medicine Antimicrobial Resistance Centre) - The resource hub lists online resources, opinion pieces, and publications available on AMR and COVID-19.

COVID-19 and Aspergillus Co-infections (University of Exeter MRC Centre for Medical Mycology) - The resource hub highlights key developments in research and clinical observations related to COVID-19, pulmonary aspergillosis, and mucormycosis.

The Global Nexus for Pandemics and Biological Threats - On Sep 1, 2020, McMaster University announced that it will launch an international and interdisciplinary network of experts devoted to preventing future pandemics and mitigating global health threats like antimicrobial resistance.

Secondary infections, antibiotic chemotherapy and antibiotic resistance in the context of COVID-19 (Liverpool School for Tropical Medicine) - The resource hub compiles details of peer-reviewed publications, preprints, other resources, blog posts, and commentaries on the role of secondary infections, antibiotic use, and antimicrobial resistance in the care of COVID-19 patients.

Toronto Antimicrobial Resistance Research Network (University of Toronto) - TARRN is carrying out a living systematic review and meta-analysis on bacterial co-infection and secondary infection in patients with COVID-19.

OUR UNDERWRITERS

Grant support for ASP provided by


bioMérieux 

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'BDSpeeDx
Become an underwriter»